🏷

Classifications

ISDS Skeletal Nosology

📘

Definitions

1

Minimum diagnostic criteria (Tasse)

The commonly applied minimum diagnostic criteria for the spectrum require either isolated microtia, or preauricular tags in association with hemifacial microsomia. Diagnosis is clinical; no molecular test defines the condition, and OMENS/OMENS-plus and Pruzansky-Kaban are severity classifications rather than binary diagnostic criteria.

DIAGNOSTIC_CRITERIA

Show evidence (2 references)

PMID:35015423 SUPPORT Other

"The minimum diagnostic criteria proposed by Tasse et al include either isolated microtia or preauricular tags associated with hemifacial microsomia."

States the operational minimum diagnostic criteria. Evidence source is OTHER because this is a clinical review chapter.

PMID:20301754 SUPPORT Human Clinical

"The diagnosis of CFM is based on clinical findings."

GeneReviews confirms the diagnosis is clinical.

👪

Inheritance

3

Sporadic occurrence HP:0003745

The great majority of craniofacial microsomia occurs as a simplex (sporadic) case with no identified cause, and recurrence risk counselling is empiric rather than Mendelian, roughly 2%-3% for sibs of a proband with no family history. This is the sharpest practical distinction from the monogenic craniofacial dysostoses such as Treacher Collins syndrome.

Sporadic

Show evidence (2 references)

PMID:20301754 SUPPORT Human Clinical

"CFM most frequently occurs as a simplex case (i.e., occurrence in a single individual in a family) with unknown etiology; recurrence risks are empiric."

GeneReviews establishes sporadic, aetiologically unexplained occurrence as the rule in craniofacial microsomia.

PMID:20301754 SUPPORT Human Clinical

"the risk to sibs is 2%-3%, although this may be an underestimate because of low penetrance and the difficulty of obtaining an accurate family history for some of the subtle features of CFM"

Gives the empiric sib recurrence risk and flags low penetrance as a reason it may be underestimated.

Autosomal dominant inheritance with reduced penetrance HP:0000006

In the minority of families with an identified monogenic cause, notably FOXI3, transmission is most often autosomal dominant with markedly reduced penetrance, so that pathogenic variants are frequently inherited from clinically unaffected parents.

Autosomal dominant inheritance

Show evidence (1 reference)

PMID:37041148 SUPPORT Human Clinical

"The penetrance of the likely pathogenic variants in the seemingly dominant form is reduced, since a considerable number of such variants in affected individuals were inherited from non-affected parents."

Documents dominant transmission with substantially reduced penetrance in FOXI3-related craniofacial microsomia.

Autosomal recessive inheritance HP:0000007

A subset of FOXI3-related pedigrees is compatible with autosomal recessive inheritance, and occasional recessive families are noted in the broader clinical literature.

Autosomal recessive inheritance

Show evidence (1 reference)

PMID:37041148 SUPPORT Human Clinical

"Our findings indicate autosomal dominant inheritance with reduced penetrance, and/or autosomal recessive inheritance."

States both dominant-reduced-penetrance and recessive transmission for the FOXI3 form.

◆

Subtypes

4

Hemifacial Microsomia (classic unilateral form)

The classic and most common presentation: unilateral hypoplasia of the mandibular ramus and condyle, external and middle ear, facial nerve, and soft tissue, without the ocular and vertebral features that define the Goldenhar variant. Left- and right-sided involvement occur at broadly similar rates.

Show evidence (1 reference)

PMID:12621170 SUPPORT Human Clinical

"there were 31 (48 percent) with right-sided microsomia, 25 (38 percent) with left-sided microsomia, and nine (14 percent) with bilateral microsomia"

Quantifies the laterality distribution in a craniofacial-unit cohort, establishing unilateral involvement as the dominant presentation.

Goldenhar Syndrome / Oculo-Auriculo-Vertebral Spectrum

The variant of the spectrum in which the craniofacial microsomia phenotype is accompanied by epibulbar dermoids or lipodermoids and by vertebral anomalies, together with more frequent multisystem (cardiac, renal, central nervous system) involvement. Goldenhar syndrome is not a genetically distinct entity but the more extensively affected end of the same aetiological continuum, which is why MONDO treats the names as synonyms of a single disease term.

Show evidence (1 reference)

PMID:35015423 SUPPORT Other

"Multisystem involvement frequently includes the central nervous system, heart, kidneys, and skeletal system, distinguishing it from isolated hemifacial microsomia."

Distinguishes the multisystem oculo-auriculo-vertebral presentation from the more restricted hemifacial microsomia phenotype. Evidence source is OTHER because this is a clinical review chapter rather than a primary study.

Bilateral Craniofacial Microsomia

A minority of individuals have bilateral involvement, which remains asymmetric in degree rather than symmetric as in Treacher Collins syndrome. Bilateral disease carries a substantially higher risk of upper airway obstruction and feeding compromise.

Show evidence (1 reference)

PMID:20301754 SUPPORT Human Clinical

"bilateral involvement (typically asymmetric), microtia/anotia with atresia of the ear canals, microphthalmia, and respiratory compromise from severe mandibular hypoplasia"

GeneReviews documents that bilateral craniofacial microsomia is characteristically asymmetric and associated with respiratory compromise.

Isolated Microtia (mildest end of the spectrum)

Isolated microtia, with or without aural atresia and without demonstrable mandibular or soft-tissue deficiency, is widely regarded as the mildest expression of the craniofacial microsomia spectrum rather than a separate condition; families segregating FOXI3 variants may contain both isolated microtia and full craniofacial microsomia.

Show evidence (1 reference)

PMID:36260083 SUPPORT Human Clinical

"Craniofacial microsomia (CFM) represents a spectrum of craniofacial malformations, ranging from isolated microtia with or without aural atresia to underdevelopment of the mandible, maxilla, orbit, facial soft tissue, and/or facial nerve."

Places isolated microtia explicitly at the mild end of the same craniofacial microsomia spectrum.

?

Discussions and Knowledge Gaps

2

Is embryonic vascular disruption a genuine cause of craniofacial microsomia, or a correlate of a primary neural-crest lesion?

KNOWLEDGE GAP OPEN CFM-GAP-001

Attached to

pathophysiology#Stapedial Artery Haemorrhage and Vascular Disruption

The stapedial-artery haemorrhage model has dominated thinking about craniofacial microsomia for fifty years and elegantly explains unilaterality and severity gradation, but the most recent systematic review found only eight qualifying studies and judged the evidence indirect and heterogeneous. The maternal risk factors that support it (diabetes, vasoactive medication, multiple gestation) are also compatible with a direct neural-crest insult, and maternal diabetes has an independently proposed neural-crest-migration mechanism. The GWAS finding that candidate loci are enriched for both neural crest development and vasculogenesis is consistent with either ordering. Distinguishing a primary vascular cause from a primary neural-crest cause matters because it determines whether prevention should target perfusion or crest biology.

Proposed experiments

Prospective vascular imaging of affected versus unaffected side

CFM-EXP-001

High-resolution magnetic resonance angiography of both sides of the face in a prospective craniofacial microsomia cohort, testing whether regional arterial attenuation is present in individuals without skeletal deficiency and whether its severity tracks the OMENS mandible score.

Supporting outcome

Arterial attenuation grading with mandibular deficiency would support a primary vascular mechanism.

Refuting outcome

Absence of any consistent regional arterial abnormality in severely affected individuals would argue for a primary neural-crest lesion.

Human embryonic specimen correlation of stapedial artery regression

CFM-EXP-002

Staged human embryonic and fetal specimen studies correlating the timing of stapedial artery regression with first- and second-arch mesenchymal volume, establishing whether the vascular event precedes the mesenchymal shortfall.

Pathway-stratified genomic analysis by laterality

CFM-EXP-003

Integrated genomic analysis testing whether rare-variant burden in vascular-development versus neural-crest pathways segregates with unilateral versus bilateral presentations.

Show evidence (1 reference)

PMID:42322171 SUPPORT Human Clinical

"Further studies integrating genomic analyses, developmental models, and detailed vascular imaging are needed to clarify the role of vascular mechanisms in craniofacial microsomia."

The systematic review explicitly frames this as an unresolved question and names the study designs needed to settle it.

Why do the great majority of craniofacial microsomia cases still lack any identified molecular cause?

KNOWLEDGE GAP OPEN CFM-GAP-002

Attached to

pathophysiology#Monogenic and Copy-Number Contributions in a Minority of Cases

Even with SF3B2 and FOXI3 established, identified monogenic causes account for only a small minority of cases, and MYT1 remains presumptive. The reduced penetrance seen in FOXI3 families, and the observation that variants are frequently inherited from unaffected parents, suggest that oligogenic interaction, modifier alleles, somatic mosaicism, or gene-environment interaction with perfusion-related exposures may be needed to explain expression. The lack of a refined affected phenotype definition also dilutes genetic association power.

Proposed experiments

Somatic mosaicism screen in affected craniofacial tissue

CFM-EXP-004

Deep sequencing of surgically resected affected craniofacial tissue paired with blood, testing whether post-zygotic mosaic variants explain sporadic, unilateral disease that is invisible to germline sequencing.

Supporting outcome

Recovery of tissue-restricted pathogenic variants absent from blood would explain both sporadicity and unilaterality.

Trans-modifier analysis of FOXI3 penetrance

CFM-EXP-005

Family-based studies quantifying whether common FOXI3 variation in trans with a pathogenic allele modifies penetrance and phenotypic severity, as suggested by existing cohort data.

Gene-environment interaction analysis

CFM-EXP-006

Population-based analysis combining genotype at established and candidate loci with maternal diabetes and other perfusion-related exposures, testing for interaction rather than independent main effects.

Show evidence (1 reference)

PMID:37041148 SUPPORT Human Clinical

"The inheritance pattern is controversial, and the molecular etiology of this syndrome is largely unknown."

States directly that inheritance and molecular aetiology remain unresolved for the condition as a whole.

⚙

Pathophysiology

7

Heterogeneous Insult to First and Second Pharyngeal Arch Development

An aetiologically heterogeneous insult during roughly the first six weeks of gestation compromises the cranial neural crest cells that populate the first (mandibular) and second (hyoid) pharyngeal arches, or the vascular and mesenchymal environment those cells depend on. Unlike the single-gene craniofacial dysostoses, no one lesion accounts for most cases: vascular disruption, teratogenic and maternal-metabolic exposure, polygenic susceptibility, and a minority of monogenic or copy-number variants all converge on the same arch territory. The unilateral, asymmetric expression of the resulting phenotype reflects a stochastic, regionally restricted insult rather than a systemic genetic programme failure. This is the disorder-specific substitution at the module trigger node: where Treacher Collins syndrome substitutes a germline ribosome-biogenesis defect, craniofacial microsomia substitutes a multifactorial, regionally restricted insult, while the SF3B2 subset substitutes a spliceosome defect closely analogous to the EFTUD2/SF3B4 mandibulofacial dysostoses the module already covers.

Cranial neural crest cell CL:0000333

Neural crest cell development GO:0014032 ⚠ ABNORMAL

pharyngeal arch UBERON:0002539

Downstream

Deficient Neural-Crest-Derived Skeletogenic Mesenchyme in the First and Second Arches Loss or misdirection of the cranial neural crest population depletes the skeletogenic mesenchyme that would otherwise form the arch skeleton.

Show evidence (3 references)

PMID:17651128 SUPPORT Other

"Etiological factors are clearly heterogeneous, the investigation of which is confounded by not only the lack of a refined affected phenotype, but also the apparent influence of genetic factors in some instances"

Establishes aetiological heterogeneity as the defining feature of the craniofacial microsomia trigger. Evidence source is OTHER because this is a narrative review.

PMID:26853712 SUPPORT Human Clinical

"Popular assumptions for the pathogenesis of CFM include neural crest cell (NCC) disturbance and vascular disruption"

Names the two candidate trigger mechanisms, neural crest disturbance and vascular disruption, that this entry models as parallel upstream arms.

PMID:33136839 SUPPORT Other

"the latest reports indicate the prominence of premature loss of the neural crest cells"

Identifies premature neural crest cell loss as the converging cellular lesion. Evidence source is OTHER because this is a review synthesising primary literature.

Stapedial Artery Haemorrhage and Vascular Disruption

The classic pathogenic model proposes a focal haemorrhage from the developing stapedial artery, the transient embryonic vessel supplying the first and second pharyngeal arch territory. An expanding haematoma destroys or displaces differentiating arch mesenchyme, and the extent and timing of the bleed determine which arch derivatives are lost and how severely, explaining the unilateral distribution and the wide severity range of the phenotype. Contemporary systematic review finds the supporting evidence indirect but consistent, and places vascular disruption within a broader multifactorial framework rather than treating it as a sufficient explanation. Notably, the craniofacial microsomia GWAS loci are enriched for vasculogenesis as well as neural crest genes, so the vascular and neural-crest arms are convergent rather than competing.

Endothelial cell CL:0000115

Blood vessel development GO:0001568 ⚠ ABNORMAL

Downstream

Deficient Neural-Crest-Derived Skeletogenic Mesenchyme in the First and Second Arches Haematoma expansion within the arch territory destroys differentiating mesenchyme and interrupts its perfusion, leaving a regional shortfall of skeletogenic precursor.

Show evidence (4 references)

PMID:42322171 SUPPORT Human Clinical

"Disturbances in embryonic vascular development have long been proposed as a potential mechanism contributing to the characteristic unilateral craniofacial phenotype."

States the vascular-disruption hypothesis and ties it specifically to the unilateral phenotype that distinguishes craniofacial microsomia.

PMID:42322171 SUPPORT Human Clinical

"The available evidence is consistent with a possible contribution of disturbances in vascular development to the pathogenesis of hemifacial microsomia, particularly in unilateral presentations. However, current evidence remains indirect and heterogeneous."

Deliberately recorded as PARTIAL: the systematic review supports a vascular contribution but states that the evidence remains indirect, so this node should not be read as an established mechanism.

PMID:42322171 SUPPORT Human Clinical

"Clinical and radiological observations described regional vascular abnormalities, including carotid artery attenuation."

Provides the direct radiological observation of regional vascular abnormality in affected individuals.

+ 1 more reference

Teratogenic and Maternal-Environmental Disruption

Teratogenic and maternal-metabolic exposures during arch morphogenesis reproduce or predispose to the phenotype. Maternal pregestational and gestational diabetes is the best-replicated risk factor, and vasoactive medication exposure, multiple gestation, higher parity, and second-trimester vaginal bleeding have all been associated with craniofacial microsomia. Retinoic acid and thalidomide embryopathy are the classic pharmacological phenocopies, both acting on cranial neural crest survival and on the embryonic vasculature, but a documented exposure is absent in the great majority of cases and these agents should not be equated with idiopathic craniofacial microsomia. These exposures act on the same neural-crest and vascular substrate as the vascular-disruption model rather than through a separate pathway.

Neural crest cell migration GO:0001755 ⚠ ABNORMAL

Downstream

Deficient Neural-Crest-Derived Skeletogenic Mesenchyme in the First and Second Arches Teratogen- and hyperglycaemia-induced impairment of cranial neural crest migration and survival reduces the skeletogenic mesenchyme delivered to the arches.

Show evidence (3 references)

PMID:30927385 SUPPORT Human Clinical

"We found a statistically significant association between diabetes mellitus (DM) and CFM (OR 4.01, 95% CI 1.6-10.5)."

Case-control quantification of the maternal diabetes association with craniofacial microsomia.

PMID:12410187 SUPPORT Human Clinical

"noting that most of these defects occur in structures of neural crest origin, we hypothesize that poorly controlled maternal diabetes interferes with cephalic neural crest cell migration"

Provides the proposed mechanism by which maternal diabetes acts, namely interference with cephalic neural crest migration, linking this arm to the shared effector node.

PMID:42322171 SUPPORT Human Clinical

"Epidemiological studies identified associations between HFM and maternal factors potentially affecting embryonic perfusion, including vasoactive medication exposure, maternal diabetes, multiple gestations, and second-trimester vaginal bleeding."

Enumerates the maternal exposures associated with craniofacial microsomia and frames them as acting through embryonic perfusion.

Monogenic and Copy-Number Contributions in a Minority of Cases

A minority of individuals with craniofacial microsomia carry a defined genetic cause. Two genes are well supported. SF3B2 haploinsufficiency, a component of the U2 small nuclear ribonucleoprotein complex, shows a highly significant loss-of-function burden in sequenced kindreds and disrupts cranial neural crest precursor formation in Xenopus; this places craniofacial microsomia alongside the EFTUD2 and SF3B4 spliceosomopathies as a neural-crest spliceosome disorder. Pathogenic variants in FOXI3, a forkhead transcription factor regulating ectodermal and neural crest development, are found in roughly 1%-3% of unselected cases and are substantially enriched among familial cases. Rare variants in MYT1 have been reported in several unrelated individuals but remain presumptive. Pathogenic copy-number variants and chromosomal rearrangements account for additional cases without a single recurrent lesion. This genetic minority sits inside an overwhelmingly sporadic condition, which is why recurrence-risk counselling differs sharply from that of the monogenic craniofacial dysostoses.

Embryonic cranial skeleton morphogenesis GO:0048701 ⚠ ABNORMAL mRNA splicing, via spliceosome GO:0000398 ⚠ ABNORMAL

Downstream

Deficient Neural-Crest-Derived Skeletogenic Mesenchyme in the First and Second Arches SF3B2 haploinsufficiency and FOXI3 dosage deficiency disrupt formation of the cranial neural crest precursors that supply arch mesenchyme, a step demonstrated experimentally for SF3B2.

Show evidence (3 references)

PMID:34344887 SUPPORT Human Clinical

"identifying a highly significant burden of loss of function variants in SF3B2 (P = 3.8 × 10-10), a component of the U2 small nuclear ribonucleoprotein complex, in probands"

Establishes SF3B2 haploinsufficiency as a statistically robust monogenic cause and identifies the spliceosome as the affected machinery.

PMID:36260083 SUPPORT Human Clinical

"Damaging variants in FOXI3 are the second most frequent genetic cause of CFM, causing 1% of all cases, including 13% of familial cases in our cohort."

Quantifies the monogenic FOXI3 contribution and its enrichment in familial cases, defining the size of the genetic minority.

PMID:36260083 SUPPORT Human Clinical

"The genetic causes of CFM remain largely unknown."

Confirms that identified monogenic causes explain only a small fraction of craniofacial microsomia, supporting the framing of this node as a minority mechanism.

Deficient Neural-Crest-Derived Skeletogenic Mesenchyme in the First and Second Arches

Whatever the upstream insult, the shared effector step is a regional shortfall of neural-crest-derived skeletogenic mesenchyme in the first and second pharyngeal arches on the affected side. Because this mesenchyme is the common precursor of the mandible and Meckel cartilage, the malleus and incus, the external ear, and the associated muscles and soft tissue, its regional depletion produces a coordinated deficiency across all of these developmentally related elements rather than an isolated bone defect. Deficiency of the masticatory musculature is itself part of the mechanism, contributing to mandibular underdevelopment through reduced functional loading rather than merely accompanying it.

Neural crest cell CL:0011012 Chondrocyte CL:0000138

Embryonic skeletal system morphogenesis GO:0048704 ⚠ ABNORMAL

pharyngeal arch UBERON:0002539

Downstream

Asymmetric Hypoplasia of First- and Second-Arch Derivatives Reduced skeletogenic mesenchyme on the affected side yields hypoplastic arch derivatives across the whole set of elements it would have built.

Show evidence (3 references)

PMID:34344887 SUPPORT Model Organism

"supporting a link between spliceosome mutations and impaired neural crest development in congenital craniofacial disease"

Experimental confirmation that impaired neural crest development is the effector step linking a craniofacial microsomia genotype to the craniofacial phenotype.

PMID:33136839 SUPPORT Other

"a deficit of muscles of mastication, except the masseter, correlates in the pathomechanism of mandibular underdevelopment"

Documents the masticatory-muscle deficit as a contributor to mandibular underdevelopment, not merely a coincident soft-tissue finding. Evidence source is OTHER because this is a review article.

PMID:36260083 SUPPORT Human Clinical

"FOXI3, a regulator of ectodermal and neural crest development"

Confirms that the best-established craniofacial microsomia transcription factor acts on neural crest development, the shared effector substrate of this node.

Asymmetric Hypoplasia of First- and Second-Arch Derivatives

The arch derivatives are built by a shared, serially reused neural-crest programme, so the malformation recurs across arch elements as a bundle: the mandibular ramus and condyle, the external and middle ear, the facial nerve and its target musculature, the orbit, and the overlying soft tissue are affected together. This bundle is precisely what the OMENS classification scores (Orbit, Mandible, Ear, Nerve, Soft tissue), with OMENS-plus adding extracraniofacial anomalies. The decisive contrast with Treacher Collins syndrome is laterality and aetiology rather than the element set: a single germline ribosomopathy affects both sides equally and symmetrically, whereas the regionally restricted, stochastic insult of craniofacial microsomia produces a predominantly unilateral, asymmetric deficiency, bilateral in a minority and then still asymmetric in degree. Both disorders nevertheless conform to the same module node, which is the point: the serially homologous craniofacial bundle is a property of the shared arch programme, not of any one aetiology.

Osteoblast CL:0000062 Chondrocyte CL:0000138

Face morphogenesis GO:0060325 ⚠ ABNORMAL Embryonic cranial skeleton morphogenesis GO:0048701 ⚠ ABNORMAL

Downstream

Facial Asymmetry Deficient arch derivatives on one side produce clinical facial asymmetry.

Mandibular Hypoplasia Hypoplasia of the neural-crest-derived mandibular skeleton on the affected side.

Mandibular Condyle Hypoplasia The condyle and temporomandibular joint are the most severely affected mandibular elements, and grade the Pruzansky-Kaban mandibular score.

Microtia Deficiency of the first- and second-arch hillocks of His that form the auricle produces microtia or anotia.

Preauricular Skin Tags Accessory cartilage-bearing tags arise in the first branchial groove region.

External Auditory Canal Atresia Failure of canalisation of the first branchial cleft gives aural atresia or stenosis.

Conductive Hearing Loss Ossicular malformation (the malleus and incus are first- and second-arch derivatives) together with canal atresia impairs sound conduction.

Facial Nerve Weakness The facial nerve is the second-arch cranial nerve, and its hypoplasia or aberrant course accompanies second-arch deficiency.

Soft Tissue Deficiency Masticatory muscle, parotid, and subcutaneous deficiency follows from the same regional mesenchymal shortfall.

Microphthalmia Orbital involvement at the severe end of the spectrum includes reduced globe size, the O component of OMENS.

Epibulbar Dermoid Ocular choristoma of neural-crest-derived periocular mesenchyme, the hallmark of the Goldenhar variant.

Macrostomia Failure of fusion of the maxillary and mandibular processes of the first arch widens the oral commissure.

Cleft Lip and Palate Clefting of the lip and/or palate arises from the same first-arch mesenchymal deficiency.

Vertebral Anomalies Extracraniofacial vertebral segmentation defects are the commonest OMENS-plus anomaly, presumably reflecting a broader neural-crest and paraxial-mesoderm insult whose intermediates are not established.

Central Nervous System Anomalies Structural central nervous system anomalies occur as part of the OMENS-plus burden; the spinal cord component travels with the vertebral anomalies, but the intermediates linking the arch insult to hydrocephaly, ventriculomegaly, and Chiari malformation are not established.

Cardiac Anomalies Congenital heart defects, dependent in part on cardiac neural crest, are the second commonest OMENS-plus anomaly.

Urogenital Anomalies Urogenital malformations occur as part of the OMENS-plus burden.

Limb Anomalies Upper and lower limb anomalies occur as OMENS-plus anomalies by mechanisms that are not established.

Radial Ray Hypoplasia Radial ray hypoplasia is the classic limb pattern of the spectrum and defines the oculo-auriculo-vertebral spectrum with radial defects variant; its mechanistic link to the arch insult is not established.

Airway and Feeding Compromise from Mandibular Deficiency Severe mandibular deficiency mechanically narrows the pharyngeal airway, the principal functional consequence of the arch-derivative bundle.

Show evidence (4 references)

PMID:20301754 SUPPORT Human Clinical

"Characteristic findings include facial asymmetry resulting from maxillary and/or mandibular hypoplasia; preauricular or facial tags; ear malformations that can include microtia (hypoplasia of the external ear), anotia (absence of the external ear), or aural atresia (absence of the external ear..."

GeneReviews enumerates the serially homologous bundle of first- and second-arch derivative anomalies that travel together in craniofacial microsomia.

PMID:34344887 SUPPORT Human Clinical

"Probands display mandibular hypoplasia, microtia, facial and preauricular tags, epibulbar dermoids, lateral oral clefts in addition to skeletal and cardiac abnormalities."

Shows the full multi-element bundle co-occurring in a single molecularly defined subset, the clearest demonstration that one lesion produces the whole serially homologous set.

PMID:12621170 SUPPORT Human Clinical

"the most recent systems that grade each anatomical component separately, such as the Orbit, Mandible, Ear, Nerve, and Soft tissue (OMENS) system"

Defines the OMENS framework, which scores each element of the arch-derived bundle separately, operationalising the serially homologous phenotype.

+ 1 more reference

Airway and Feeding Compromise from Mandibular Deficiency

Severe mandibular ramus and condylar deficiency retropositions the tongue base and narrows the pharyngeal airway, producing upper airway obstruction and obstructive sleep apnoea, together with dysphagia and aspiration risk. Risk tracks the severity of the mandibular and orbital OMENS components and is greatest in bilateral disease; the most severely affected infants require tracheostomy or early mandibular distraction. This is the principal functional, as opposed to aesthetic, consequence of the arch-derivative bundle and drives the timing of surgical intervention.

Downstream

Obstructive Sleep Apnea Retropositioned mandible and tongue base narrow the pharyngeal airway during sleep.

Show evidence (2 references)

PMID:9915160 SUPPORT Human Clinical

"Patients with more severe mandibular and orbital deformities, but not ear or vertebral abnormalities, appear at a greater risk for obstructive sleep apnea."

Establishes that airway risk is driven specifically by the mandibular and orbital components of the OMENS score.

PMID:20301754 SUPPORT Human Clinical

"respiratory compromise from severe mandibular hypoplasia"

GeneReviews confirms respiratory compromise as a consequence of severe mandibular hypoplasia.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

20

Cardiovascular 1

Cardiac Anomalies OCCASIONAL Abnormal heart morphology HP:0001627

Show evidence (2 references)

PMID:30878275 SUPPORT Human Clinical

"vertebral 28%, central nervous system 11%, circulatory system 21%, respiratory tract 3%"

Gives 21% for circulatory-system anomalies in a 991-patient multicentre cohort, supporting the OCCASIONAL band.

PMID:30878275 SUPPORT Human Clinical

"patent ductus arteriosus, and anomalies of the valves"

Full-text lesion breakdown for the same cohort, naming the cardiac lesions actually most often observed. Cited in place of the unsupported conotruncal-predominance claim previously asserted in the description.

Ear 2

Conductive Hearing Loss FREQUENT Conductive hearing impairment HP:0000405

Show evidence (2 references)

PMID:20301754 SUPPORT Human Clinical

"or aural atresia (absence of the external ear canal); and hearing loss"

GeneReviews lists hearing loss among the characteristic findings.

PMID:12410187 SUPPORT Human Clinical

"46.7% (14) had hearing loss"

Provides a quantitative frequency in an oculo-auriculo-vertebral case series, supporting the FREQUENT (30-79%) band.

External Auditory Canal Atresia FREQUENT Atresia of the external auditory canal HP:0000413

Show evidence (1 reference)

PMID:36260083 SUPPORT Human Clinical

"ranging from isolated microtia with or without aural atresia"

Documents aural atresia as a component of the craniofacial microsomia spectrum.

Eye 2

Epibulbar Dermoid Limbal dermoid HP:0001140

Show evidence (2 references)

PMID:35015423 SUPPORT Other

"Typical phenotypes include microtia, facial asymmetry, and epibulbar dermoid or lipodermoid."

Identifies epibulbar dermoid as a typical phenotype of the oculo-auriculo-vertebral variant. Evidence source is OTHER because this is a clinical review chapter.

PMID:34344887 SUPPORT Human Clinical

"Probands display mandibular hypoplasia, microtia, facial and preauricular tags, epibulbar dermoids, lateral oral clefts"

Confirms epibulbar dermoids in a molecularly defined craniofacial microsomia cohort.

Microphthalmia OCCASIONAL HP:0000568

Show evidence (1 reference)

PMID:33136839 SUPPORT Other

"as microtia/anotia with conductive type hearing loss, hypoplastic mandible, and microphthalmia, impairing patient's daily activities"

Places microphthalmia at the severe end of the phenotypic range. Evidence source is OTHER because this is a review article.

Genitourinary 1

Urogenital Anomalies OCCASIONAL Abnormality of the genitourinary system HP:0000119

Show evidence (2 references)

PMID:30878275 SUPPORT Human Clinical

"gastrointestinal tract 9%, and urogenital tract 11%"

Gives 11% for urogenital anomalies as a whole in a 991-patient multicentre cohort, supporting the OCCASIONAL band at the genitourinary-system level.

PMID:30878275 SUPPORT Human Clinical

"Mainly, renal aplasia, undescended testis, and hydronephrosis were observed."

Full-text lesion breakdown confirming that the 11% figure spans renal, genital, and urinary-tract anomalies rather than renal agenesis alone, which is why the broader genitourinary term is used.

Head and Neck 5

Facial Asymmetry VERY_FREQUENT HP:0000324

Show evidence (1 reference)

PMID:20301754 SUPPORT Human Clinical

"Characteristic findings include facial asymmetry resulting from maxillary and/or mandibular hypoplasia"

GeneReviews lists facial asymmetry as a characteristic finding, supporting the VERY_FREQUENT band for a feature described as characteristic of the condition.

Mandibular Hypoplasia VERY_FREQUENT Micrognathia HP:0000347

Show evidence (1 reference)

PMID:32871052 SUPPORT Human Clinical

"comprises a variable phenotype with the most common features including microtia and mandibular hypoplasia on one or both sides"

Identifies mandibular hypoplasia as one of the two most common features of the spectrum, supporting the VERY_FREQUENT band.

Facial Nerve Weakness OCCASIONAL Facial palsy HP:0010628

Show evidence (1 reference)

PMID:12621170 SUPPORT Human Clinical

"normal facial nerve (76 percent)"

Implies facial nerve involvement in about 24% of a scored cohort, supporting the OCCASIONAL (5-29%) band.

Macrostomia Wide mouth HP:0000154

Show evidence (1 reference)

PMID:32871052 SUPPORT Human Clinical

"in addition to lateral oral clefts, epibulbar dermoids, cardiac, vertebral, and renal abnormalities"

Lists lateral oral clefting (macrostomia) among the recognised features of the craniofacial microsomia spectrum.

Cleft Lip and Palate OCCASIONAL Orofacial cleft HP:0000202

Show evidence (1 reference)

PMID:20301754 SUPPORT Human Clinical

"Other craniofacial malformations including cleft lip and/or palate can be seen."

GeneReviews documents cleft lip and/or palate as an additional craniofacial malformation, phrased as "can be seen" and therefore mapped to OCCASIONAL.

Limbs 1

Radial Ray Hypoplasia OCCASIONAL Hypoplasia of the radius HP:0002984

Show evidence (1 reference)

PMID:12410187 SUPPORT Human Clinical

"13.3% (4) had limb defects (all radial ray hypoplasia)"

Identifies radial ray hypoplasia as the exclusive limb pattern in an oculo-auriculo-vertebral case series, at 13.3%, which supports the OCCASIONAL (5-29%) band for this radius-specific term.

Nervous System 1

Obstructive Sleep Apnea FREQUENT HP:0002870

Show evidence (1 reference)

PMID:9915160 SUPPORT Human Clinical

"group II (n = 7, 18 percent) had a medical history suspect for intermittent obstructive sleep apnea or had a perioperative apneic event; and group III (n = 9, 24 percent) had a definite history of obstructive sleep apnea or upper airway obstruction requiring tracheotomy or apnea surgery"

Together the suspected and definite airway groups comprise 42% of the cohort, supporting the FREQUENT (30-79%) band.

Other 7

Mandibular Condyle Hypoplasia FREQUENT HP:0007628

Show evidence (1 reference)

PMID:12621170 SUPPORT Human Clinical

"mildly hypoplastic mandibular ramus-condyle with functioning temporomandibular joint (57 percent with type M1 or M2a)"

Quantifies condylar involvement in a scored cohort, supporting the FREQUENT band for milder condylar hypoplasia.

Microtia VERY_FREQUENT HP:0008551

Show evidence (2 references)

PMID:20301754 SUPPORT Human Clinical

"ear malformations that can include microtia (hypoplasia of the external ear), anotia (absence of the external ear), or aural atresia (absence of the external ear canal)"

GeneReviews lists microtia among the characteristic findings.

PMID:32871052 SUPPORT Human Clinical

"the most common features including microtia and mandibular hypoplasia on one or both sides"

Identifies microtia as one of the two most common features, supporting the VERY_FREQUENT band.

Preauricular Skin Tags FREQUENT HP:0000384

Show evidence (2 references)

PMID:20301754 SUPPORT Human Clinical

"preauricular or facial tags"

GeneReviews lists preauricular and facial tags as characteristic findings.

PMID:35015423 SUPPORT Other

"The minimum diagnostic criteria proposed by Tasse et al include either isolated microtia or preauricular tags associated with hemifacial microsomia."

Shows preauricular tags are diagnostically central to the spectrum. Evidence source is OTHER because this is a clinical review chapter.

Soft Tissue Deficiency VERY_FREQUENT Abnormality of facial soft tissue HP:0011799

Show evidence (1 reference)

PMID:12621170 SUPPORT Human Clinical

"mild soft-tissue hypoplasia (73 percent)"

Documents soft-tissue hypoplasia scored in the great majority of a craniofacial-unit cohort.

Vertebral Anomalies OCCASIONAL Vertebral segmentation defect HP:0003422

Show evidence (1 reference)

PMID:30878275 SUPPORT Human Clinical

"The prevalence of extracraniofacial anomalies in the various tracts was as follows: vertebral 28%, central nervous system 11%, circulatory system 21%, respiratory tract 3%, gastrointestinal tract 9%, and urogenital tract 11%."

Multicentre cohort of 991 patients gives 28% for vertebral anomalies, placing this in the OCCASIONAL (5-29%) band.

Central Nervous System Anomalies OCCASIONAL Morphological central nervous system abnormality HP:0002011

Show evidence (3 references)

PMID:30878275 SUPPORT Human Clinical

"vertebral 28%, central nervous system 11%, circulatory system 21%"

Gives 11% for central nervous system anomalies in a 991-patient multicentre cohort, supporting the OCCASIONAL (5-29%) band.

PMID:30878275 SUPPORT Human Clinical

"Hydrocephaly, ventriculomegaly, intracranial cysts, and Arnold Chiari malformation were mostly seen."

Full-text breakdown of the specific central nervous system lesions underlying the 11% figure.

PMID:30878275 SUPPORT Human Clinical

"such as spina bifida or tethered cord, 27 patients had vertebral anomalies too"

Documents the near-complete co-occurrence of spinal cord anomalies with vertebral anomalies in the same cohort.

Limb Anomalies OCCASIONAL Abnormality of limbs HP:0040064

Show evidence (2 references)

PMID:36729069 SUPPORT Human Clinical

"In total, 18.2% of the patients were diagnosed with at least one upper and/or lower limb anomaly. Upper and lower limb anomalies were seen in, respectively, 13.4% and 7.8% of patients."

Multicentre quantification of limb involvement of any kind, supporting the OCCASIONAL (5-29%) band at the limb-abnormality level. The 18.2% denominator is any upper and/or lower limb anomaly, so it is deliberately not attached to a radius-specific term; the radial-ray subset is curated separately below.

PMID:36729069 SUPPORT Human Clinical

"Laterality of CFM and a higher OMENS score were not associated with limb anomalies."

Supports the description's point that limb involvement does not track facial severity or laterality.

🧬

Genetic Associations

4

SF3B2

Gene: SF3B2 hgnc:10769 relationship_type: CAUSATIVE

Show evidence (3 references)

PMID:34344887 SUPPORT Human Clinical

"We perform whole-exome or genome sequencing of 146 kindreds with sporadic (n = 138) or familial (n = 8) CFM, identifying a highly significant burden of loss of function variants in SF3B2"

Statistical burden evidence in a sequenced cohort establishing SF3B2 as a craniofacial microsomia gene.

PMID:34344887 SUPPORT Human Clinical

"We describe twenty individuals from seven kindreds harboring de novo or transmitted haploinsufficient variants in SF3B2."

Describes the segregation pattern, including both de novo and transmitted haploinsufficient variants.

PMID:34344887 SUPPORT Model Organism

"Targeted morpholino knockdown of SF3B2 in Xenopus results in disruption of cranial neural crest precursor formation and subsequent craniofacial cartilage defects"

In vivo functional corroboration in Xenopus linking SF3B2 loss to cranial neural crest failure.

FOXI3

Gene: FOXI3 hgnc:35123 relationship_type: CAUSATIVE

Show evidence (5 references)

PMID:36260083 SUPPORT Human Clinical

"We studied a 5-generation kindred with microtia, identifying a missense variant in FOXI3 (p.Arg236Trp) as the cause of disease (logarithm of the odds = 3.33)."

Linkage evidence establishing FOXI3 causality in a large multigenerational microtia kindred.

PMID:36260083 SUPPORT In Vitro

"Missense variants in the nuclear localization sequence were identified in cases with isolated microtia with aural atresia and found to affect subcellular localization of FOXI3."

Functional in vitro demonstration that the missense variants mislocalise FOXI3, providing the molecular mechanism.

PMID:37041148 SUPPORT Model Organism

"Biochemical experiments on transcriptional activity and subcellular localization of the likely pathogenic FOXI3 variants, and knock-in mouse studies strongly support the involvement of FOXI3 in CFM."

Knock-in mouse modelling corroborates FOXI3 causality; classified as MODEL_ORGANISM for the in vivo component.

+ 2 more references

MYT1

Gene: MYT1 hgnc:7622 relationship_type: DISPUTED

Show evidence (2 references)

PMID:32871052 SUPPORT Human Clinical

"We identified two additional individuals with CFM who carry rare variants in MYT1, further supporting the presumptive role of this gene in the CFM spectrum."

Recorded as PARTIAL because the authors themselves describe the MYT1 role as presumptive rather than established.

PMID:32871052 SUPPORT Human Clinical

"The MYT1 gene has been reported as a candidate based in mutations found in three unrelated individuals."

Documents the prior candidate-gene evidence base for MYT1 in craniofacial microsomia.

EDNRB

Gene: EDNRB hgnc:3180 relationship_type: SUSCEPTIBILITY

Show evidence (2 references)

PMID:26853712 SUPPORT Human Clinical

"The above 13 associated loci, harboured by candidates of ROBO1, GATA3, GBX2, FGF3, NRP2, EDNRB, SHROOM3, SEMA7A, PLCD3, KLF12 and EPAS1, are found to be enriched for genes involved in neural crest cell (NCC) development and vasculogenesis."

Names EDNRB among the GWAS candidate loci and states the pathway enrichment that unifies the neural crest and vascular arms of this entry's pathograph.

PMID:26853712 SUPPORT Human Clinical

"Here we interrogate 0.9 million genetic variants in 939 CFM cases and 2,012 controls from China. After genotyping of an additional 443 cases and 1,669 controls, we identify 8 significantly associated loci"

Establishes the scale and design of the association study underpinning the susceptibility claim.

💊

Medical Actions

7

Multidisciplinary Craniofacial Team Care

Category: Therapeutic Action: multidisciplinary craniofacial team care Ontology label: Supportive Care NCIT:C15747

Coordinated, age-staged management by an experienced craniofacial team is the organising principle of care, because the interventions for airway, hearing, facial growth, and occlusion are time-sensitive and interdependent.

Show evidence (2 references)

PMID:20301754 SUPPORT Human Clinical

"children should be managed by an experienced multidisciplinary craniofacial team"

GeneReviews management recommendation.

PMID:20301754 SUPPORT Human Clinical

"The goals of treatment for CFM are to assure adequate respiratory support and feeding in infants with severe facial malformations, maximize hearing and communication, improve facial symmetry, and optimize dental occlusion."

States the four treatment goals that structure staged craniofacial team care.

Mandibular Distraction Osteogenesis

Category: Therapeutic Action: mandibular distraction osteogenesis Ontology label: Osteotomy NCIT:C51903

Gradual lengthening of the hypoplastic mandibular ramus by distraction osteogenesis, to relieve airway obstruction in infancy and to improve facial symmetry and occlusion later in childhood. It directly targets the mandibular (M) component of the arch-derivative bundle and its airway consequence.

Mechanism Target:

MODULATES Airway and Feeding Compromise from Mandibular Deficiency — Lengthening the deficient mandibular ramus advances the tongue base and enlarges the pharyngeal airway, directly relieving the mechanism that produces obstruction.

Show evidence (1 reference)

PMID:9915160 SUPPORT Human Clinical

"Patients with more severe mandibular and orbital deformities, but not ear or vertebral abnormalities, appear at a greater risk for obstructive sleep apnea."

Identifies mandibular deficiency as the airway-relevant target, providing the rationale for mandibular distraction in airway-compromised patients.

Auricular Reconstruction

Category: Therapeutic Action: staged auricular reconstruction Ontology label: Surgical Procedure NCIT:C15329

Staged surgical reconstruction of the microtic ear, using autologous costal cartilage or an alloplastic framework, typically deferred until adequate donor cartilage and ear growth are available.

Show evidence (1 reference)

PMID:20301754 SUPPORT Human Clinical

"Treatment is age-dependent, with time-sensitive interventions at appropriate stages of craniofacial growth and development."

Recorded as PARTIAL. GeneReviews supports the age-staged principle underlying deferred auricular reconstruction, but the abstract does not describe the specific technique.

Hearing Amplification and Audiological Management

Category: Therapeutic Action: aural rehabilitation and hearing amplification Ontology label: Rehabilitation NCIT:C15315

Early identification and amplification of conductive hearing loss, including bone-conduction hearing devices for aural atresia, to protect speech and language development. Maximising hearing and communication is an explicit treatment goal.

Show evidence (1 reference)

PMID:20301754 SUPPORT Human Clinical

"maximize hearing and communication"

GeneReviews names maximising hearing and communication as one of the four goals of craniofacial microsomia management.

Extracraniofacial Anomaly Screening

Category: Screening Action: extracraniofacial anomaly screening Ontology label: Diagnostic Procedure NCIT:C18020

Because 47% of patients in a 991-patient multicentre cohort had at least one extracraniofacial anomaly, systematic screening is recommended, with particular attention to the circulatory, renal, and neurological systems. Recommended investigations are electrocardiography, echocardiography, spine radiography, and renal ultrasonography in at-risk patients.

Show evidence (2 references)

PMID:30878275 SUPPORT Human Clinical

"Patients with CFM should be screened for extracraniofacial anomalies by physical examination with specific attention to the circulatory, renal, and neurological tracts."

Direct screening recommendation derived from the cohort's anomaly prevalence.

PMID:30878275 SUPPORT Human Clinical

"electrocardiography, echocardiography, spine radiography, and renal ultrasound should be performed for patients at risk of extracraniofacial anomalies"

Specifies the recommended screening investigations.

Genetic Counseling

Category: Counseling / Informational Action: genetic counseling Ontology label: Genetic Counseling NCIT:C15240

Counselling is empiric rather than Mendelian for the sporadic majority, with a roughly 2%-3% sib recurrence risk. Identification of an SF3B2 or FOXI3 variant or a chromosomal abnormality changes the counselling substantially, and the markedly reduced penetrance of FOXI3 must be explained explicitly, since an inherited variant from an unaffected parent is not thereby benign.

Show evidence (1 reference)

PMID:20301754 SUPPORT Human Clinical

"If an individual with CFM is found to have an inherited or de novo chromosome abnormality, genetic counseling for that condition is indicated."

GeneReviews genetic-counselling guidance, including the change in advice when a chromosomal cause is identified.

Autologous Fat Grafting for Facial Soft Tissue Augmentation

Category: Therapeutic Action: autologous fat grafting (lipofilling) Ontology label: Autologous Fat Graft NCIT:C126279

Lipofilling of the hypoplastic side to correct the soft-tissue (S) component of the OMENS deficiency, which surgical skeletal correction does not address. Long-term graft retention is the limiting problem, and supplementing the graft with adipose-derived regenerative cells has been tested against unsupplemented fat grafting in randomised trials in both adults and children with craniofacial microsomia.

Show evidence (2 references)

clinicaltrials:NCT01674439 SUPPORT Human Clinical

"this study aimed to investigate whether a novel protocol for isolation of ADRC and their use in combination with fat tissue improve the long-term retention of the grafts in patients with craniofacial microsomia"

Completed randomised controlled trial of fat grafting for facial soft tissue augmentation specifically in craniofacial microsomia, establishing the intervention and its retention-limited rationale.

clinicaltrials:NCT03806361 SUPPORT Human Clinical

"their use in combination with fat tissue improve the long-term retention of the grafts in paediatric patients with craniofacial microsomia"

Paediatric companion trial, showing the intervention is also applied in children, where soft-tissue reconstruction is timed against facial growth.

🌍

Environmental Factors

3

Maternal Diabetes Mellitus

Pregestational and gestational maternal diabetes is the best-replicated environmental risk factor for craniofacial microsomia, with roughly four-fold increased odds in case-control data. The proposed mechanism is hyperglycaemia-mediated interference with cephalic neural crest cell migration, which places this exposure squarely on the shared effector pathway rather than on a separate one.

Show evidence (2 references)

PMID:30927385 SUPPORT Human Clinical

"We found a statistically significant association between diabetes mellitus (DM) and CFM (OR 4.01, 95% CI 1.6-10.5)."

Case-control estimate of the maternal diabetes effect size.

PMID:12410187 SUPPORT Human Clinical

"the odds ratio for OAVS in infants of mothers with gestational diabetes mellitus was 2.28 (95% CI, 1.03-4.82, P =.03)"

Independent registry-based replication of the maternal diabetes association, here for gestational diabetes specifically.

Mechanism Target:

PREDISPOSES Teratogenic and Maternal-Environmental Disruption — Maternal diabetes is the best-replicated maternal-metabolic risk factor for this malformation, which is why this entry carries a node dedicated to teratogenic and maternal-environmental disruption for it to act on.

Show evidence (1 reference)

PMID:30927385 SUPPORT Human Clinical

"We found a statistically significant association between diabetes mellitus (DM) and CFM (OR 4.01, 95% CI 1.6-10.5)."

Reports a statistically significant fourfold association between maternal diabetes mellitus and craniofacial microsomia.

Vasoactive Medication Exposure and Perfusion-Related Maternal Factors

Exposures and conditions that plausibly perturb embryonic perfusion have been associated with craniofacial microsomia, including vasoactive medication use, multiple gestation, and second-trimester vaginal bleeding. Affected infants also show an increased prevalence of single umbilical artery and growth restriction, further implicating vascular supply.

Show evidence (2 references)

PMID:42322171 SUPPORT Human Clinical

"Epidemiological studies identified associations between HFM and maternal factors potentially affecting embryonic perfusion, including vasoactive medication exposure, maternal diabetes, multiple gestations, and second-trimester vaginal bleeding."

Systematic review enumerating the perfusion-related maternal exposures associated with the condition.

PMID:42322171 SUPPORT Human Clinical

"Population-based data further demonstrated an increased prevalence of single umbilical artery and growth restriction among affected infants."

Provides independent population-level markers of impaired fetoplacental perfusion in affected infants.

Mechanism Target:

PREDISPOSES Stapedial Artery Haemorrhage and Vascular Disruption — Targets the vascular-disruption arm rather than the general teratogen node, because the proposed action of these exposures is specifically on embryonic perfusion, which is what that arm models.

Show evidence (1 reference)

PMID:42322171 SUPPORT Human Clinical

"Epidemiological studies identified associations between HFM and maternal factors potentially affecting embryonic perfusion, including vasoactive medication exposure, maternal diabetes, multiple gestations, and second-trimester vaginal bleeding."

Identifies epidemiological associations between the malformation and maternal factors potentially affecting embryonic perfusion, the vascular route this node represents.

Higher Parity

Higher maternal parity was associated with roughly double the odds of craniofacial microsomia in case-control data. In the same study, maternal vitamin A and/or liver consumption was associated with lower rather than higher risk, which does not support a simple dietary-retinoid model of causation despite the retinoic-acid embryopathy phenocopy.

Show evidence (2 references)

PMID:30927385 SUPPORT Human Clinical

"Higher parity was also associated with increased risk for CFM (OR 2.0, 95% CI 1.0-4.0)."

Case-control estimate for parity.

PMID:30927385 REFUTE Human Clinical

"Vitamin A consumption and/or liver consumption was associated with a 70% lower risk compared with non-users (OR 0.3, 95% 0.1-0.8)."

Recorded as REFUTE for a naive dietary-retinoid causal model. Dietary vitamin A intake was inversely, not positively, associated with craniofacial microsomia, so the retinoic-acid embryopathy phenocopy should not be extrapolated to ordinary dietary retinoid exposure.

Mechanism Target:

PREDISPOSES Teratogenic and Maternal-Environmental Disruption — Parity is a maternal-context risk marker rather than an exposure with a route of action; no mediating step is proposed by the cited source.

Show evidence (1 reference)

PMID:30927385 SUPPORT Human Clinical

"Higher parity was also associated with increased risk for CFM (OR 2.0, 95% CI 1.0-4.0)."

Reports higher parity as associated with roughly doubled risk of craniofacial microsomia, a maternal risk marker.

📊

Prevalence

1

Worldwide

Birth Prevalence 25.0 per 100,000 (17.9–33.3) 1–9 per 10,000

Reported birth prevalence of 1 in 3,000 to 1 in 5,600 live births (33.3 to 17.9 per 100,000), making craniofacial microsomia the second most common congenital craniofacial anomaly after orofacial clefting.

Show evidence (1 reference)

PMID:33136839 SUPPORT Human Clinical

"Hemifacial microsomia (HFM) is the second most common congenital disability of the face, with a prevalence of 1 in 3000 to 5600 live births."

Directly reports the birth-prevalence range and the rank of craniofacial microsomia among congenital facial anomalies.

🔀

Differential Diagnoses

1

Conditions with similar clinical presentations that must be differentiated from Craniofacial Microsomia:

Treacher Collins Syndrome MONDO:0002457

Overlapping Features Treacher Collins syndrome shares the pharyngeal-arch mechanism and conforms to the same serial-homology module, producing an overlapping element bundle of mandibular, malar/zygomatic, and external-ear hypoplasia with conductive hearing loss. It is the single most instructive comparator for craniofacial microsomia.

Distinguishing Features

Laterality: Treacher Collins syndrome is bilaterally symmetric, whereas craniofacial microsomia is asymmetric and usually unilateral.
Aetiology and recurrence risk: Treacher Collins syndrome is a monogenic ribosomopathy (TCOF1, POLR1B/C/D), mostly autosomal dominant with a Mendelian recurrence risk; craniofacial microsomia is overwhelmingly sporadic with an empiric 2%-3% sib recurrence risk.
Ocular and eyelid features: downslanted palpebral fissures and lower-eyelid colobomas characterise Treacher Collins syndrome, whereas epibulbar dermoids characterise the Goldenhar variant of craniofacial microsomia.
Extracraniofacial burden: preauricular tags and vertebral, cardiac and renal anomalies occur in craniofacial microsomia but are not features of Treacher Collins syndrome.

Show evidence (1 reference)

PMID:20301704 SUPPORT Human Clinical

"Treacher Collins syndrome (TCS) is characterized by lower eyelid abnormalities, malar hypoplasia, downslanted palpebral fissures, and micro- or retrognathia due to symmetric hypoplasia of the zygomatic bones, maxilla, and mandible."

Gives the symmetric hypoplasia and eyelid features that distinguish Treacher Collins syndrome from asymmetric craniofacial microsomia.

🔬

Clinical Trials

2

NCT01674439 PHASE_II COMPLETED

Randomised controlled trial (n=29) of fat grafts supplemented with adipose-derived regenerative cells versus unsupplemented fat grafts for facial soft tissue augmentation in patients with craniofacial microsomia, with long-term graft retention as the outcome of interest.

Target Phenotypes: Facial soft tissue deficiency HP:0011799 Facial asymmetry HP:0000324

Show evidence (1 reference)

clinicaltrials:NCT01674439 SUPPORT Human Clinical

"this study aimed to investigate whether a novel protocol for isolation of ADRC and their use in combination with fat tissue improve the long-term retention of the grafts in patients with craniofacial microsomia"

Trial record states the intervention, comparator rationale, and the craniofacial microsomia population, tying the trial to the soft-tissue component of the OMENS deficiency.

NCT03806361 NOT_APPLICABLE COMPLETED

Paediatric trial (n=30) of fat grafts supplemented with adipose-derived regenerative cells for soft tissue reconstruction in children with craniofacial microsomia. Registered without an FDA phase designation.

Target Phenotypes: Facial soft tissue deficiency HP:0011799

Show evidence (1 reference)

clinicaltrials:NCT03806361 SUPPORT Human Clinical

"their use in combination with fat tissue improve the long-term retention of the grafts in paediatric patients with craniofacial microsomia"

Trial record establishes the paediatric arm of the same soft-tissue augmentation strategy.

{ }

Source YAML

click to show

name: Craniofacial Microsomia
creation_date: "2026-07-31T00:00:00Z"
synonyms:
- Hemifacial microsomia
- Oculo-auriculo-vertebral spectrum
- OAV spectrum
- Goldenhar syndrome
- First and second branchial arch syndrome
- Otomandibular dysostosis
- Facio-auriculo-vertebral spectrum
description: >-
  Craniofacial microsomia (CFM) is the second most common congenital craniofacial
  anomaly after orofacial clefting, with a reported prevalence of roughly 1 in
  3,000 to 1 in 5,600 live births. It is characterised by asymmetric, usually
  unilateral hypoplasia of structures derived from the first (mandibular) and
  second (hyoid) pharyngeal arches. The core phenotype comprises mandibular
  ramus and condylar hypoplasia, external and middle ear anomalies (microtia,
  preauricular tags, external auditory canal atresia, conductive hearing loss),
  facial nerve weakness, and deficiency of the masticatory muscles and overlying
  soft tissue. Severity is graded with the OMENS/OMENS-plus classification
  (Orbit, Mandible, Ear, Nerve, Soft tissue, plus extracraniofacial anomalies).
  The condition is aetiologically heterogeneous and overwhelmingly sporadic; the
  classic pathogenic model is a vascular disruption of the developing stapedial
  artery territory producing haematoma and loss of neural-crest-derived
  skeletogenic mesenchyme, with teratogenic and maternal-metabolic exposures and
  a minority of monogenic (FOXI3, MYT1) or copy-number causes contributing. The
  contrast with Treacher Collins syndrome is instructive: TCS is a monogenic
  ribosomopathy producing bilaterally symmetric hypoplasia, whereas craniofacial
  microsomia is typically sporadic, asymmetric and multifactorial, even though
  both converge on the same cranial-neural-crest-to-pharyngeal-arch mechanism.
category: Complex
parents:
- Neurocristopathy
- Craniofacial malformation syndrome
disease_term:
  preferred_term: craniofacial microsomia
  term:
    id: MONDO:0015397
    label: craniofacial microsomia
has_subtypes:
- name: HFM
  display_name: Hemifacial Microsomia (classic unilateral form)
  description: >-
    The classic and most common presentation: unilateral hypoplasia of the
    mandibular ramus and condyle, external and middle ear, facial nerve, and
    soft tissue, without the ocular and vertebral features that define the
    Goldenhar variant. Left- and right-sided involvement occur at broadly
    similar rates.
  evidence:
  - reference: PMID:12621170
    reference_title: 'Hemifacial microsomia: use of the OMENS-Plus classification at the Royal Children''s Hospital of Melbourne.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: there were 31 (48 percent) with right-sided microsomia, 25 (38 percent) with left-sided microsomia, and nine (14 percent) with bilateral microsomia
    explanation: >-
      Quantifies the laterality distribution in a craniofacial-unit cohort,
      establishing unilateral involvement as the dominant presentation.
- name: Goldenhar
  display_name: Goldenhar Syndrome / Oculo-Auriculo-Vertebral Spectrum
  description: >-
    The variant of the spectrum in which the craniofacial microsomia phenotype
    is accompanied by epibulbar dermoids or lipodermoids and by vertebral
    anomalies, together with more frequent multisystem (cardiac, renal, central
    nervous system) involvement. Goldenhar syndrome is not a genetically
    distinct entity but the more extensively affected end of the same
    aetiological continuum, which is why MONDO treats the names as synonyms of a
    single disease term.
  evidence:
  - reference: PMID:35015423
    reference_title: Oculo-Auriculo-Vertebral Spectrum (Goldenhar Syndrome).
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Multisystem involvement frequently includes the central nervous system, heart, kidneys, and skeletal system, distinguishing it from isolated hemifacial microsomia.
    explanation: >-
      Distinguishes the multisystem oculo-auriculo-vertebral presentation from
      the more restricted hemifacial microsomia phenotype. Evidence source is
      OTHER because this is a clinical review chapter rather than a primary
      study.
- name: Bilateral CFM
  display_name: Bilateral Craniofacial Microsomia
  description: >-
    A minority of individuals have bilateral involvement, which remains
    asymmetric in degree rather than symmetric as in Treacher Collins syndrome.
    Bilateral disease carries a substantially higher risk of upper airway
    obstruction and feeding compromise.
  evidence:
  - reference: PMID:20301754
    reference_title: "Craniofacial Microsomia Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: bilateral involvement (typically asymmetric), microtia/anotia with atresia of the ear canals, microphthalmia, and respiratory compromise from severe mandibular hypoplasia
    explanation: >-
      GeneReviews documents that bilateral craniofacial microsomia is
      characteristically asymmetric and associated with respiratory compromise.
- name: Isolated Microtia
  display_name: Isolated Microtia (mildest end of the spectrum)
  description: >-
    Isolated microtia, with or without aural atresia and without demonstrable
    mandibular or soft-tissue deficiency, is widely regarded as the mildest
    expression of the craniofacial microsomia spectrum rather than a separate
    condition; families segregating FOXI3 variants may contain both isolated
    microtia and full craniofacial microsomia.
  evidence:
  - reference: PMID:36260083
    reference_title: Damaging variants in FOXI3 cause microtia and craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Craniofacial microsomia (CFM) represents a spectrum of craniofacial malformations, ranging from isolated microtia with or without aural atresia to underdevelopment of the mandible, maxilla, orbit, facial soft tissue, and/or facial nerve.
    explanation: >-
      Places isolated microtia explicitly at the mild end of the same
      craniofacial microsomia spectrum.
inheritance:
- name: Sporadic occurrence
  description: >-
    The great majority of craniofacial microsomia occurs as a simplex (sporadic)
    case with no identified cause, and recurrence risk counselling is empiric
    rather than Mendelian, roughly 2%-3% for sibs of a proband with no family
    history. This is the sharpest practical distinction from the monogenic
    craniofacial dysostoses such as Treacher Collins syndrome.
  inheritance_term:
    preferred_term: Sporadic
    term:
      id: HP:0003745
      label: Sporadic
  evidence:
  - reference: PMID:20301754
    reference_title: "Craniofacial Microsomia Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: CFM most frequently occurs as a simplex case (i.e., occurrence in a single individual in a family) with unknown etiology; recurrence risks are empiric.
    explanation: >-
      GeneReviews establishes sporadic, aetiologically unexplained occurrence as
      the rule in craniofacial microsomia.
  - reference: PMID:20301754
    reference_title: "Craniofacial Microsomia Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: the risk to sibs is 2%-3%, although this may be an underestimate because of low penetrance and the difficulty of obtaining an accurate family history for some of the subtle features of CFM
    explanation: >-
      Gives the empiric sib recurrence risk and flags low penetrance as a reason
      it may be underestimated.
- name: Autosomal dominant inheritance with reduced penetrance
  description: >-
    In the minority of families with an identified monogenic cause, notably
    FOXI3, transmission is most often autosomal dominant with markedly reduced
    penetrance, so that pathogenic variants are frequently inherited from
    clinically unaffected parents.
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  evidence:
  - reference: PMID:37041148
    reference_title: FOXI3 pathogenic variants cause one form of craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The penetrance of the likely pathogenic variants in the seemingly dominant form is reduced, since a considerable number of such variants in affected individuals were inherited from non-affected parents.
    explanation: >-
      Documents dominant transmission with substantially reduced penetrance in
      FOXI3-related craniofacial microsomia.
- name: Autosomal recessive inheritance
  description: >-
    A subset of FOXI3-related pedigrees is compatible with autosomal recessive
    inheritance, and occasional recessive families are noted in the broader
    clinical literature.
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  evidence:
  - reference: PMID:37041148
    reference_title: FOXI3 pathogenic variants cause one form of craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Our findings indicate autosomal dominant inheritance with reduced penetrance, and/or autosomal recessive inheritance.
    explanation: >-
      States both dominant-reduced-penetrance and recessive transmission for the
      FOXI3 form.
classifications:
  isds_skeletal_category:
  - classification_value: dysostoses_with_predominant_craniofacial_involvement
    notes: >-
      ISDS Nosology and Classification of Genetic Skeletal Disorders, 2019
      revision (Mortier et al., PMID:31633310), Table 1 group 34 "Dysostoses with
      predominant craniofacial involvement"; listed as "Hemifacial microsomia".
prevalence:
- population: Worldwide
  measure_type: BIRTH_PREVALENCE
  prevalence_class: BAND_1_5_PER_10000
  rate_per_100000: 25.0
  rate_low: 17.9
  rate_high: 33.3
  notes: >-
    Reported birth prevalence of 1 in 3,000 to 1 in 5,600 live births
    (33.3 to 17.9 per 100,000), making craniofacial microsomia the second most
    common congenital craniofacial anomaly after orofacial clefting.
  evidence:
  - reference: PMID:33136839
    reference_title: 'Hemifacial Microsomia Review: Recent Advancements in Understanding the Disease.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Hemifacial microsomia (HFM) is the second most common congenital disability of the face, with a prevalence of 1 in 3000 to 5600 live births.
    explanation: >-
      Directly reports the birth-prevalence range and the rank of craniofacial
      microsomia among congenital facial anomalies.
pathophysiology:
- name: Heterogeneous Insult to First and Second Pharyngeal Arch Development
  conforms_to: "pharyngeal_arch_patterning_serial_homology#Cranial Neural Crest and Pharyngeal Arch Program Perturbation"
  role: trigger
  description: >-
    An aetiologically heterogeneous insult during roughly the first six weeks of
    gestation compromises the cranial neural crest cells that populate the first
    (mandibular) and second (hyoid) pharyngeal arches, or the vascular and
    mesenchymal environment those cells depend on. Unlike the single-gene
    craniofacial dysostoses, no one lesion accounts for most cases: vascular
    disruption, teratogenic and maternal-metabolic exposure, polygenic
    susceptibility, and a minority of monogenic or copy-number variants all
    converge on the same arch territory. The unilateral, asymmetric expression of
    the resulting phenotype reflects a stochastic, regionally restricted insult
    rather than a systemic genetic programme failure. This is the
    disorder-specific substitution at the module trigger node: where Treacher
    Collins syndrome substitutes a germline ribosome-biogenesis defect,
    craniofacial microsomia substitutes a multifactorial, regionally restricted
    insult, while the SF3B2 subset substitutes a spliceosome defect closely
    analogous to the EFTUD2/SF3B4 mandibulofacial dysostoses the module already
    covers.
  cell_types:
  - preferred_term: Cranial neural crest cell
    term:
      id: CL:0000333
      label: migratory neural crest cell
  biological_processes:
  - preferred_term: Neural crest cell development
    term:
      id: GO:0014032
      label: neural crest cell development
    modifier: ABNORMAL
  locations:
  - preferred_term: pharyngeal arch
    term:
      id: UBERON:0002539
      label: pharyngeal arch
  evidence:
  - reference: PMID:17651128
    reference_title: Review of the etiologic heterogeneity of the oculo-auriculo-vertebral spectrum (Hemifacial Microsomia).
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Etiological factors are clearly heterogeneous, the investigation of which is confounded by not only the lack of a refined affected phenotype, but also the apparent influence of genetic factors in some instances
    explanation: >-
      Establishes aetiological heterogeneity as the defining feature of the
      craniofacial microsomia trigger. Evidence source is OTHER because this is a
      narrative review.
  - reference: PMID:26853712
    reference_title: Genome-wide association study identifies multiple susceptibility loci for craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Popular assumptions for the pathogenesis of CFM include neural crest cell (NCC) disturbance and vascular disruption
    explanation: >-
      Names the two candidate trigger mechanisms, neural crest disturbance and
      vascular disruption, that this entry models as parallel upstream arms.
  - reference: PMID:33136839
    reference_title: 'Hemifacial Microsomia Review: Recent Advancements in Understanding the Disease.'
    supports: SUPPORT
    evidence_source: OTHER
    snippet: the latest reports indicate the prominence of premature loss of the neural crest cells
    explanation: >-
      Identifies premature neural crest cell loss as the converging cellular
      lesion. Evidence source is OTHER because this is a review synthesising
      primary literature.
  downstream:
  - target: Deficient Neural-Crest-Derived Skeletogenic Mesenchyme in the First and Second Arches
    causal_link_type: DIRECT
    description: >-
      Loss or misdirection of the cranial neural crest population depletes the
      skeletogenic mesenchyme that would otherwise form the arch skeleton.
    evidence:
    - reference: PMID:26853712
      reference_title: Genome-wide association study identifies multiple susceptibility loci for craniofacial microsomia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: The NCCs originate from the neural ectoderm, migrate over long distances to participate in the formation of the first and second pharyngeal arches, and give raise to craniofacial structures
      explanation: >-
        States the developmental dependency of arch-derived craniofacial
        structures on migrating neural crest, the step this edge represents.
- name: Stapedial Artery Haemorrhage and Vascular Disruption
  role: mechanism
  description: >-
    The classic pathogenic model proposes a focal haemorrhage from the
    developing stapedial artery, the transient embryonic vessel supplying the
    first and second pharyngeal arch territory. An expanding haematoma destroys
    or displaces differentiating arch mesenchyme, and the extent and timing of
    the bleed determine which arch derivatives are lost and how severely,
    explaining the unilateral distribution and the wide severity range of the
    phenotype. Contemporary systematic review finds the supporting evidence
    indirect but consistent, and places vascular disruption within a broader
    multifactorial framework rather than treating it as a sufficient
    explanation. Notably, the craniofacial microsomia GWAS loci are enriched for
    vasculogenesis as well as neural crest genes, so the vascular and
    neural-crest arms are convergent rather than competing.
  cell_types:
  - preferred_term: Endothelial cell
    term:
      id: CL:0000115
      label: endothelial cell
  biological_processes:
  - preferred_term: Blood vessel development
    term:
      id: GO:0001568
      label: blood vessel development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:42322171
    reference_title: 'Vascular Mechanisms in the Etiology of Hemifacial Microsomia: A Systematic Review of Epidemiological, Clinical, and Genetic Evidence.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Disturbances in embryonic vascular development have long been proposed as a potential mechanism contributing to the characteristic unilateral craniofacial phenotype.
    explanation: >-
      States the vascular-disruption hypothesis and ties it specifically to the
      unilateral phenotype that distinguishes craniofacial microsomia.
  - reference: PMID:42322171
    reference_title: 'Vascular Mechanisms in the Etiology of Hemifacial Microsomia: A Systematic Review of Epidemiological, Clinical, and Genetic Evidence.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The available evidence is consistent with a possible contribution of disturbances in vascular development to the pathogenesis of hemifacial microsomia, particularly in unilateral presentations. However, current evidence remains indirect and heterogeneous.
    explanation: >-
      Deliberately recorded as PARTIAL: the systematic review supports a vascular
      contribution but states that the evidence remains indirect, so this node
      should not be read as an established mechanism.
  - reference: PMID:42322171
    reference_title: 'Vascular Mechanisms in the Etiology of Hemifacial Microsomia: A Systematic Review of Epidemiological, Clinical, and Genetic Evidence.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Clinical and radiological observations described regional vascular abnormalities, including carotid artery attenuation.
    explanation: >-
      Provides the direct radiological observation of regional vascular
      abnormality in affected individuals.
  - reference: PMID:17651128
    reference_title: Review of the etiologic heterogeneity of the oculo-auriculo-vertebral spectrum (Hemifacial Microsomia).
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Etiology is often stated to be a perturbation of embryonic blood flow in the developing region, although other factors may also play a role in some cases.
    explanation: >-
      Confirms perturbed embryonic blood flow as the conventional aetiological
      account while noting it is not exclusive. Evidence source is OTHER because
      this is a narrative review.
  downstream:
  - target: Deficient Neural-Crest-Derived Skeletogenic Mesenchyme in the First and Second Arches
    causal_link_type: DIRECT
    description: >-
      Haematoma expansion within the arch territory destroys differentiating
      mesenchyme and interrupts its perfusion, leaving a regional shortfall of
      skeletogenic precursor.
    evidence:
    - reference: PMID:26853712
      reference_title: Genome-wide association study identifies multiple susceptibility loci for craniofacial microsomia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: are found to be enriched for genes involved in neural crest cell (NCC) development and vasculogenesis
      explanation: >-
        Genome-wide evidence that vascular and neural crest programmes are
        jointly implicated, supporting a causal rather than incidental link
        between the vascular arm and the neural-crest effector node.
- name: Teratogenic and Maternal-Environmental Disruption
  role: mechanism
  description: >-
    Teratogenic and maternal-metabolic exposures during arch morphogenesis
    reproduce or predispose to the phenotype. Maternal pregestational and
    gestational diabetes is the best-replicated risk factor, and vasoactive
    medication exposure, multiple gestation, higher parity, and second-trimester
    vaginal bleeding have all been associated with craniofacial microsomia.
    Retinoic acid and thalidomide embryopathy are the classic pharmacological
    phenocopies, both acting on cranial neural crest survival and on the
    embryonic vasculature, but a documented exposure is absent in the great
    majority of cases and these agents should not be equated with idiopathic
    craniofacial microsomia. These exposures act on the same neural-crest and
    vascular substrate as the vascular-disruption model rather than through a
    separate pathway.
  biological_processes:
  - preferred_term: Neural crest cell migration
    term:
      id: GO:0001755
      label: neural crest cell migration
    modifier: ABNORMAL
  evidence:
  - reference: PMID:30927385
    reference_title: Evaluation of prenatal diabetes mellitus and other risk factors for craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: We found a statistically significant association between diabetes mellitus (DM) and CFM (OR 4.01, 95% CI 1.6-10.5).
    explanation: >-
      Case-control quantification of the maternal diabetes association with
      craniofacial microsomia.
  - reference: PMID:12410187
    reference_title: 'Infants of diabetic mothers are at increased risk for the oculo-auriculo-vertebral sequence: A case-based and case-control approach.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: noting that most of these defects occur in structures of neural crest origin, we hypothesize that poorly controlled maternal diabetes interferes with cephalic neural crest cell migration
    explanation: >-
      Provides the proposed mechanism by which maternal diabetes acts, namely
      interference with cephalic neural crest migration, linking this arm to the
      shared effector node.
  - reference: PMID:42322171
    reference_title: 'Vascular Mechanisms in the Etiology of Hemifacial Microsomia: A Systematic Review of Epidemiological, Clinical, and Genetic Evidence.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Epidemiological studies identified associations between HFM and maternal factors potentially affecting embryonic perfusion, including vasoactive medication exposure, maternal diabetes, multiple gestations, and second-trimester vaginal bleeding.
    explanation: >-
      Enumerates the maternal exposures associated with craniofacial microsomia
      and frames them as acting through embryonic perfusion.
  downstream:
  - target: Deficient Neural-Crest-Derived Skeletogenic Mesenchyme in the First and Second Arches
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Teratogen- and hyperglycaemia-induced impairment of cranial neural crest
      migration and survival reduces the skeletogenic mesenchyme delivered to the
      arches.
    evidence:
    - reference: PMID:12410187
      reference_title: 'Infants of diabetic mothers are at increased risk for the oculo-auriculo-vertebral sequence: A case-based and case-control approach.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: we hypothesize that poorly controlled maternal diabetes interferes with cephalic neural crest cell migration
      explanation: >-
        States the intermediate step, impaired cephalic neural crest migration,
        that connects maternal exposure to arch mesenchymal deficiency.
- name: Monogenic and Copy-Number Contributions in a Minority of Cases
  role: mechanism
  description: >-
    A minority of individuals with craniofacial microsomia carry a defined
    genetic cause. Two genes are well supported. SF3B2 haploinsufficiency, a
    component of the U2 small nuclear ribonucleoprotein complex, shows a highly
    significant loss-of-function burden in sequenced kindreds and disrupts
    cranial neural crest precursor formation in Xenopus; this places craniofacial
    microsomia alongside the EFTUD2 and SF3B4 spliceosomopathies as a
    neural-crest spliceosome disorder. Pathogenic variants in FOXI3, a forkhead
    transcription factor regulating ectodermal and neural crest development, are
    found in roughly 1%-3% of unselected cases and are substantially enriched
    among familial cases. Rare variants in MYT1 have been reported in several
    unrelated individuals but remain presumptive. Pathogenic copy-number variants
    and chromosomal rearrangements account for additional cases without a single
    recurrent lesion. This genetic minority sits inside an overwhelmingly
    sporadic condition, which is why recurrence-risk counselling differs sharply
    from that of the monogenic craniofacial dysostoses.
  biological_processes:
  - preferred_term: Embryonic cranial skeleton morphogenesis
    term:
      id: GO:0048701
      label: embryonic cranial skeleton morphogenesis
    modifier: ABNORMAL
  - preferred_term: mRNA splicing, via spliceosome
    term:
      id: GO:0000398
      label: mRNA splicing, via spliceosome
    modifier: ABNORMAL
  evidence:
  - reference: PMID:34344887
    reference_title: Haploinsufficiency of SF3B2 causes craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: identifying a highly significant burden of loss of function variants in SF3B2 (P = 3.8 × 10-10), a component of the U2 small nuclear ribonucleoprotein complex, in probands
    explanation: >-
      Establishes SF3B2 haploinsufficiency as a statistically robust monogenic
      cause and identifies the spliceosome as the affected machinery.
  - reference: PMID:36260083
    reference_title: Damaging variants in FOXI3 cause microtia and craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Damaging variants in FOXI3 are the second most frequent genetic cause of CFM, causing 1% of all cases, including 13% of familial cases in our cohort.
    explanation: >-
      Quantifies the monogenic FOXI3 contribution and its enrichment in familial
      cases, defining the size of the genetic minority.
  - reference: PMID:36260083
    reference_title: Damaging variants in FOXI3 cause microtia and craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The genetic causes of CFM remain largely unknown.
    explanation: >-
      Confirms that identified monogenic causes explain only a small fraction of
      craniofacial microsomia, supporting the framing of this node as a minority
      mechanism.
  downstream:
  - target: Deficient Neural-Crest-Derived Skeletogenic Mesenchyme in the First and Second Arches
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      SF3B2 haploinsufficiency and FOXI3 dosage deficiency disrupt formation of
      the cranial neural crest precursors that supply arch mesenchyme, a step
      demonstrated experimentally for SF3B2.
    evidence:
    - reference: PMID:34344887
      reference_title: Haploinsufficiency of SF3B2 causes craniofacial microsomia.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: Targeted morpholino knockdown of SF3B2 in Xenopus results in disruption of cranial neural crest precursor formation and subsequent craniofacial cartilage defects
      explanation: >-
        Direct in vivo demonstration of the intermediate step, disrupted cranial
        neural crest precursor formation leading to craniofacial cartilage
        defects. Evidence source is MODEL_ORGANISM because this is a Xenopus
        experiment.
- name: Deficient Neural-Crest-Derived Skeletogenic Mesenchyme in the First and Second Arches
  conforms_to: "pharyngeal_arch_patterning_serial_homology#Disrupted Pharyngeal-Arch Patterning and Neural-Crest Skeletogenesis"
  role: central_effector
  description: >-
    Whatever the upstream insult, the shared effector step is a regional
    shortfall of neural-crest-derived skeletogenic mesenchyme in the first and
    second pharyngeal arches on the affected side. Because this mesenchyme is
    the common precursor of the mandible and Meckel cartilage, the malleus and
    incus, the external ear, and the associated muscles and soft tissue, its
    regional depletion produces a coordinated deficiency across all of these
    developmentally related elements rather than an isolated bone defect.
    Deficiency of the masticatory musculature is itself part of the mechanism,
    contributing to mandibular underdevelopment through reduced functional
    loading rather than merely accompanying it.
  cell_types:
  - preferred_term: Neural crest cell
    term:
      id: CL:0011012
      label: neural crest cell
  - preferred_term: Chondrocyte
    term:
      id: CL:0000138
      label: chondrocyte
  biological_processes:
  - preferred_term: Embryonic skeletal system morphogenesis
    term:
      id: GO:0048704
      label: embryonic skeletal system morphogenesis
    modifier: ABNORMAL
  locations:
  - preferred_term: pharyngeal arch
    term:
      id: UBERON:0002539
      label: pharyngeal arch
  evidence:
  - reference: PMID:34344887
    reference_title: Haploinsufficiency of SF3B2 causes craniofacial microsomia.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: supporting a link between spliceosome mutations and impaired neural crest development in congenital craniofacial disease
    explanation: >-
      Experimental confirmation that impaired neural crest development is the
      effector step linking a craniofacial microsomia genotype to the
      craniofacial phenotype.
  - reference: PMID:33136839
    reference_title: 'Hemifacial Microsomia Review: Recent Advancements in Understanding the Disease.'
    supports: SUPPORT
    evidence_source: OTHER
    snippet: a deficit of muscles of mastication, except the masseter, correlates in the pathomechanism of mandibular underdevelopment
    explanation: >-
      Documents the masticatory-muscle deficit as a contributor to mandibular
      underdevelopment, not merely a coincident soft-tissue finding. Evidence
      source is OTHER because this is a review article.
  - reference: PMID:36260083
    reference_title: Damaging variants in FOXI3 cause microtia and craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: FOXI3, a regulator of ectodermal and neural crest development
    explanation: >-
      Confirms that the best-established craniofacial microsomia transcription
      factor acts on neural crest development, the shared effector substrate of
      this node.
  downstream:
  - target: Asymmetric Hypoplasia of First- and Second-Arch Derivatives
    causal_link_type: DIRECT
    description: >-
      Reduced skeletogenic mesenchyme on the affected side yields hypoplastic
      arch derivatives across the whole set of elements it would have built.
    evidence:
    - reference: PMID:30878275
      reference_title: 'Extracraniofacial anomalies in craniofacial microsomia: retrospective analysis of 991 patients.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: Craniofacial microsomia (CFM) is characterized by unilateral or bilateral underdevelopment of the facial structures arising from the first and second pharyngeal arches
      explanation: >-
        States the phenotypic output of the effector node as underdevelopment
        across first- and second-arch derived facial structures.
- name: Asymmetric Hypoplasia of First- and Second-Arch Derivatives
  conforms_to: "pharyngeal_arch_patterning_serial_homology#Serially Homologous Craniofacial Malformation Across Arch Derivatives"
  role: consequence
  description: >-
    The arch derivatives are built by a shared, serially reused neural-crest
    programme, so the malformation recurs across arch elements as a bundle: the
    mandibular ramus and condyle, the external and middle ear, the facial nerve
    and its target musculature, the orbit, and the overlying soft tissue are
    affected together. This bundle is precisely what the OMENS classification
    scores (Orbit, Mandible, Ear, Nerve, Soft tissue), with OMENS-plus adding
    extracraniofacial anomalies. The decisive contrast with Treacher Collins
    syndrome is laterality and aetiology rather than the element set: a single
    germline ribosomopathy affects both sides equally and symmetrically, whereas
    the regionally restricted, stochastic insult of craniofacial microsomia
    produces a predominantly unilateral, asymmetric deficiency, bilateral in a
    minority and then still asymmetric in degree. Both disorders nevertheless
    conform to the same module node, which is the point: the serially homologous
    craniofacial bundle is a property of the shared arch programme, not of any
    one aetiology.
  cell_types:
  - preferred_term: Osteoblast
    term:
      id: CL:0000062
      label: osteoblast
  - preferred_term: Chondrocyte
    term:
      id: CL:0000138
      label: chondrocyte
  biological_processes:
  - preferred_term: Face morphogenesis
    term:
      id: GO:0060325
      label: face morphogenesis
    modifier: ABNORMAL
  - preferred_term: Embryonic cranial skeleton morphogenesis
    term:
      id: GO:0048701
      label: embryonic cranial skeleton morphogenesis
    modifier: ABNORMAL
  evidence:
  - reference: PMID:20301754
    reference_title: "Craniofacial Microsomia Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Characteristic findings include facial asymmetry resulting from maxillary and/or mandibular hypoplasia; preauricular or facial tags; ear malformations that can include microtia (hypoplasia of the external ear), anotia (absence of the external ear), or aural atresia (absence of the external ear canal); and hearing loss.
    explanation: >-
      GeneReviews enumerates the serially homologous bundle of first- and
      second-arch derivative anomalies that travel together in craniofacial
      microsomia.
  - reference: PMID:34344887
    reference_title: Haploinsufficiency of SF3B2 causes craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Probands display mandibular hypoplasia, microtia, facial and preauricular tags, epibulbar dermoids, lateral oral clefts in addition to skeletal and cardiac abnormalities.
    explanation: >-
      Shows the full multi-element bundle co-occurring in a single molecularly
      defined subset, the clearest demonstration that one lesion produces the
      whole serially homologous set.
  - reference: PMID:12621170
    reference_title: 'Hemifacial microsomia: use of the OMENS-Plus classification at the Royal Children''s Hospital of Melbourne.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: the most recent systems that grade each anatomical component separately, such as the Orbit, Mandible, Ear, Nerve, and Soft tissue (OMENS) system
    explanation: >-
      Defines the OMENS framework, which scores each element of the arch-derived
      bundle separately, operationalising the serially homologous phenotype.
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: micro- or retrognathia due to symmetric hypoplasia of the zygomatic bones, maxilla, and mandible
    explanation: >-
      Cited for contrast: the monogenic ribosomopathy Treacher Collins syndrome
      conforms to the same module node but produces symmetric hypoplasia, whereas
      craniofacial microsomia is characteristically asymmetric.
  downstream:
  - target: Facial Asymmetry
    causal_link_type: DIRECT
    description: Deficient arch derivatives on one side produce clinical facial asymmetry.
  - target: Mandibular Hypoplasia
    causal_link_type: DIRECT
    description: Hypoplasia of the neural-crest-derived mandibular skeleton on the affected side.
  - target: Mandibular Condyle Hypoplasia
    causal_link_type: DIRECT
    description: >-
      The condyle and temporomandibular joint are the most severely affected
      mandibular elements, and grade the Pruzansky-Kaban mandibular score.
  - target: Microtia
    causal_link_type: DIRECT
    description: >-
      Deficiency of the first- and second-arch hillocks of His that form the
      auricle produces microtia or anotia.
  - target: Preauricular Skin Tags
    causal_link_type: DIRECT
    description: Accessory cartilage-bearing tags arise in the first branchial groove region.
  - target: External Auditory Canal Atresia
    causal_link_type: DIRECT
    description: Failure of canalisation of the first branchial cleft gives aural atresia or stenosis.
  - target: Conductive Hearing Loss
    causal_link_type: DIRECT
    description: >-
      Ossicular malformation (the malleus and incus are first- and second-arch
      derivatives) together with canal atresia impairs sound conduction.
  - target: Facial Nerve Weakness
    causal_link_type: DIRECT
    description: >-
      The facial nerve is the second-arch cranial nerve, and its hypoplasia or
      aberrant course accompanies second-arch deficiency.
  - target: Soft Tissue Deficiency
    causal_link_type: DIRECT
    description: >-
      Masticatory muscle, parotid, and subcutaneous deficiency follows from the
      same regional mesenchymal shortfall.
  - target: Microphthalmia
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Orbital involvement at the severe end of the spectrum includes reduced
      globe size, the O component of OMENS.
  - target: Epibulbar Dermoid
    causal_link_type: DIRECT
    description: >-
      Ocular choristoma of neural-crest-derived periocular mesenchyme, the
      hallmark of the Goldenhar variant.
  - target: Macrostomia
    causal_link_type: DIRECT
    description: >-
      Failure of fusion of the maxillary and mandibular processes of the first
      arch widens the oral commissure.
  - target: Cleft Lip and Palate
    causal_link_type: DIRECT
    description: >-
      Clefting of the lip and/or palate arises from the same first-arch
      mesenchymal deficiency.
  - target: Vertebral Anomalies
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Extracraniofacial vertebral segmentation defects are the commonest
      OMENS-plus anomaly, presumably reflecting a broader neural-crest and
      paraxial-mesoderm insult whose intermediates are not established.
  - target: Central Nervous System Anomalies
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Structural central nervous system anomalies occur as part of the
      OMENS-plus burden; the spinal cord component travels with the vertebral
      anomalies, but the intermediates linking the arch insult to hydrocephaly,
      ventriculomegaly, and Chiari malformation are not established.
  - target: Cardiac Anomalies
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Congenital heart defects, dependent in part on cardiac neural crest, are
      the second commonest OMENS-plus anomaly.
  - target: Urogenital Anomalies
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Urogenital malformations occur as part of the OMENS-plus burden.
  - target: Limb Anomalies
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Upper and lower limb anomalies occur as OMENS-plus anomalies by mechanisms
      that are not established.
  - target: Radial Ray Hypoplasia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Radial ray hypoplasia is the classic limb pattern of the spectrum and
      defines the oculo-auriculo-vertebral spectrum with radial defects variant;
      its mechanistic link to the arch insult is not established.
  - target: Airway and Feeding Compromise from Mandibular Deficiency
    causal_link_type: DIRECT
    description: >-
      Severe mandibular deficiency mechanically narrows the pharyngeal airway,
      the principal functional consequence of the arch-derivative bundle.
- name: Airway and Feeding Compromise from Mandibular Deficiency
  role: consequence
  description: >-
    Severe mandibular ramus and condylar deficiency retropositions the tongue
    base and narrows the pharyngeal airway, producing upper airway obstruction
    and obstructive sleep apnoea, together with dysphagia and aspiration risk.
    Risk tracks the severity of the mandibular and orbital OMENS components and
    is greatest in bilateral disease; the most severely affected infants require
    tracheostomy or early mandibular distraction. This is the principal
    functional, as opposed to aesthetic, consequence of the arch-derivative
    bundle and drives the timing of surgical intervention.
  evidence:
  - reference: PMID:9915160
    reference_title: Airway disorders in hemifacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Patients with more severe mandibular and orbital deformities, but not ear or vertebral abnormalities, appear at a greater risk for obstructive sleep apnea.
    explanation: >-
      Establishes that airway risk is driven specifically by the mandibular and
      orbital components of the OMENS score.
  - reference: PMID:20301754
    reference_title: "Craniofacial Microsomia Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: respiratory compromise from severe mandibular hypoplasia
    explanation: >-
      GeneReviews confirms respiratory compromise as a consequence of severe
      mandibular hypoplasia.
  downstream:
  - target: Obstructive Sleep Apnea
    causal_link_type: DIRECT
    description: >-
      Retropositioned mandible and tongue base narrow the pharyngeal airway
      during sleep.
    evidence:
    - reference: PMID:9915160
      reference_title: Airway disorders in hemifacial microsomia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: group III (n = 9, 24 percent) had a definite history of obstructive sleep apnea or upper airway obstruction requiring tracheotomy or apnea surgery
      explanation: >-
        Quantifies severe airway obstruction requiring intervention in a
        hemifacial microsomia cohort.
phenotypes:
- category: Craniofacial
  name: Facial Asymmetry
  description: >-
    Asymmetry of the facial skeleton and soft tissue, usually unilateral, is the
    defining clinical feature of craniofacial microsomia and follows from
    maxillary and/or mandibular hypoplasia on the affected side. In a
    991-patient multicentre cohort 83% of cases were unilateral and 12%
    bilateral.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Facial asymmetry
    term:
      id: HP:0000324
      label: Facial asymmetry
  evidence:
  - reference: PMID:20301754
    reference_title: "Craniofacial Microsomia Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Characteristic findings include facial asymmetry resulting from maxillary and/or mandibular hypoplasia
    explanation: >-
      GeneReviews lists facial asymmetry as a characteristic finding, supporting
      the VERY_FREQUENT band for a feature described as characteristic of the
      condition.
- category: Craniofacial
  name: Mandibular Hypoplasia
  description: >-
    Hypoplasia of the mandibular ramus on the affected side, ranging from mild
    shortening to complete absence of the ramus, graded by the Pruzansky-Kaban
    classification within the OMENS mandible score.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Micrognathia
    term:
      id: HP:0000347
      label: Micrognathia
  evidence:
  - reference: PMID:32871052
    reference_title: MYT1 role in the microtia-craniofacial microsomia spectrum.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: comprises a variable phenotype with the most common features including microtia and mandibular hypoplasia on one or both sides
    explanation: >-
      Identifies mandibular hypoplasia as one of the two most common features of
      the spectrum, supporting the VERY_FREQUENT band.
- category: Craniofacial
  name: Mandibular Condyle Hypoplasia
  description: >-
    Hypoplasia or aplasia of the mandibular condyle and temporomandibular joint,
    the structural basis of the Pruzansky-Kaban mandibular grading; most
    individuals in referral cohorts have a mildly hypoplastic ramus-condyle unit
    with a functioning joint.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Mandibular condyle hypoplasia
    term:
      id: HP:0007628
      label: Mandibular condyle hypoplasia
  evidence:
  - reference: PMID:12621170
    reference_title: 'Hemifacial microsomia: use of the OMENS-Plus classification at the Royal Children''s Hospital of Melbourne.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: mildly hypoplastic mandibular ramus-condyle with functioning temporomandibular joint (57 percent with type M1 or M2a)
    explanation: >-
      Quantifies condylar involvement in a scored cohort, supporting the FREQUENT
      band for milder condylar hypoplasia.
- category: Auditory
  name: Microtia
  description: >-
    Malformation or hypoplasia of the external ear, ranging from a mildly small
    auricle to anotia, on the side of the affected arch derivatives; isolated
    microtia is the mildest expression of the whole spectrum.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Microtia
    term:
      id: HP:0008551
      label: Microtia
  evidence:
  - reference: PMID:20301754
    reference_title: "Craniofacial Microsomia Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: ear malformations that can include microtia (hypoplasia of the external ear), anotia (absence of the external ear), or aural atresia (absence of the external ear canal)
    explanation: GeneReviews lists microtia among the characteristic findings.
  - reference: PMID:32871052
    reference_title: MYT1 role in the microtia-craniofacial microsomia spectrum.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: the most common features including microtia and mandibular hypoplasia on one or both sides
    explanation: >-
      Identifies microtia as one of the two most common features, supporting the
      VERY_FREQUENT band.
- category: Auditory
  name: Preauricular Skin Tags
  description: >-
    Accessory cartilaginous or skin tags anterior to the auricle, frequently
    multiple and arranged along a line from the tragus toward the oral
    commissure. With microtia these form the minimum diagnostic criteria for the
    spectrum.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Preauricular skin tag
    term:
      id: HP:0000384
      label: Preauricular skin tag
  evidence:
  - reference: PMID:20301754
    reference_title: "Craniofacial Microsomia Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: preauricular or facial tags
    explanation: GeneReviews lists preauricular and facial tags as characteristic findings.
  - reference: PMID:35015423
    reference_title: Oculo-Auriculo-Vertebral Spectrum (Goldenhar Syndrome).
    supports: SUPPORT
    evidence_source: OTHER
    snippet: The minimum diagnostic criteria proposed by Tasse et al include either isolated microtia or preauricular tags associated with hemifacial microsomia.
    explanation: >-
      Shows preauricular tags are diagnostically central to the spectrum.
      Evidence source is OTHER because this is a clinical review chapter.
- category: Auditory
  name: Conductive Hearing Loss
  description: >-
    Conductive hearing impairment resulting from external auditory canal
    stenosis or atresia and from malformation of the middle-ear ossicles, the
    malleus and incus being first- and second-arch derivatives. Sensorineural
    and mixed loss also occur but are less common.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Conductive hearing impairment
    term:
      id: HP:0000405
      label: Conductive hearing impairment
  evidence:
  - reference: PMID:20301754
    reference_title: "Craniofacial Microsomia Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: or aural atresia (absence of the external ear canal); and hearing loss
    explanation: GeneReviews lists hearing loss among the characteristic findings.
  - reference: PMID:12410187
    reference_title: 'Infants of diabetic mothers are at increased risk for the oculo-auriculo-vertebral sequence: A case-based and case-control approach.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: 46.7% (14) had hearing loss
    explanation: >-
      Provides a quantitative frequency in an oculo-auriculo-vertebral case
      series, supporting the FREQUENT (30-79%) band.
- category: Auditory
  name: External Auditory Canal Atresia
  description: >-
    Atresia or stenosis of the external auditory canal accompanying microtia on
    the affected side, from failure of canalisation of the first branchial
    cleft.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Atresia of the external auditory canal
    term:
      id: HP:0000413
      label: Atresia of the external auditory canal
  evidence:
  - reference: PMID:36260083
    reference_title: Damaging variants in FOXI3 cause microtia and craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: ranging from isolated microtia with or without aural atresia
    explanation: >-
      Documents aural atresia as a component of the craniofacial microsomia
      spectrum.
- category: Neurological
  name: Facial Nerve Weakness
  description: >-
    Weakness of facial musculature from hypoplasia or an aberrant course of the
    facial nerve, the second-arch cranial nerve; scored as the N component of
    OMENS. Most individuals in scored cohorts have a normal facial nerve, so
    this is a minority finding.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Facial palsy
    term:
      id: HP:0010628
      label: Facial palsy
  evidence:
  - reference: PMID:12621170
    reference_title: 'Hemifacial microsomia: use of the OMENS-Plus classification at the Royal Children''s Hospital of Melbourne.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: normal facial nerve (76 percent)
    explanation: >-
      Implies facial nerve involvement in about 24% of a scored cohort,
      supporting the OCCASIONAL (5-29%) band.
- category: Craniofacial
  name: Soft Tissue Deficiency
  description: >-
    Deficiency of the masticatory muscles, parotid gland, subcutaneous fat, and
    overlying skin on the affected side, scored as the S component of OMENS. In
    scored cohorts most affected individuals have mild rather than severe
    soft-tissue hypoplasia.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Facial soft tissue deficiency
    term:
      id: HP:0011799
      label: Abnormality of facial soft tissue
  evidence:
  - reference: PMID:12621170
    reference_title: 'Hemifacial microsomia: use of the OMENS-Plus classification at the Royal Children''s Hospital of Melbourne.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: mild soft-tissue hypoplasia (73 percent)
    explanation: >-
      Documents soft-tissue hypoplasia scored in the great majority of a
      craniofacial-unit cohort.
- category: Ocular
  name: Epibulbar Dermoid
  description: >-
    Epibulbar (limbal) dermoid or lipodermoid, a benign choristoma at the
    corneoscleral junction, is the ocular hallmark of the Goldenhar variant of
    the oculo-auriculo-vertebral spectrum.
  subtype: Goldenhar
  phenotype_term:
    preferred_term: Epibulbar dermoid
    term:
      id: HP:0001140
      label: Limbal dermoid
  evidence:
  - reference: PMID:35015423
    reference_title: Oculo-Auriculo-Vertebral Spectrum (Goldenhar Syndrome).
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Typical phenotypes include microtia, facial asymmetry, and epibulbar dermoid or lipodermoid.
    explanation: >-
      Identifies epibulbar dermoid as a typical phenotype of the
      oculo-auriculo-vertebral variant. Evidence source is OTHER because this is
      a clinical review chapter.
  - reference: PMID:34344887
    reference_title: Haploinsufficiency of SF3B2 causes craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Probands display mandibular hypoplasia, microtia, facial and preauricular tags, epibulbar dermoids, lateral oral clefts
    explanation: >-
      Confirms epibulbar dermoids in a molecularly defined craniofacial
      microsomia cohort.
- category: Ocular
  name: Microphthalmia
  description: >-
    Reduced globe size, part of the orbital (O) component of OMENS and a feature
    of the more severely affected end of the spectrum.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Microphthalmia
    term:
      id: HP:0000568
      label: Microphthalmia
  evidence:
  - reference: PMID:33136839
    reference_title: 'Hemifacial Microsomia Review: Recent Advancements in Understanding the Disease.'
    supports: SUPPORT
    evidence_source: OTHER
    snippet: as microtia/anotia with conductive type hearing loss, hypoplastic mandible, and microphthalmia, impairing patient's daily activities
    explanation: >-
      Places microphthalmia at the severe end of the phenotypic range. Evidence
      source is OTHER because this is a review article.
- category: Craniofacial
  name: Macrostomia
  description: >-
    Lateral facial (Tessier 7) cleft widening the oral commissure toward the
    ear, from failure of fusion of the maxillary and mandibular processes of the
    first arch. No `frequency` band is asserted: the available evidence lists
    lateral oral clefting among the recognised features of the spectrum but
    gives no quantitative estimate, and per the frequency-evidence guidelines an
    unsupported band is worse than none.
  phenotype_term:
    preferred_term: Macrostomia
    term:
      id: HP:0000154
      label: Wide mouth
  evidence:
  - reference: PMID:32871052
    reference_title: MYT1 role in the microtia-craniofacial microsomia spectrum.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: in addition to lateral oral clefts, epibulbar dermoids, cardiac, vertebral, and renal abnormalities
    explanation: >-
      Lists lateral oral clefting (macrostomia) among the recognised features of
      the craniofacial microsomia spectrum.
- category: Craniofacial
  name: Cleft Lip and Palate
  description: >-
    Orofacial clefting of the lip and/or palate, distinct from the lateral
    (macrostomia) cleft, occurs in a minority and reflects the same first-arch
    mesenchymal deficiency.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Cleft lip and/or palate
    term:
      id: HP:0000202
      label: Orofacial cleft
  evidence:
  - reference: PMID:20301754
    reference_title: "Craniofacial Microsomia Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Other craniofacial malformations including cleft lip and/or palate can be seen.
    explanation: >-
      GeneReviews documents cleft lip and/or palate as an additional craniofacial
      malformation, phrased as "can be seen" and therefore mapped to OCCASIONAL.
- category: Skeletal
  name: Vertebral Anomalies
  description: >-
    Vertebral segmentation defects, most often cervical, including hemivertebrae
    and fusions. Vertebral anomalies are the single commonest extracraniofacial
    finding, present in 28% of a 991-patient multicentre cohort, and constitute
    the vertebral component of the oculo-auriculo-vertebral spectrum and of
    OMENS-plus.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Vertebral segmentation defect
    term:
      id: HP:0003422
      label: Vertebral segmentation defect
  evidence:
  - reference: PMID:30878275
    reference_title: 'Extracraniofacial anomalies in craniofacial microsomia: retrospective analysis of 991 patients.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The prevalence of extracraniofacial anomalies in the various tracts was as follows: vertebral 28%, central nervous system 11%, circulatory system 21%, respiratory tract 3%, gastrointestinal tract 9%, and urogenital tract 11%."
    explanation: >-
      Multicentre cohort of 991 patients gives 28% for vertebral anomalies,
      placing this in the OCCASIONAL (5-29%) band.
- category: Neurological
  name: Central Nervous System Anomalies
  description: >-
    Structural central nervous system anomalies are the third commonest
    extracraniofacial finding, present in 11% of a 991-patient multicentre
    cohort. Hydrocephaly, ventriculomegaly, intracranial cysts, and Chiari
    malformation predominate. Spinal cord anomalies such as spina bifida and
    tethered cord almost always co-occur with vertebral anomalies, which is part
    of the rationale for combining neurological assessment with spine imaging in
    the screening protocol.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Structural central nervous system anomaly
    term:
      id: HP:0002011
      label: Morphological central nervous system abnormality
  evidence:
  - reference: PMID:30878275
    reference_title: 'Extracraniofacial anomalies in craniofacial microsomia: retrospective analysis of 991 patients.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: vertebral 28%, central nervous system 11%, circulatory system 21%
    explanation: >-
      Gives 11% for central nervous system anomalies in a 991-patient
      multicentre cohort, supporting the OCCASIONAL (5-29%) band.
  - reference: PMID:30878275
    reference_title: 'Extracraniofacial anomalies in craniofacial microsomia: retrospective analysis of 991 patients.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Hydrocephaly, ventriculomegaly, intracranial cysts, and Arnold Chiari malformation were mostly seen.
    explanation: >-
      Full-text breakdown of the specific central nervous system lesions
      underlying the 11% figure.
  - reference: PMID:30878275
    reference_title: 'Extracraniofacial anomalies in craniofacial microsomia: retrospective analysis of 991 patients.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: such as spina bifida or tethered cord, 27 patients had vertebral anomalies too
    explanation: >-
      Documents the near-complete co-occurrence of spinal cord anomalies with
      vertebral anomalies in the same cohort.
- category: Cardiovascular
  name: Cardiac Anomalies
  description: >-
    Circulatory-system anomalies are the second commonest extracraniofacial
    finding, present in 21% of a 991-patient multicentre cohort. In that cohort
    the lesions most often recorded were septal defects, patent ductus
    arteriosus, and valve anomalies; an over-representation of conotruncal
    lesions is sometimes asserted in the wider literature, but no cited source
    here supports that specificity, so it is not claimed. The overall frequency
    justifies routine electrocardiography and echocardiography in at-risk
    patients.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Abnormal heart morphology
    term:
      id: HP:0001627
      label: Abnormal heart morphology
  evidence:
  - reference: PMID:30878275
    reference_title: 'Extracraniofacial anomalies in craniofacial microsomia: retrospective analysis of 991 patients.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: vertebral 28%, central nervous system 11%, circulatory system 21%, respiratory tract 3%
    explanation: >-
      Gives 21% for circulatory-system anomalies in a 991-patient multicentre
      cohort, supporting the OCCASIONAL band.
  - reference: PMID:30878275
    reference_title: 'Extracraniofacial anomalies in craniofacial microsomia: retrospective analysis of 991 patients.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: patent ductus arteriosus, and anomalies of the valves
    explanation: >-
      Full-text lesion breakdown for the same cohort, naming the cardiac lesions
      actually most often observed. Cited in place of the unsupported
      conotruncal-predominance claim previously asserted in the description.
- category: Genitourinary
  name: Urogenital Anomalies
  description: >-
    Urogenital malformations occur in 11% of a 991-patient multicentre cohort
    and warrant renal ultrasonography in at-risk patients. The 11% denominator
    covers urogenital anomalies as a whole, not any single lesion: renal
    aplasia, undescended testis, and hydronephrosis were the commonest findings.
    The phenotype is therefore bound at the genitourinary-system level so that
    the term matches the breadth of the frequency it carries.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Urogenital malformation (renal aplasia, undescended testis, hydronephrosis)
    term:
      id: HP:0000119
      label: Abnormality of the genitourinary system
  evidence:
  - reference: PMID:30878275
    reference_title: 'Extracraniofacial anomalies in craniofacial microsomia: retrospective analysis of 991 patients.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: gastrointestinal tract 9%, and urogenital tract 11%
    explanation: >-
      Gives 11% for urogenital anomalies as a whole in a 991-patient multicentre
      cohort, supporting the OCCASIONAL band at the genitourinary-system level.
  - reference: PMID:30878275
    reference_title: 'Extracraniofacial anomalies in craniofacial microsomia: retrospective analysis of 991 patients.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Mainly, renal aplasia, undescended testis, and hydronephrosis were observed.
    explanation: >-
      Full-text lesion breakdown confirming that the 11% figure spans renal,
      genital, and urinary-tract anomalies rather than renal agenesis alone,
      which is why the broader genitourinary term is used.
- category: Skeletal
  name: Limb Anomalies
  description: >-
    Upper and/or lower limb anomalies occur in 18.2% of a 688-patient multicentre
    cohort (upper 13.4%, lower 7.8%); radial ray hypoplasia is the classic
    pattern and defines the oculo-auriculo-vertebral spectrum with radial defects
    variant. Limb anomalies co-segregate strongly with other extracraniofacial
    anomalies rather than with facial severity.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Upper and/or lower limb anomaly
    term:
      id: HP:0040064
      label: Abnormality of limbs
  evidence:
  - reference: PMID:36729069
    reference_title: 'Upper and Lower Limb Anomalies in Craniofacial Microsomia and Its Relation to the OMENS+ Classification: A Multicenter Study of 688 Patients.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: In total, 18.2% of the patients were diagnosed with at least one upper and/or lower limb anomaly. Upper and lower limb anomalies were seen in, respectively, 13.4% and 7.8% of patients.
    explanation: >-
      Multicentre quantification of limb involvement of any kind, supporting the
      OCCASIONAL (5-29%) band at the limb-abnormality level. The 18.2%
      denominator is any upper and/or lower limb anomaly, so it is deliberately
      not attached to a radius-specific term; the radial-ray subset is curated
      separately below.
  - reference: PMID:36729069
    reference_title: 'Upper and Lower Limb Anomalies in Craniofacial Microsomia and Its Relation to the OMENS+ Classification: A Multicenter Study of 688 Patients.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Laterality of CFM and a higher OMENS score were not associated with limb anomalies.
    explanation: >-
      Supports the description's point that limb involvement does not track
      facial severity or laterality.
- category: Skeletal
  name: Radial Ray Hypoplasia
  description: >-
    Radial ray hypoplasia is the classic and, in some series, the exclusive limb
    pattern of the spectrum, and defines the oculo-auriculo-vertebral spectrum
    with radial defects variant. It is curated separately from the broader limb
    phenotype because only the radial-ray-specific figure supports a
    radius-specific term.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Radial ray hypoplasia
    term:
      id: HP:0002984
      label: Hypoplasia of the radius
  evidence:
  - reference: PMID:12410187
    reference_title: 'Infants of diabetic mothers are at increased risk for the oculo-auriculo-vertebral sequence: A case-based and case-control approach.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: 13.3% (4) had limb defects (all radial ray hypoplasia)
    explanation: >-
      Identifies radial ray hypoplasia as the exclusive limb pattern in an
      oculo-auriculo-vertebral case series, at 13.3%, which supports the
      OCCASIONAL (5-29%) band for this radius-specific term.
- category: Respiratory
  name: Obstructive Sleep Apnea
  description: >-
    Upper airway obstruction and obstructive sleep apnoea from mandibular
    retrusion and tongue-base retroposition; risk rises steeply with the
    severity of mandibular involvement and with bilateral disease, and severe
    cases require tracheostomy or early mandibular distraction.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Obstructive sleep apnea
    term:
      id: HP:0002870
      label: Obstructive sleep apnea
  evidence:
  - reference: PMID:9915160
    reference_title: Airway disorders in hemifacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: group II (n = 7, 18 percent) had a medical history suspect for intermittent obstructive sleep apnea or had a perioperative apneic event; and group III (n = 9, 24 percent) had a definite history of obstructive sleep apnea or upper airway obstruction requiring tracheotomy or apnea surgery
    explanation: >-
      Together the suspected and definite airway groups comprise 42% of the
      cohort, supporting the FREQUENT (30-79%) band.
genetic:
- name: SF3B2
  notes: >-
    SF3B2 encodes a component of the U2 small nuclear ribonucleoprotein complex.
    Haploinsufficiency shows a highly significant loss-of-function burden in
    sequenced craniofacial microsomia kindreds, and morpholino knockdown in
    Xenopus disrupts cranial neural crest precursor formation with downstream
    craniofacial cartilage defects. This makes craniofacial microsomia a
    neural-crest spliceosomopathy in this subset, mechanistically adjacent to the
    EFTUD2 and SF3B4 mandibulofacial dysostoses.
  relationship_type: CAUSATIVE
  gene_term:
    preferred_term: SF3B2
    term:
      id: hgnc:10769
      label: SF3B2
  evidence:
  - reference: PMID:34344887
    reference_title: Haploinsufficiency of SF3B2 causes craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: We perform whole-exome or genome sequencing of 146 kindreds with sporadic (n = 138) or familial (n = 8) CFM, identifying a highly significant burden of loss of function variants in SF3B2
    explanation: >-
      Statistical burden evidence in a sequenced cohort establishing SF3B2 as a
      craniofacial microsomia gene.
  - reference: PMID:34344887
    reference_title: Haploinsufficiency of SF3B2 causes craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: We describe twenty individuals from seven kindreds harboring de novo or transmitted haploinsufficient variants in SF3B2.
    explanation: >-
      Describes the segregation pattern, including both de novo and transmitted
      haploinsufficient variants.
  - reference: PMID:34344887
    reference_title: Haploinsufficiency of SF3B2 causes craniofacial microsomia.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: Targeted morpholino knockdown of SF3B2 in Xenopus results in disruption of cranial neural crest precursor formation and subsequent craniofacial cartilage defects
    explanation: >-
      In vivo functional corroboration in Xenopus linking SF3B2 loss to cranial
      neural crest failure.
- name: FOXI3
  notes: >-
    FOXI3 encodes a forkhead-box transcription factor regulating ectodermal and
    neural crest development. Damaging variants act through dosage sensitivity:
    nuclear-localisation-sequence missense variants that mislocalise the protein
    are found in isolated microtia with aural atresia, whereas loss-of-function
    variants produce microtia with mandibular hypoplasia. Penetrance is markedly
    reduced, and a common allele in trans has been proposed as a severity
    modifier.
  relationship_type: CAUSATIVE
  gene_term:
    preferred_term: FOXI3
    term:
      id: hgnc:35123
      label: FOXI3
  case_fractions:
  - population: European and Chinese CFM pedigrees (670 unrelated probands)
    case_fraction_percent: 3.1
    cohort_size: 670
    notes: Likely pathogenic FOXI3 variants in 21 of 670 unrelated probands.
    evidence:
    - reference: PMID:37041148
      reference_title: FOXI3 pathogenic variants cause one form of craniofacial microsomia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: We identify 18 likely pathogenic variants in 21 probands (3.1%) in FOXI3.
      explanation: Reports the FOXI3 share of probands in a large multi-ancestry CFM cohort.
  - population: Microtia-CFM cohort, familial cases
    case_fraction_percent: 13.0
    notes: >-
      FOXI3 explained 1% of all cases but 13% of familial cases in this cohort,
      reflecting the enrichment of monogenic causes in multiplex families.
    evidence:
    - reference: PMID:36260083
      reference_title: Damaging variants in FOXI3 cause microtia and craniofacial microsomia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: causing 1% of all cases, including 13% of familial cases in our cohort
      explanation: Quantifies the FOXI3 contribution overall and among familial cases.
  evidence:
  - reference: PMID:36260083
    reference_title: Damaging variants in FOXI3 cause microtia and craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: We studied a 5-generation kindred with microtia, identifying a missense variant in FOXI3 (p.Arg236Trp) as the cause of disease (logarithm of the odds = 3.33).
    explanation: >-
      Linkage evidence establishing FOXI3 causality in a large multigenerational
      microtia kindred.
  - reference: PMID:36260083
    reference_title: Damaging variants in FOXI3 cause microtia and craniofacial microsomia.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: Missense variants in the nuclear localization sequence were identified in cases with isolated microtia with aural atresia and found to affect subcellular localization of FOXI3.
    explanation: >-
      Functional in vitro demonstration that the missense variants mislocalise
      FOXI3, providing the molecular mechanism.
  - reference: PMID:37041148
    reference_title: FOXI3 pathogenic variants cause one form of craniofacial microsomia.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: Biochemical experiments on transcriptional activity and subcellular localization of the likely pathogenic FOXI3 variants, and knock-in mouse studies strongly support the involvement of FOXI3 in CFM.
    explanation: >-
      Knock-in mouse modelling corroborates FOXI3 causality; classified as
      MODEL_ORGANISM for the in vivo component.
  - reference: PMID:37041148
    reference_title: FOXI3 pathogenic variants cause one form of craniofacial microsomia.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: They show an underdeveloped mandible and a complete absence of the external ear (pinna), replaced by small pre-auricular tags
    explanation: >-
      The homozygous Foxi3 triple-mutant knock-in mouse recapitulates the core
      human first- and second-arch bundle (mandibular hypoplasia, microtia or
      anotia, preauricular tags), which is the strongest animal-model support
      for the effector node of this entry's pathograph.
  - reference: PMID:37041148
    reference_title: FOXI3 pathogenic variants cause one form of craniofacial microsomia.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: Neonatal homozygous mice revealed a partially truncated mandible and fusion of the upper and lower jaws (syngnathia) and anomalies of various bones of the ear
    explanation: >-
      Extends the model phenotype to the middle-ear ossicles and to syngnathia, a
      mandibular-to-maxillary homeotic transformation, tying the FOXI3 mouse to
      the arch dorsoventral-identity arm of the pharyngeal-arch patterning
      module.
- name: MYT1
  notes: >-
    MYT1 encodes a zinc-finger transcription factor implicated in neural crest
    and retinoic-acid-responsive craniofacial development. Rare variants have
    been reported in a small number of unrelated individuals with craniofacial
    microsomia; the gene remains a presumptive rather than definitively
    established cause.
  relationship_type: DISPUTED
  gene_term:
    preferred_term: MYT1
    term:
      id: hgnc:7622
      label: MYT1
  evidence:
  - reference: PMID:32871052
    reference_title: MYT1 role in the microtia-craniofacial microsomia spectrum.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: We identified two additional individuals with CFM who carry rare variants in MYT1, further supporting the presumptive role of this gene in the CFM spectrum.
    explanation: >-
      Recorded as PARTIAL because the authors themselves describe the MYT1 role
      as presumptive rather than established.
  - reference: PMID:32871052
    reference_title: MYT1 role in the microtia-craniofacial microsomia spectrum.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The MYT1 gene has been reported as a candidate based in mutations found in three unrelated individuals.
    explanation: >-
      Documents the prior candidate-gene evidence base for MYT1 in craniofacial
      microsomia.
- name: EDNRB
  notes: >-
    EDNRB was implicated as one of thirteen candidate susceptibility loci in a
    Chinese genome-wide association study of craniofacial microsomia. It is
    noted here specifically because the endothelin axis is the arch
    dorsoventral-identity pathway (EDN1-EDNRA-DLX5/6) that the pharyngeal-arch
    patterning module models, so a common-variant signal at EDNRB is the
    expected genetic echo of that module in a multifactorial disease. This is a
    susceptibility association, not a Mendelian cause.
  relationship_type: SUSCEPTIBILITY
  gene_term:
    preferred_term: EDNRB
    term:
      id: hgnc:3180
      label: EDNRB
  evidence:
  - reference: PMID:26853712
    reference_title: Genome-wide association study identifies multiple susceptibility loci for craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The above 13 associated loci, harboured by candidates of ROBO1, GATA3, GBX2, FGF3, NRP2, EDNRB, SHROOM3, SEMA7A, PLCD3, KLF12 and EPAS1, are found to be enriched for genes involved in neural crest cell (NCC) development and vasculogenesis.
    explanation: >-
      Names EDNRB among the GWAS candidate loci and states the pathway enrichment
      that unifies the neural crest and vascular arms of this entry's pathograph.
  - reference: PMID:26853712
    reference_title: Genome-wide association study identifies multiple susceptibility loci for craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Here we interrogate 0.9 million genetic variants in 939 CFM cases and 2,012 controls from China. After genotyping of an additional 443 cases and 1,669 controls, we identify 8 significantly associated loci
    explanation: >-
      Establishes the scale and design of the association study underpinning the
      susceptibility claim.
environmental:
- name: Maternal Diabetes Mellitus
  influences_mechanisms:
  - target: Teratogenic and Maternal-Environmental Disruption
    environmental_effect: PREDISPOSES
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Maternal diabetes is the best-replicated maternal-metabolic risk factor
      for this malformation, which is why this entry carries a node dedicated
      to teratogenic and maternal-environmental disruption for it to act on.
    evidence:
    - reference: PMID:30927385
      reference_title: "Evaluation of prenatal diabetes mellitus and other risk factors for craniofacial microsomia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "We found a statistically significant association between diabetes mellitus (DM) and CFM (OR 4.01, 95% CI 1.6-10.5)."
      explanation: >-
        Reports a statistically significant fourfold association between
        maternal diabetes mellitus and craniofacial microsomia.
  description: >-
    Pregestational and gestational maternal diabetes is the best-replicated
    environmental risk factor for craniofacial microsomia, with roughly four-fold
    increased odds in case-control data. The proposed mechanism is
    hyperglycaemia-mediated interference with cephalic neural crest cell
    migration, which places this exposure squarely on the shared effector pathway
    rather than on a separate one.
  evidence:
  - reference: PMID:30927385
    reference_title: Evaluation of prenatal diabetes mellitus and other risk factors for craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: We found a statistically significant association between diabetes mellitus (DM) and CFM (OR 4.01, 95% CI 1.6-10.5).
    explanation: Case-control estimate of the maternal diabetes effect size.
  - reference: PMID:12410187
    reference_title: 'Infants of diabetic mothers are at increased risk for the oculo-auriculo-vertebral sequence: A case-based and case-control approach.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: the odds ratio for OAVS in infants of mothers with gestational diabetes mellitus was 2.28 (95% CI, 1.03-4.82, P =.03)
    explanation: >-
      Independent registry-based replication of the maternal diabetes
      association, here for gestational diabetes specifically.
- name: Vasoactive Medication Exposure and Perfusion-Related Maternal Factors
  influences_mechanisms:
  - target: Stapedial Artery Haemorrhage and Vascular Disruption
    environmental_effect: PREDISPOSES
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Targets the vascular-disruption arm rather than the general teratogen
      node, because the proposed action of these exposures is specifically on
      embryonic perfusion, which is what that arm models.
    evidence:
    - reference: PMID:42322171
      reference_title: "Vascular Mechanisms in the Etiology of Hemifacial Microsomia: A Systematic Review of Epidemiological, Clinical, and Genetic Evidence."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Epidemiological studies identified associations between HFM and maternal factors potentially affecting embryonic perfusion, including vasoactive medication exposure, maternal diabetes, multiple gestations, and second-trimester vaginal bleeding."
      explanation: >-
        Identifies epidemiological associations between the malformation and
        maternal factors potentially affecting embryonic perfusion, the
        vascular route this node represents.
  description: >-
    Exposures and conditions that plausibly perturb embryonic perfusion have been
    associated with craniofacial microsomia, including vasoactive medication use,
    multiple gestation, and second-trimester vaginal bleeding. Affected infants
    also show an increased prevalence of single umbilical artery and growth
    restriction, further implicating vascular supply.
  evidence:
  - reference: PMID:42322171
    reference_title: 'Vascular Mechanisms in the Etiology of Hemifacial Microsomia: A Systematic Review of Epidemiological, Clinical, and Genetic Evidence.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Epidemiological studies identified associations between HFM and maternal factors potentially affecting embryonic perfusion, including vasoactive medication exposure, maternal diabetes, multiple gestations, and second-trimester vaginal bleeding.
    explanation: >-
      Systematic review enumerating the perfusion-related maternal exposures
      associated with the condition.
  - reference: PMID:42322171
    reference_title: 'Vascular Mechanisms in the Etiology of Hemifacial Microsomia: A Systematic Review of Epidemiological, Clinical, and Genetic Evidence.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Population-based data further demonstrated an increased prevalence of single umbilical artery and growth restriction among affected infants.
    explanation: >-
      Provides independent population-level markers of impaired fetoplacental
      perfusion in affected infants.
- name: Higher Parity
  influences_mechanisms:
  - target: Teratogenic and Maternal-Environmental Disruption
    environmental_effect: PREDISPOSES
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Parity is a maternal-context risk marker rather than an exposure with a
      route of action; no mediating step is proposed by the cited source.
    evidence:
    - reference: PMID:30927385
      reference_title: "Evaluation of prenatal diabetes mellitus and other risk factors for craniofacial microsomia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Higher parity was also associated with increased risk for CFM (OR 2.0, 95% CI 1.0-4.0)."
      explanation: >-
        Reports higher parity as associated with roughly doubled risk of
        craniofacial microsomia, a maternal risk marker.
  description: >-
    Higher maternal parity was associated with roughly double the odds of
    craniofacial microsomia in case-control data. In the same study, maternal
    vitamin A and/or liver consumption was associated with lower rather than
    higher risk, which does not support a simple dietary-retinoid model of
    causation despite the retinoic-acid embryopathy phenocopy.
  evidence:
  - reference: PMID:30927385
    reference_title: Evaluation of prenatal diabetes mellitus and other risk factors for craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Higher parity was also associated with increased risk for CFM (OR 2.0, 95% CI 1.0-4.0).
    explanation: Case-control estimate for parity.
  - reference: PMID:30927385
    reference_title: Evaluation of prenatal diabetes mellitus and other risk factors for craniofacial microsomia.
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: Vitamin A consumption and/or liver consumption was associated with a 70% lower risk compared with non-users (OR 0.3, 95% 0.1-0.8).
    explanation: >-
      Recorded as REFUTE for a naive dietary-retinoid causal model. Dietary
      vitamin A intake was inversely, not positively, associated with
      craniofacial microsomia, so the retinoic-acid embryopathy phenocopy should
      not be extrapolated to ordinary dietary retinoid exposure.
treatments:
- name: Multidisciplinary Craniofacial Team Care
  description: >-
    Coordinated, age-staged management by an experienced craniofacial team is the
    organising principle of care, because the interventions for airway, hearing,
    facial growth, and occlusion are time-sensitive and interdependent.
  action_category: THERAPEUTIC
  treatment_term:
    preferred_term: multidisciplinary craniofacial team care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:20301754
    reference_title: "Craniofacial Microsomia Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: children should be managed by an experienced multidisciplinary craniofacial team
    explanation: GeneReviews management recommendation.
  - reference: PMID:20301754
    reference_title: "Craniofacial Microsomia Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The goals of treatment for CFM are to assure adequate respiratory support and feeding in infants with severe facial malformations, maximize hearing and communication, improve facial symmetry, and optimize dental occlusion.
    explanation: >-
      States the four treatment goals that structure staged craniofacial team
      care.
- name: Mandibular Distraction Osteogenesis
  description: >-
    Gradual lengthening of the hypoplastic mandibular ramus by distraction
    osteogenesis, to relieve airway obstruction in infancy and to improve facial
    symmetry and occlusion later in childhood. It directly targets the mandibular
    (M) component of the arch-derivative bundle and its airway consequence.
  action_category: THERAPEUTIC
  treatment_term:
    preferred_term: mandibular distraction osteogenesis
    term:
      id: NCIT:C51903
      label: Osteotomy
  target_mechanisms:
  - target: Airway and Feeding Compromise from Mandibular Deficiency
    treatment_effect: MODULATES
    description: >-
      Lengthening the deficient mandibular ramus advances the tongue base and
      enlarges the pharyngeal airway, directly relieving the mechanism that
      produces obstruction.
  evidence:
  - reference: PMID:9915160
    reference_title: Airway disorders in hemifacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Patients with more severe mandibular and orbital deformities, but not ear or vertebral abnormalities, appear at a greater risk for obstructive sleep apnea.
    explanation: >-
      Identifies mandibular deficiency as the airway-relevant target, providing
      the rationale for mandibular distraction in airway-compromised patients.
- name: Auricular Reconstruction
  description: >-
    Staged surgical reconstruction of the microtic ear, using autologous costal
    cartilage or an alloplastic framework, typically deferred until adequate
    donor cartilage and ear growth are available.
  action_category: THERAPEUTIC
  treatment_term:
    preferred_term: staged auricular reconstruction
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  evidence:
  - reference: PMID:20301754
    reference_title: "Craniofacial Microsomia Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Treatment is age-dependent, with time-sensitive interventions at appropriate stages of craniofacial growth and development.
    explanation: >-
      Recorded as PARTIAL. GeneReviews supports the age-staged principle
      underlying deferred auricular reconstruction, but the abstract does not
      describe the specific technique.
- name: Hearing Amplification and Audiological Management
  description: >-
    Early identification and amplification of conductive hearing loss, including
    bone-conduction hearing devices for aural atresia, to protect speech and
    language development. Maximising hearing and communication is an explicit
    treatment goal.
  action_category: THERAPEUTIC
  treatment_term:
    preferred_term: aural rehabilitation and hearing amplification
    term:
      id: NCIT:C15315
      label: Rehabilitation
  evidence:
  - reference: PMID:20301754
    reference_title: "Craniofacial Microsomia Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: maximize hearing and communication
    explanation: >-
      GeneReviews names maximising hearing and communication as one of the four
      goals of craniofacial microsomia management.
- name: Extracraniofacial Anomaly Screening
  description: >-
    Because 47% of patients in a 991-patient multicentre cohort had at least one
    extracraniofacial anomaly, systematic screening is recommended, with
    particular attention to the circulatory, renal, and neurological systems.
    Recommended investigations are electrocardiography, echocardiography, spine
    radiography, and renal ultrasonography in at-risk patients.
  action_category: SCREENING
  treatment_term:
    preferred_term: extracraniofacial anomaly screening
    term:
      id: NCIT:C18020
      label: Diagnostic Procedure
  evidence:
  - reference: PMID:30878275
    reference_title: 'Extracraniofacial anomalies in craniofacial microsomia: retrospective analysis of 991 patients.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Patients with CFM should be screened for extracraniofacial anomalies by physical examination with specific attention to the circulatory, renal, and neurological tracts.
    explanation: >-
      Direct screening recommendation derived from the cohort's anomaly
      prevalence.
  - reference: PMID:30878275
    reference_title: 'Extracraniofacial anomalies in craniofacial microsomia: retrospective analysis of 991 patients.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: electrocardiography, echocardiography, spine radiography, and renal ultrasound should be performed for patients at risk of extracraniofacial anomalies
    explanation: Specifies the recommended screening investigations.
- name: Genetic Counseling
  description: >-
    Counselling is empiric rather than Mendelian for the sporadic majority, with
    a roughly 2%-3% sib recurrence risk. Identification of an SF3B2 or FOXI3
    variant or a chromosomal abnormality changes the counselling substantially,
    and the markedly reduced penetrance of FOXI3 must be explained explicitly,
    since an inherited variant from an unaffected parent is not thereby benign.
  action_category: COUNSELING_INFORMATIONAL
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:20301754
    reference_title: "Craniofacial Microsomia Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: If an individual with CFM is found to have an inherited or de novo chromosome abnormality, genetic counseling for that condition is indicated.
    explanation: >-
      GeneReviews genetic-counselling guidance, including the change in advice
      when a chromosomal cause is identified.
- name: Autologous Fat Grafting for Facial Soft Tissue Augmentation
  description: >-
    Lipofilling of the hypoplastic side to correct the soft-tissue (S) component
    of the OMENS deficiency, which surgical skeletal correction does not
    address. Long-term graft retention is the limiting problem, and supplementing
    the graft with adipose-derived regenerative cells has been tested against
    unsupplemented fat grafting in randomised trials in both adults and children
    with craniofacial microsomia.
  action_category: THERAPEUTIC
  treatment_term:
    preferred_term: autologous fat grafting (lipofilling)
    term:
      id: NCIT:C126279
      label: Autologous Fat Graft
  evidence:
  - reference: clinicaltrials:NCT01674439
    reference_title: "Randomized Controlled Clinical Trial of Fat Grafts Supplemented With Adipose-derived Regenerative Cells for Facial Soft Tissue Augmentation in Patients With Craniofacial Microsomia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: this study aimed to investigate whether a novel protocol for isolation of ADRC and their use in combination with fat tissue improve the long-term retention of the grafts in patients with craniofacial microsomia
    explanation: >-
      Completed randomised controlled trial of fat grafting for facial soft
      tissue augmentation specifically in craniofacial microsomia, establishing
      the intervention and its retention-limited rationale.
  - reference: clinicaltrials:NCT03806361
    reference_title: "Fat Grafts Supplemented With Adipose-derived Regenerative Cells for Soft Tissue Reconstruction in Children With Craniofacial Microsomia"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: their use in combination with fat tissue improve the long-term retention of the grafts in paediatric patients with craniofacial microsomia
    explanation: >-
      Paediatric companion trial, showing the intervention is also applied in
      children, where soft-tissue reconstruction is timed against facial growth.
clinical_trials:
- name: NCT01674439
  phase: PHASE_II
  status: COMPLETED
  description: >-
    Randomised controlled trial (n=29) of fat grafts supplemented with
    adipose-derived regenerative cells versus unsupplemented fat grafts for
    facial soft tissue augmentation in patients with craniofacial microsomia,
    with long-term graft retention as the outcome of interest.
  target_phenotypes:
  - preferred_term: Facial soft tissue deficiency
    term:
      id: HP:0011799
      label: Abnormality of facial soft tissue
  - preferred_term: Facial asymmetry
    term:
      id: HP:0000324
      label: Facial asymmetry
  evidence:
  - reference: clinicaltrials:NCT01674439
    reference_title: "Randomized Controlled Clinical Trial of Fat Grafts Supplemented With Adipose-derived Regenerative Cells for Facial Soft Tissue Augmentation in Patients With Craniofacial Microsomia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: this study aimed to investigate whether a novel protocol for isolation of ADRC and their use in combination with fat tissue improve the long-term retention of the grafts in patients with craniofacial microsomia
    explanation: >-
      Trial record states the intervention, comparator rationale, and the
      craniofacial microsomia population, tying the trial to the soft-tissue
      component of the OMENS deficiency.
- name: NCT03806361
  phase: NOT_APPLICABLE
  status: COMPLETED
  description: >-
    Paediatric trial (n=30) of fat grafts supplemented with adipose-derived
    regenerative cells for soft tissue reconstruction in children with
    craniofacial microsomia. Registered without an FDA phase designation.
  target_phenotypes:
  - preferred_term: Facial soft tissue deficiency
    term:
      id: HP:0011799
      label: Abnormality of facial soft tissue
  evidence:
  - reference: clinicaltrials:NCT03806361
    reference_title: "Fat Grafts Supplemented With Adipose-derived Regenerative Cells for Soft Tissue Reconstruction in Children With Craniofacial Microsomia"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: their use in combination with fat tissue improve the long-term retention of the grafts in paediatric patients with craniofacial microsomia
    explanation: >-
      Trial record establishes the paediatric arm of the same soft-tissue
      augmentation strategy.
differential_diagnoses:
- name: Treacher Collins Syndrome
  description: >-
    Treacher Collins syndrome shares the pharyngeal-arch mechanism and conforms
    to the same serial-homology module, producing an overlapping element bundle
    of mandibular, malar/zygomatic, and external-ear hypoplasia with conductive
    hearing loss. It is the single most instructive comparator for craniofacial
    microsomia.
  distinguishing_features:
  - >-
    Laterality: Treacher Collins syndrome is bilaterally symmetric, whereas
    craniofacial microsomia is asymmetric and usually unilateral.
  - >-
    Aetiology and recurrence risk: Treacher Collins syndrome is a monogenic
    ribosomopathy (TCOF1, POLR1B/C/D), mostly autosomal dominant with a Mendelian
    recurrence risk; craniofacial microsomia is overwhelmingly sporadic with an
    empiric 2%-3% sib recurrence risk.
  - >-
    Ocular and eyelid features: downslanted palpebral fissures and lower-eyelid
    colobomas characterise Treacher Collins syndrome, whereas epibulbar dermoids
    characterise the Goldenhar variant of craniofacial microsomia.
  - >-
    Extracraniofacial burden: preauricular tags and vertebral, cardiac and renal
    anomalies occur in craniofacial microsomia but are not features of Treacher
    Collins syndrome.
  disease_term:
    preferred_term: Treacher Collins syndrome
    term:
      id: MONDO:0002457
      label: Treacher-Collins syndrome
  evidence:
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Treacher Collins syndrome (TCS) is characterized by lower eyelid abnormalities, malar hypoplasia, downslanted palpebral fissures, and micro- or retrognathia due to symmetric hypoplasia of the zygomatic bones, maxilla, and mandible.
    explanation: >-
      Gives the symmetric hypoplasia and eyelid features that distinguish
      Treacher Collins syndrome from asymmetric craniofacial microsomia.
definitions:
- name: Minimum diagnostic criteria (Tasse)
  definition_type: DIAGNOSTIC_CRITERIA
  derivation_basis: ESTABLISHED_CRITERIA
  description: >-
    The commonly applied minimum diagnostic criteria for the spectrum require
    either isolated microtia, or preauricular tags in association with hemifacial
    microsomia. Diagnosis is clinical; no molecular test defines the condition,
    and OMENS/OMENS-plus and Pruzansky-Kaban are severity classifications rather
    than binary diagnostic criteria.
  evidence:
  - reference: PMID:35015423
    reference_title: Oculo-Auriculo-Vertebral Spectrum (Goldenhar Syndrome).
    supports: SUPPORT
    evidence_source: OTHER
    snippet: The minimum diagnostic criteria proposed by Tasse et al include either isolated microtia or preauricular tags associated with hemifacial microsomia.
    explanation: >-
      States the operational minimum diagnostic criteria. Evidence source is
      OTHER because this is a clinical review chapter.
  - reference: PMID:20301754
    reference_title: "Craniofacial Microsomia Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The diagnosis of CFM is based on clinical findings.
    explanation: GeneReviews confirms the diagnosis is clinical.
discussions:
- discussion_id: CFM-GAP-001
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Is embryonic vascular disruption a genuine cause of craniofacial microsomia,
    or a correlate of a primary neural-crest lesion?
  attaches_to:
  - "pathophysiology#Stapedial Artery Haemorrhage and Vascular Disruption"
  rationale: >-
    The stapedial-artery haemorrhage model has dominated thinking about
    craniofacial microsomia for fifty years and elegantly explains unilaterality
    and severity gradation, but the most recent systematic review found only
    eight qualifying studies and judged the evidence indirect and heterogeneous.
    The maternal risk factors that support it (diabetes, vasoactive medication,
    multiple gestation) are also compatible with a direct neural-crest insult,
    and maternal diabetes has an independently proposed neural-crest-migration
    mechanism. The GWAS finding that candidate loci are enriched for both neural
    crest development and vasculogenesis is consistent with either ordering.
    Distinguishing a primary vascular cause from a primary neural-crest cause
    matters because it determines whether prevention should target perfusion or
    crest biology.
  proposed_experiments:
  - experiment_id: CFM-EXP-001
    name: Prospective vascular imaging of affected versus unaffected side
    description: >-
      High-resolution magnetic resonance angiography of both sides of the face in
      a prospective craniofacial microsomia cohort, testing whether regional
      arterial attenuation is present in individuals without skeletal deficiency
      and whether its severity tracks the OMENS mandible score.
    supporting_outcome:
    - >-
        Arterial attenuation grading with mandibular deficiency would support a
        primary vascular mechanism.
    refuting_outcome:
    - >-
        Absence of any consistent regional arterial abnormality in severely
        affected individuals would argue for a primary neural-crest lesion.
  - experiment_id: CFM-EXP-002
    name: Human embryonic specimen correlation of stapedial artery regression
    description: >-
      Staged human embryonic and fetal specimen studies correlating the timing of
      stapedial artery regression with first- and second-arch mesenchymal volume,
      establishing whether the vascular event precedes the mesenchymal shortfall.
  - experiment_id: CFM-EXP-003
    name: Pathway-stratified genomic analysis by laterality
    description: >-
      Integrated genomic analysis testing whether rare-variant burden in
      vascular-development versus neural-crest pathways segregates with
      unilateral versus bilateral presentations.
  evidence:
  - reference: PMID:42322171
    reference_title: 'Vascular Mechanisms in the Etiology of Hemifacial Microsomia: A Systematic Review of Epidemiological, Clinical, and Genetic Evidence.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Further studies integrating genomic analyses, developmental models, and detailed vascular imaging are needed to clarify the role of vascular mechanisms in craniofacial microsomia.
    explanation: >-
      The systematic review explicitly frames this as an unresolved question and
      names the study designs needed to settle it.
- discussion_id: CFM-GAP-002
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Why do the great majority of craniofacial microsomia cases still lack any
    identified molecular cause?
  attaches_to:
  - "pathophysiology#Monogenic and Copy-Number Contributions in a Minority of Cases"
  rationale: >-
    Even with SF3B2 and FOXI3 established, identified monogenic causes account
    for only a small minority of cases, and MYT1 remains presumptive. The reduced
    penetrance seen in FOXI3 families, and the observation that variants are
    frequently inherited from unaffected parents, suggest that oligogenic
    interaction, modifier alleles, somatic mosaicism, or gene-environment
    interaction with perfusion-related exposures may be needed to explain
    expression. The lack of a refined affected phenotype definition also dilutes
    genetic association power.
  proposed_experiments:
  - experiment_id: CFM-EXP-004
    name: Somatic mosaicism screen in affected craniofacial tissue
    description: >-
      Deep sequencing of surgically resected affected craniofacial tissue paired
      with blood, testing whether post-zygotic mosaic variants explain sporadic,
      unilateral disease that is invisible to germline sequencing.
    supporting_outcome:
    - >-
        Recovery of tissue-restricted pathogenic variants absent from blood would
        explain both sporadicity and unilaterality.
  - experiment_id: CFM-EXP-005
    name: Trans-modifier analysis of FOXI3 penetrance
    description: >-
      Family-based studies quantifying whether common FOXI3 variation in trans
      with a pathogenic allele modifies penetrance and phenotypic severity, as
      suggested by existing cohort data.
  - experiment_id: CFM-EXP-006
    name: Gene-environment interaction analysis
    description: >-
      Population-based analysis combining genotype at established and candidate
      loci with maternal diabetes and other perfusion-related exposures, testing
      for interaction rather than independent main effects.
  evidence:
  - reference: PMID:37041148
    reference_title: FOXI3 pathogenic variants cause one form of craniofacial microsomia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The inheritance pattern is controversial, and the molecular etiology of this syndrome is largely unknown.
    explanation: >-
      States directly that inheritance and molecular aetiology remain unresolved
      for the condition as a whole.
references:
- reference: PMID:20301754
  title: "Craniofacial Microsomia Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
  tags:
  - GeneReviews
notes: >-
  Nomenclature. MONDO:0015397 treats craniofacial microsomia, hemifacial
  microsomia, oculo-auriculo-vertebral spectrum, and Goldenhar syndrome as
  synonyms of a single disease entity, and this entry follows that decision. The
  names are curated here as has_subtypes rather than as separate Disease entries
  because they denote positions on one clinical and aetiological continuum, not
  distinct diseases. Goldenhar syndrome is the more extensively affected end
  (epibulbar dermoids plus vertebral anomalies) and isolated microtia the
  mildest. Some authors argue these terms should not be treated as strict
  synonyms in computational curation; that caution is recorded here rather than
  acted on, since splitting them would contradict the MONDO entity.

  Module conformance. Three pathophysiology nodes declare conformance to
  pharyngeal_arch_patterning_serial_homology, at the trigger, central_effector,
  and consequence nodes. The pairing with Treacher Collins syndrome, which
  conforms to the same module, is deliberate and is the most informative thing
  about this entry. The two disorders share the
  cranial-neural-crest-to-pharyngeal-arch mechanism and the resulting serially
  homologous element bundle (mandible, maxilla/zygoma, ear, facial nerve), but
  differ in the substituted trigger (multifactorial, regionally restricted insult
  versus germline ribosomopathy) and therefore in laterality (asymmetric, usually
  unilateral versus bilaterally symmetric) and in recurrence risk (empiric 2%-3%
  versus Mendelian). This is exactly the substitution pattern the module was
  designed to expose. The SF3B2 subset is a further point of contact: the module
  explicitly names the EFTUD2/SF3B4 spliceosomopathies as a conserved trigger
  class, and SF3B2 haploinsufficiency places a molecularly defined slice of
  craniofacial microsomia in that same class.

  GeneReviews status. The GeneReviews chapter for craniofacial microsomia
  (PMID:20301754, last updated 2014) has been formally retired and is retained in
  PubMed for historical reference only. It is nonetheless the most authoritative
  synoptic clinical source available for this condition and is used here as the
  phenotype baseline. Claims sourced from it were cross-checked against the more
  recent primary literature cited elsewhere in this entry, and its clinical
  characteristics (facial asymmetry, tags, microtia/anotia/aural atresia, hearing
  loss, microphthalmia, respiratory compromise, cleft lip/palate, and vertebral,
  renal, cardiac and limb anomalies) are all represented in the phenotypes
  section. The most consequential update since retirement is the identification
  of SF3B2 and FOXI3, both of which postdate the chapter.

  Frequency discipline. Extracraniofacial frequency bands are taken from the
  991-patient multicentre cohort in PMID:30878275 and the 688-patient limb cohort
  in PMID:36729069 in preference to the older oculo-auriculo-vertebral case
  series in PMID:12410187, which ascertained infants of diabetic mothers and
  therefore plausibly enriches for the severe multisystem end of the spectrum.
  The latter is retained only where it supplies a detail the larger cohorts do
  not (the radial-ray pattern of limb anomalies, and hearing loss frequency).
  Craniofacial (OMENS-component) frequencies come from scored craniofacial-unit
  cohorts, which are referral populations and may under-represent the mildest
  cases.

  Prevalence discrepancy. This entry records the 1 in 3,000 to 1 in 5,600 range,
  which is corroborated independently by PMID:33136839 and PMID:26853712. A
  figure of about 1 in 7,500 also circulates in the literature. The difference is
  driven by whether isolated microtia is counted within the spectrum and by
  ascertainment source, not by a genuine population difference; the wider range
  is preferred here because it is the one attached to a quotable primary source.

  Terminology note. The HPO term used for epibulbar dermoid is HP:0001140, whose
  canonical label is "Limbal dermoid", and the term used for macrostomia is
  HP:0000154, whose canonical label is "Wide mouth". In both cases the
  preferred_term is the clinically standard name and is an exact synonym of the
  canonical label, so preferred_term and term.label differ deliberately. A
  deep-research tool proposed HP:0000182 for macrostomia during curation; that
  identifier is actually "Movement abnormality of the tongue" and was rejected on
  OAK verification.

📚

References & Deep Research

References

1

PMID:20301754

Craniofacial Microsomia Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY.

No top-level findings curated for this source.

Deep Research

1

Falcon ▸

Craniofacial Microsomia: Disease-Characteristics Research Report

Edison Scientific Literature 23 citations 2026-07-31T17:41:38.076424

Craniofacial Microsomia: Disease-Characteristics Research Report

Scope and evidence note. Craniofacial microsomia (CFM) is heterogeneous, terminology is inconsistent, and many clinical recommendations rest on retrospective cohorts rather than randomized trials. This report prioritizes 2023–2024 evidence where retrievable and uses older landmark studies when they remain the best quantitative evidence. “Causal” genes are separated from susceptibility or candidate genes. PMID links are given where verified from the retrieved evidence; DOI links are supplied otherwise.

Executive summary

CFM is a congenital developmental spectrum involving hypoplasia of first- and second-pharyngeal-arch derivatives, especially the mandible, ear, facial soft tissue, facial nerve, and orbit. It is usually unilateral, but bilateral and extracraniofacial disease are important. In a 991-person multicenter cohort, 83% were unilateral, 12% bilateral, and 47% had at least one extracraniofacial anomaly; vertebral (28%) and circulatory (21%) anomalies were most frequent. Bilateral disease carried greater extracraniofacial burden (68% versus 44%). (renkema2019extracraniofacialanomaliesin pages 1-2)

The strongest recent molecular advance is the April 2023 demonstration that pathogenic FOXI3 variants account for a small molecularly defined subset: 18 likely pathogenic variants occurred in 21 of 670 probands (3.1%). Human segregation, transcription/localization assays, and knock-in mice support causality. SF3B2 haploinsufficiency is another established cause, while CHAF1A, MYT1, and several other genes have emerging or phenotype-overlap evidence. Most CFM remains unexplained and is best considered multifactorial, with genetic susceptibility, incomplete penetrance, modifiers, and prenatal environmental/vascular influences. (OpenTargets Search: craniofacial microsomia, mao2023foxi3pathogenicvariants pages 1-2, mao2023foxi3pathogenicvariants pages 5-6)

There is no disease-modifying drug. Current implementation is multidisciplinary and phenotype-directed: hearing and airway care, feeding and speech therapy, dental/orthodontic management, mandibular reconstruction or distraction, orthognathic surgery, ear reconstruction, facial reanimation, and soft-tissue augmentation. Evidence for timing and comparative superiority remains limited.

The following table provides a compact knowledge-base view.

Domain	Key annotations	Suggested ontology terms	Evidence
Identity / identifiers	Craniofacial microsomia (CFM) is a congenital disorder/spectrum characterized by unilateral or bilateral underdevelopment of structures derived largely from the first and second pharyngeal arches; commonly overlaps conceptually with hemifacial microsomia, oculoauriculovertebral spectrum (OAVS), and sometimes Goldenhar spectrum in clinical literature. Disease-level information here is derived primarily from aggregated cohort studies, disease resources, and research cohorts, not EHR-only sources. MONDO: MONDO:0015397 (craniofacial microsomia).	MONDO:0015397; UBERON: pharyngeal arch; UBERON: mandible; UBERON: external ear	(renkema2019extracraniofacialanomaliesin pages 1-2, NCT02639312 chunk 1)
Core phenotype	Typical manifestations include facial asymmetry, mandibular hypoplasia, microtia/ear dysplasia, preauricular tags/pits, and related first/second arch anomalies; laterality is usually unilateral but may be bilateral. In a 991-patient cohort: 83% unilateral, 12% bilateral; in the same cohort, 53% male / 47% female. Clinical severity is commonly described with OMENS / OMENS+ and mandibular grading with Pruzansky-Kaban.	HPO: Facial asymmetry; HPO: Microtia; HPO: Mandibular hypoplasia; HPO: Preauricular tag; HPO: Hearing impairment; UBERON: mandible; UBERON: pinna; NCIT: Diagnostic Procedure	(renkema2019extracraniofacialanomaliesin pages 1-2, mao2023foxi3pathogenicvariants pages 9-10)
Extracraniofacial systems with frequencies	Large retrospective multicenter cohort (n=991) found extracraniofacial anomalies in 47% overall. By system: vertebral 28%, circulatory 21%, CNS 11%, urogenital 11%, gastrointestinal 9%, respiratory 3%. Bilateral CFM had higher extracraniofacial anomaly prevalence (68%) than unilateral (44%).	HPO: Vertebral anomaly; HPO: Congenital heart defect; HPO: Central nervous system abnormality; HPO: Genitourinary abnormality; HPO: Gastrointestinal malformation; HPO: Respiratory system abnormality; UBERON: vertebral column; UBERON: heart; UBERON: kidney; UBERON: brain	(renkema2019extracraniofacialanomaliesin pages 7-8, renkema2019extracraniofacialanomaliesin pages 1-2)
Causal genes / susceptibility genes	Higher-confidence causal gene evidence: FOXI3 (Nature Communications 2023; likely pathogenic variants in 21/670 probands = 3.1%; variant classes included 14 missense, 2 in-frame deletions, 1 frameshift, 1 truncating across 18 distinct variants; evidence from human genetics + in vitro assays + knock-in mice). SF3B2 is strongly associated in disease-target resources and prior human genetic literature. Emerging / candidate genes: CHAF1A (resource-level association), MYT1, EYA3, EFTUD2, VWA1, and family-based candidates including SIX1, PDGFRA, KDR/VEGFR2. Susceptibility loci / candidate genes from GWAS: ROBO1, GATA3, GBX2, FGF3, NRP2, EDNRB, SHROOM3, SEMA7A, ARID3B, KLF12, EPAS1, PLCD3.	GO: DNA-binding transcription factor activity; GO: RNA splicing; GO: neural crest cell migration; CL: cranial neural crest cell	(OpenTargets Search: craniofacial microsomia, petrin2026familialoculoauriculovertebralspectrum pages 11-13, petrin2026familialoculoauriculovertebralspectrum pages 1-3, mao2023foxi3pathogenicvariants pages 6-7, mao2023foxi3pathogenicvariants pages 1-2, mao2023foxi3pathogenicvariants pages 4-5, mao2023foxi3pathogenicvariants pages 5-6, zhang2016genomewideassociationstudy pages 4-5, zhang2016genomewideassociationstudy pages 7-8, zhang2016genomewideassociationstudy pages 3-3)
Inheritance / penetrance	Most CFM is sporadic, but familial forms occur. For FOXI3, inheritance can be autosomal dominant with reduced penetrance and/or autosomal recessive. Reduced penetrance is supported by transmission from apparently unaffected parents and a proposed modifier haplotype / gene-dosage model. Family-based OAVS/CFM studies further support incomplete penetrance and variable expressivity.	HPO: Reduced penetrance; HPO: Variable expressivity	(petrin2026familialoculoauriculovertebralspectrum pages 1-3, mao2023foxi3pathogenicvariants pages 1-2, mao2023foxi3pathogenicvariants pages 7-8, mao2023foxi3pathogenicvariants pages 8-9, petrin2026familialoculoauriculovertebralspectrum pages 10-11, petrin2026familialoculoauriculovertebralspectrum pages 15-19)
Developmental mechanism / pathophysiology	Best-supported model is disturbed development of first/second pharyngeal arch derivatives during the first ~6 weeks of embryogenesis, involving cranial neural crest cell migration/differentiation and likely vascular patterning / mandibular growth defects. GWAS candidates are enriched for embryonic development, organ/system development, and cell migration pathways. FOXI3 variants reduce transcriptional activity; NLS variants impair nuclear entry, forkhead-domain variants can cause intranuclear aggregation.	GO: Neural crest cell migration; GO: embryonic craniofacial morphogenesis; GO: regulation of transcription by RNA polymerase II; GO: angiogenesis; CL: cranial neural crest cell; UBERON: Meckel cartilage; UBERON: pharyngeal arch	(mao2023foxi3pathogenicvariants pages 6-7, mao2023foxi3pathogenicvariants pages 5-6, renkema2019extracraniofacialanomaliesin pages 1-2, zhang2016genomewideassociationstudy pages 4-5, zhang2016genomewideassociationstudy pages 3-3, petrin2026familialoculoauriculovertebralspectrum pages 10-11)
Model-organism evidence	Knock-in mouse models of Foxi3 support causality. Homozygotes showed severe craniofacial phenotypes including underdeveloped mandible, microtia/absent external ear, asymmetric skull, cleft palate in ~50%, absent ear bones, and syngnathia; heterozygotes showed milder or variable abnormalities. This provides strong experimental recapitulation of human disease mechanisms.	CL: cranial neural crest cell; GO: animal organ morphogenesis; UBERON: mandible; UBERON: palate; HPO analog terms for human mapping: cleft palate, microtia, mandibular hypoplasia	(mao2023foxi3pathogenicvariants pages 6-7, mao2023foxi3pathogenicvariants pages 7-8, mao2023foxi3pathogenicvariants pages 9-10, mao2023foxi3pathogenicvariants pages 12-13)
Diagnostics	Diagnosis is primarily clinical + imaging-based, using OMENS/OMENS+ and Pruzansky-Kaban classification. Recommended workup includes physical examination plus targeted screening for extracraniofacial anomalies: electrocardiography/echocardiography, renal ultrasound, spinal radiographs, and brain/spine MRI when indicated. Research and specialty-center phenotyping increasingly use 3D imaging / cone-beam CT and genomic sequencing.	NCIT: Magnetic Resonance Imaging; NCIT: Echocardiography; NCIT: Ultrasonography; NCIT: Computed Tomography; NCIT: Genetic Testing; UBERON: kidney; UBERON: vertebral column; UBERON: brain	(renkema2019extracraniofacialanomaliesin pages 7-8, renkema2019extracraniofacialanomaliesin pages 1-2, NCT02639312 chunk 1, NCT03270618 chunk 1)
Management / real-world implementation	Current care is multidisciplinary and predominantly surgical/reconstructive plus hearing, speech, dental/orthodontic, and psychosocial support. Active real-world/research implementations include mandibular distraction osteogenesis with CAD/CAM or computer-guided templates, fat grafting with or without adipose-derived regenerative cells (ADRC) for soft-tissue augmentation, and regenerative adjuncts such as bone marrow aspirate concentrate. Observational registries/natural-history cohorts are also major current applications.	NCIT: Mandibular Distraction Osteogenesis; NCIT: Fat Grafting; NCIT: Reconstructive Surgical Procedure; NCIT: Orthodontic Procedure; NCIT: Speech Therapy; NCIT: Psychosocial Intervention	(NCT01674439 chunk 1, NCT03270618 chunk 1, NCT03869021 chunk 2, NCT03806361 chunk 1, NCT03861650 chunk 2, NCT00340964 chunk 1)
Epidemiology	Frequently cited birth prevalence estimate is approximately 1 in 7,500 live births (from NIH natural-history protocol context). Sex distribution in a large cohort was 53% male / 47% female. Disease burden spans childhood into adulthood because facial growth, occlusion, hearing, airway, and reconstructive needs evolve over time.	HPO: Congenital onset; HPO: Facial asymmetry	(renkema2019extracraniofacialanomaliesin pages 1-2, NCT02639312 chunk 1)
Environmental / prenatal risk factors	Evidence supports multifactorial etiology. Environmental factors mentioned in human studies/reviews include maternal obesity, periconceptional folic acid use, and vasoactive exposures during pregnancy as studied/implicated risk modifiers, but effect sizes and causal certainty remain less robust than for the strongest recent genetic evidence.	CHEBI term suggestions if curating exposures: folic acid; vasoactive agents	(zhang2016genomewideassociationstudy pages 7-8)
Evidence gaps / unavailable or limited data	No validated disease-specific blood/urine biomarkers were identified in retrieved evidence. No established pharmacotherapy, gene therapy, or routine omics-based diagnostic biomarker is in clinical use. Protective genetic/environmental factors are poorly defined. Population-specific prevalence, mortality, life expectancy, penetrance estimates for most genes, and standardized treatment-response rates remain limited. Some recent 2023–2024 surveys/reviews were not fully retrievable in this session, so large parts of current practice still rely on older cohort data plus ongoing trials/registries.	NCIT: Biomarker; NCIT: Gene Therapy; NCIT: Clinical Trial	(OpenTargets Search: craniofacial microsomia, NCT01674439 chunk 1, NCT02639312 chunk 1)

Table: This table condenses the main knowledge-base annotations for craniofacial microsomia, covering identity, phenotype, genetics, mechanisms, diagnostics, management, and gaps. It is useful as a compact structured summary for ontology mapping and evidence-backed curation.

1. Disease information

Definition and terminology

CFM is congenital unilateral or bilateral underdevelopment of facial structures derived predominantly from the first and second pharyngeal arches. Its minimum diagnostic phenotype is debated; ear anomalies, mandibular hypoplasia, facial asymmetry, epibulbar dermoid, and facial tags are variably included. (renkema2019extracraniofacialanomaliesin pages 1-2)

Common names include hemifacial microsomia, oculo-auriculo-vertebral spectrum (OAVS), oculoauriculovertebral dysplasia, first-and-second branchial-arch syndrome, and, less precisely, Goldenhar syndrome/spectrum. “Goldenhar” is often reserved for CFM/OAVS with ocular dermoids and vertebral anomalies. These terms overlap but should not automatically be treated as exact synonyms in computational curation.

Identifiers

MONDO: MONDO:0015397, craniofacial microsomia. A narrower genetic entry, “craniofacial microsomia 2,” is represented as MONDO:0958194 in Open Targets. (OpenTargets Search: craniofacial microsomia)
MeSH: the literature is commonly indexed under Facial Hemiatrophy, Goldenhar Syndrome, Microtia, or related craniofacial-abnormality headings; no single MeSH term perfectly captures the modern CFM spectrum.
ICD-10-CM: no unique, validated CFM code. Coding generally uses Q67.4 (other congenital deformities of skull, face and jaw), Q87.0 (congenital malformation syndromes predominantly affecting facial appearance), and component-specific codes such as microtia or mandibular hypoplasia. Administrative-code case ascertainment can therefore misclassify disease.
ICD-11: component abnormalities or broader congenital craniofacial-malformation categories are generally used; a dedicated universally adopted CFM code was not established in the retrieved evidence.
OMIM/Orphanet: CFM is genetically heterogeneous rather than one uniformly mapped Mendelian entity; gene-defined forms and OAVS-related entries should be curated separately. Exact resource identifiers should be verified against the live databases before production ingestion.

The evidence summarized here is aggregated disease-level evidence from cohorts, trials, genetic studies, and curated resources—not individual EHR data.

2. Etiology and risk factors

Causal model

CFM is a developmental field defect with heterogeneous causes. The likely vulnerable interval is approximately the first six weeks of embryogenesis, when cranial neural-crest cells migrate into the pharyngeal arches and interact with mesoderm, ectoderm, endoderm, and developing vasculature. Disruption can impair mandibular, auricular, facial-muscle, nerve, and soft-tissue development. (renkema2019extracraniofacialanomaliesin pages 1-2, zhang2016genomewideassociationstudy pages 4-5)

Genetic factors

Higher-confidence causes include FOXI3 pathogenic variants and SF3B2 haploinsufficiency. Open Targets associates CFM with SF3B2, FOXI3, and CHAF1A, but database association alone does not establish equal causal certainty. (OpenTargets Search: craniofacial microsomia)

A GWAS of 939 cases and 2,012 controls implicated 13 regions/candidate genes—including ROBO1, GATA3, EPAS1, PARD3B, GBX2, SHROOM3, FGF3, KLF12, EDNRB, SEMA7A, PLCD3, and others—enriched in embryonic-development and neural-crest migration processes. These are susceptibility findings, not individually diagnostic Mendelian causes. (zhang2016genomewideassociationstudy pages 4-5, zhang2016genomewideassociationstudy pages 3-3)

Other reported or emerging genes include MYT1, EYA3, EFTUD2, VWA1, ZYG11B, and family-based candidates SIX1, PDGFRA, and KDR/VEGFR2. Digenic EYA3–EFTUD2 and multilocus models have been proposed, but replication and penetrance estimates remain inadequate. (petrin2026familialoculoauriculovertebralspectrum pages 11-13, petrin2026familialoculoauriculovertebralspectrum pages 10-11, petrin2026familialoculoauriculovertebralspectrum pages 15-19)

Environmental and maternal factors

Reported associations include maternal diabetes/obesity, multiple gestation, assisted reproduction, vasoactive medications or vascular-disrupting exposures, smoking, and altered periconceptional folate exposure. The retrieved GWAS discussion specifically notes maternal obesity, periconceptional folic-acid use, and vasoactive exposures. These associations should be treated as risk modifiers, not proven deterministic causes; confounding and exposure heterogeneity are substantial. (zhang2016genomewideassociationstudy pages 7-8)

No infectious agent is established as a specific cause. Alcohol, retinoids, thalidomide, and other teratogens can produce overlapping first/second-arch phenotypes but should not be equated with idiopathic CFM without exposure evidence.

Protective factors and gene–environment interaction

No validated protective allele or intervention specifically prevents CFM. Standard preconception folate, diabetes control, smoking/alcohol avoidance, medication review, and avoidance of known teratogens are prudent general congenital-anomaly prevention measures, but CFM-specific risk reduction has not been quantified. FOXI3 provides a plausible gene-modifier model: a common allele/haplotype in trans may reduce expression of the normal allele, increasing phenotypic expression of a rare pathogenic allele. Environmental or epigenetic effects could further alter this dosage-sensitive developmental system, but direct human G×E estimates are unavailable. (mao2023foxi3pathogenicvariants pages 1-2, mao2023foxi3pathogenicvariants pages 7-8, mao2023foxi3pathogenicvariants pages 8-9)

3. Phenotypes

CFM is present at birth, although asymmetry may become more conspicuous with growth. Severity and combinations vary markedly.

Mandibular/craniofacial hypoplasia: mandibular ramus/condyle deficiency, micrognathia, chin deviation, malocclusion, maxillary cant, and facial asymmetry. Usually chronic; growth can magnify asymmetry. Suggested HPO: Mandibular hypoplasia, Micrognathia (HP:0000347), Facial asymmetry (HP:0000324), Malocclusion.
Ear and hearing: microtia/anotia, external auditory canal atresia/stenosis, preauricular tags/pits, ossicular abnormalities, and usually conductive hearing loss; sensorineural or mixed loss may occur. Suggested HPO: Microtia (HP:0008551), Preauricular skin tag (HP:0000384), External auditory canal atresia, Conductive hearing impairment (HP:0000405).
Soft tissue/muscle: unilateral facial soft-tissue deficiency and masticatory-muscle hypoplasia; stable defect but relative asymmetry may evolve. Suggested HPO: Hemifacial hypoplasia, Abnormality of facial soft tissue.
Facial nerve: partial facial weakness involving one or more branches, affecting expression, eye closure, oral competence, and speech. Suggested HPO: Facial palsy (HP:0010628).
Orbit/eye: orbital size or position asymmetry, epibulbar dermoid/lipodermoid, upper-eyelid coloboma, and ocular motility/vision problems. Suggested HPO: Epibulbar dermoid, Orbital asymmetry, Coloboma of eyelid.
Oral clefts/macrostomia: lateral facial cleft/macrostomia and cleft lip/palate occur in subsets. Suggested HPO: Macrostomia (HP:0000182), Cleft palate (HP:0000175).
Airway, feeding, and sleep: neonatal airway obstruction is possible in severe micrognathia or bilateral disease; dysphagia, prolonged feeding, aspiration risk, and obstructive sleep apnea may occur.
Speech/language and neurodevelopment: hearing loss, facial/oral structural differences, and treatment burden can affect articulation and language. Population-level neurodevelopment is variable rather than uniformly impaired.
Psychosocial: visible difference, repeated operations, stigma, teasing, and communication impairment may affect self-esteem, social participation, and family stress. The Positive Exposure pilot explicitly measured self-esteem, perceived stigma, and hope, but with only 44 participants and no power for efficacy conclusions. (NCT00340964 chunk 1)

Extracraniofacial phenotype frequencies

Among 991 patients, 47% had extracraniofacial anomalies: vertebral 28%, circulatory 21%, CNS 11%, urogenital 11%, gastrointestinal 9%, and respiratory 3%. Bilateral disease and more severe mandibular, facial-nerve, or soft-tissue scores predicted greater systemic burden. (renkema2019extracraniofacialanomaliesin pages 7-8, renkema2019extracraniofacialanomaliesin pages 1-2)

Quality-of-life effects are phenotype-dependent: hearing and speech affect education and communication; mandibular/occlusal disease affects chewing and appearance; airway disease affects sleep and safety; facial weakness and ocular disease affect function; and visible difference affects psychosocial participation. Validated CFM-specific minimal clinically important differences remain limited.

4. Genetic and molecular information

FOXI3

The landmark April 2023 Nature Communications study examined 670 unrelated CFM pedigrees/probands of European and Chinese ancestry and found 18 likely pathogenic FOXI3 variants in 21 probands (3.1%; 5/124, 4.0%, in the European subset). Variant classes were 14 missense, two in-frame deletions, one frameshift, and one truncating variant. (mao2023foxi3pathogenicvariants pages 1-2, mao2023foxi3pathogenicvariants pages 4-5)

The abstract states: “We identify 18 likely pathogenic variants in 21 probands (3.1%) in FOXI3.” It further concludes that the findings indicate “autosomal dominant inheritance with reduced penetrance, and/or autosomal recessive inheritance.” [Mao et al., published April 2023; DOI: https://doi.org/10.1038/s41467-023-37703-6; PMID: https://pubmed.ncbi.nlm.nih.gov/37041148/] (mao2023foxi3pathogenicvariants pages 1-2)

All tested variants reduced transcriptional activation. Nuclear-localization-signal variants impaired nuclear entry; forkhead-domain variants caused abnormal intranuclear aggregation; other variants had less obvious localization effects. ClinVar submissions include SCV003803092–SCV003803100 and SCV003806728–SCV003806732. (mao2023foxi3pathogenicvariants pages 5-6, mao2023foxi3pathogenicvariants pages 12-13)

SF3B2 and other genes

SF3B2 haploinsufficiency is supported as a Mendelian cause of CFM/OAVS-like disease (PMID: https://pubmed.ncbi.nlm.nih.gov/34344887/). Its likely mechanism is loss of function affecting spliceosome function and neural-crest development. Open Targets ranks SF3B2, FOXI3, and CHAF1A as associated targets, but CHAF1A evidence is currently less mature for routine CFM interpretation. (OpenTargets Search: craniofacial microsomia, petrin2026familialoculoauriculovertebralspectrum pages 11-13)

Reported chromosomal abnormalities include heterogeneous deletions/duplications—among them 1p36 and 1p32–p34 regions—but no single recurrent copy-number change explains most CFM. (petrin2026familialoculoauriculovertebralspectrum pages 11-13)

Variant interpretation

Most causal findings are germline, not somatic.
Expected pathogenic mechanisms include FOXI3 transcription-factor loss/dysfunction and SF3B2 haploinsufficiency.
Population frequency should be checked variant-by-variant in current gnomAD; a universal CFM allele frequency is not meaningful.
Reduced penetrance means an inherited variant from an unaffected parent is not automatically benign.
Most panel/WES findings in candidate genes remain VUS unless segregation, phenotype, population frequency, and functional evidence satisfy ACMG/AMP criteria.

No validated epigenetic signature, disease-specific methylation episignature, proteomic biomarker, metabolomic signature, or modifier gene suitable for routine diagnosis was identified.

5. Environmental information

The vascular-disruption hypothesis is biologically plausible because pharyngeal-arch growth depends on transient embryonic arteries and neural-crest–vascular signaling. Reported maternal vasoactive exposures and vascular-risk states are compatible with this model, but causal attribution in an individual pregnancy is generally impossible. (zhang2016genomewideassociationstudy pages 7-8, petrin2026familialoculoauriculovertebralspectrum pages 10-11)

Smoking, alcohol, poor glycemic control, obesity, and teratogenic medications are modifiable general pregnancy risks. Exercise is not known to alter CFM risk. CFM is not infectious, contagious, occupationally acquired, or zoonotic.

6. Mechanism and pathophysiology

Proposed causal chain

Upstream trigger: rare damaging variants (e.g., FOXI3 or SF3B2), polygenic susceptibility, chromosomal variation, and/or an embryonic vascular/environmental insult.
Cellular disturbance: altered transcription or RNA splicing; impaired cranial neural-crest specification, migration, survival, differentiation, or signaling with arch mesoderm and vasculature.
Developmental field effect: abnormal first/second pharyngeal-arch patterning and Meckel-cartilage/mandibular, auricular, ossicular, muscle, nerve, and soft-tissue morphogenesis.
Primary phenotype: microtia, mandibular hypoplasia, facial asymmetry, facial tags, ocular dermoids, facial-nerve weakness.
Downstream consequences: conductive hearing loss, malocclusion, feeding/speech impairment, airway obstruction/OSA, altered facial growth, and psychosocial burden.

GWAS genes are enriched in cell differentiation, migration, and organ development. VEGF–KDR signaling is a plausible vascular/mechanistic bridge: neural-crest-derived VEGF supports vessel growth and Meckel-cartilage/mandibular development. (zhang2016genomewideassociationstudy pages 4-5, zhang2016genomewideassociationstudy pages 3-3, petrin2026familialoculoauriculovertebralspectrum pages 10-11)

Suggested annotations include GO: neural crest cell migration; embryonic craniofacial morphogenesis; pharyngeal system development; angiogenesis; RNA splicing; regulation of transcription by RNA polymerase II. Relevant cell types are cranial neural crest cell, pharyngeal-arch mesenchymal cell, chondrocyte, osteoblast, myocyte, Schwann-cell/facial motor-neuron lineage, endothelial cell, and otic epithelial cell. Relevant compartments for FOXI3 include nucleus and cytoplasm; SF3B2 localizes to the spliceosomal/nuclear machinery.

There is no established primary immune, inflammatory, metabolic, mitochondrial, lysosomal, or protein-aggregation mechanism. Multi-omics, single-cell, spatial-transcriptomic, and CRISPR-screen evidence in human CFM remains research-stage.

7. Anatomical structures affected

Primary sites include the mandible (ramus, condyle, temporomandibular joint), maxilla, zygoma, temporal bone, external/middle ear, orbit, facial soft tissue and muscles of mastication, facial nerve, oral commissure, and pharyngeal airway. Secondary systems include vertebral column, heart/great vessels, kidney/urogenital tract, CNS, gastrointestinal, and respiratory systems. (renkema2019extracraniofacialanomaliesin pages 1-2)

Suggested UBERON terms: pharyngeal arch, mandible, Meckel cartilage, temporomandibular joint, maxilla, zygomatic bone, pinna, external acoustic meatus, middle ear, orbit, facial nerve, vertebral column, heart, kidney, brain, pharynx.

CFM is characteristically asymmetric: 83% unilateral and 12% bilateral in the large cohort; percentages do not sum to 100% because of missing/other classification data. (renkema2019extracraniofacialanomaliesin pages 1-2)

8. Temporal development

Onset is prenatal/congenital, not acute or episodic. The malformation itself does not remit. Its clinical expression changes with growth: hearing and airway problems may be evident in infancy; speech, dental, and educational consequences emerge in childhood; skeletal asymmetry and malocclusion may become more pronounced during facial growth; definitive orthognathic correction is often deferred until near skeletal maturity.

Critical windows are: early embryogenesis for causation; neonatal infancy for airway, feeding, and hearing detection; early childhood for language and psychosocial development; mixed dentition for orthodontic planning; and skeletal maturity for definitive jaw correction. NIH protocol NCT02639312 follows participants across developmental strata for as long as 17 years, illustrating the need for longitudinal rather than single-time-point assessment. (NCT02639312 chunk 1)

9. Inheritance and population

A commonly cited birth prevalence is approximately 1 in 7,500 live births (about 13.3/100,000), although estimates vary by definition and ascertainment. The 991-person cohort was 53% male and 47% female. (renkema2019extracraniofacialanomaliesin pages 1-2, NCT02639312 chunk 1)

Most cases are sporadic. Gene-defined families may show autosomal-dominant inheritance with incomplete penetrance and variable expressivity; FOXI3 also supports recessive or compound dosage models. Anticipation is not established. Germline mosaicism is possible in principle but not quantified. No robust founder variant, carrier frequency, consanguinity effect, or ancestry-specific incidence is established for CFM overall. (mao2023foxi3pathogenicvariants pages 1-2, mao2023foxi3pathogenicvariants pages 7-8)

10. Diagnostics

Clinical diagnosis

Diagnosis is based on physical examination and imaging. OMENS/OMENS+ scores the orbit, mandible, ear, facial nerve, soft tissue, and extracraniofacial findings; Pruzansky–Kaban grades mandibular/TMJ deficiency. These are severity/classification systems, not perfectly validated binary diagnostic criteria. The 2023 FOXI3 study used OMENS phenotyping. (mao2023foxi3pathogenicvariants pages 9-10)

Baseline evaluation

A craniofacial team should assess airway/sleep, feeding/swallowing, growth, ear anatomy and hearing, speech/language, vision, facial nerve, occlusion/dentition, spine, cardiac examination, renal/urogenital findings, development, and psychosocial needs.

Because 47% of a large cohort had extracraniofacial anomalies, authors recommended careful circulatory, renal, and neurologic examination, ECG/echocardiography, renal ultrasound, spinal imaging when indicated, and brain/spine MRI where neurologic abnormalities warrant it. Local guidelines differ on universal versus phenotype-triggered screening. (renkema2019extracraniofacialanomaliesin pages 7-8)

Useful tests include newborn/diagnostic audiology, temporal-bone CT for conductive anatomy and implant planning, low-dose craniofacial CT or cone-beam CT for skeletal planning, 3D photography, polysomnography when OSA is suspected, ophthalmologic examination, echocardiography, renal ultrasound, and spine radiography/MRI. No diagnostic blood chemistry, enzyme assay, biopsy, EEG, or disease-specific circulating biomarker exists.

Genetic testing

A reasonable algorithm is:

Clinical genetics examination and three-generation pedigree.
Chromosomal microarray when there are multiple congenital anomalies, developmental delay, or dysmorphism beyond typical CFM.
Trio exome or genome sequencing, preferably with CNV/SV analysis, for bilateral/severe disease, positive family history, or syndromic findings.
Include FOXI3 and SF3B2; broader craniofacial/OAVS panels may include MYT1 and differential-diagnosis genes. Candidate-gene results require cautious interpretation.
Targeted parental testing for segregation and penetrance assessment.

WGS is attractive because CFM may involve coding variants, CNVs, structural variants, and noncoding modifiers; however, routine diagnostic yield for unselected CFM is not established. The NIH natural-history study combines 3D imaging and genomic testing. (NCT02639312 chunk 1)

Differential diagnosis

Important alternatives include Treacher Collins syndrome (TCOF1, POLR1D, POLR1C; usually bilateral symmetric zygomatic/mandibular disease), mandibulofacial dysostosis with microcephaly (EFTUD2), Nager syndrome (SF3B4, preaxial limb defects), auriculocondylar syndrome (PLCB4, GNAI3, EDN1), CHARGE (CHD7), branchio-oto-renal syndrome (EYA1/SIX1), isolated microtia, craniofacial clefts, Parry–Romberg syndrome/progressive hemifacial atrophy (acquired progressive tissue loss), and teratogenic embryopathies.

There is no population newborn genetic screen or general carrier screen. Newborn hearing screening is clinically important but is not CFM-specific.

11. Outcome and prognosis

CFM itself usually does not shorten life expectancy. Mortality and five- or ten-year survival estimates are not established because prognosis depends on associated cardiac, airway, neurologic, and other anomalies. Severe neonatal airway obstruction or major congenital heart disease drives the greatest medical risk.

Long-term morbidity includes hearing impairment, speech/language difficulty, malocclusion and chewing impairment, OSA, feeding problems, facial weakness, visual problems, spinal disease, repeated surgery, and psychosocial burden. More severe OMENS/Pruzansky–Kaban findings and bilateral disease predict greater systemic anomaly burden. (renkema2019extracraniofacialanomaliesin pages 1-2, renkema2019extracraniofacialanomaliesin pages 7-8)

Anatomic “recovery” does not occur spontaneously. Treatment can improve airway, hearing, occlusion, symmetry, and participation, but growth-related recurrence/residual asymmetry and revision surgery are common. No validated molecular prognostic biomarker exists.

12. Treatment and current implementation

Multidisciplinary strategy

Care should be individualized through craniofacial surgery, otology/audiology, orthodontics, maxillofacial surgery, speech-language pathology, ophthalmology, sleep/airway specialists, clinical genetics, pediatrics, psychology, and social work.

Airway: positioning and noninvasive support in mild cases; tongue–lip adhesion, tracheostomy, or mandibular distraction in severe obstruction, selected by anatomy and physiology.
Hearing: bone-conduction amplification in infancy, conventional aids where feasible, canal/ossicular reconstruction in selected patients, and implantable bone-conduction devices.
Mandible/TMJ: mandibular distraction osteogenesis, costochondral graft or vascularized bone reconstruction for severe ramus/condyle absence, and orthognathic surgery at/near maturity. Early distraction can relieve airway or severe asymmetry but does not reliably eliminate later orthognathic surgery.
Orthodontics: functional appliances in selected growing children, occlusal management, presurgical orthodontics.
Ear: autologous rib-cartilage reconstruction, porous polyethylene reconstruction, or prosthetic rehabilitation; coordinate timing with hearing surgery.
Soft tissue: structural fat grafting, free-flap augmentation, or other contour procedures.
Facial nerve: eye protection, static procedures, nerve/muscle transfer, or free functional muscle transfer in selected patients.
Rehabilitation: feeding therapy, speech/language treatment, dental care, physical therapy where spine/limb anomalies occur, and psychosocial support.

Suggested NCIt intervention concepts include reconstructive surgery, mandibular distraction osteogenesis, orthognathic surgery, bone grafting, fat grafting, hearing aid, cochlear/osseointegrated hearing device, speech therapy, orthodontic treatment, and psychosocial intervention.

Trials and applications

NCT01674439: completed phase 2 randomized double-blind trial, 29 participants aged 10–35, comparing adipose-derived regenerative-cell-supplemented fat grafting with standard grafting; primary outcome was six-month CT volume retention. (NCT01674439 chunk 1)
NCT03806361: completed randomized pediatric trial, 30 children, comparing the same strategies with serial 3D-photogrammetric retention outcomes. (NCT03806361 chunk 1)
NCT03270618: approximately 30 participants; evaluated CAD/CAM/3D-printed templates for osteotomy and distractor placement. (NCT03270618 chunk 1)
NCT03869021: randomized 12-person comparison of computer-guided versus free-hand mandibular distraction, assessing six-month cephalometric/cosmetic outcomes. (NCT03869021 chunk 2)
NCT03861650: controlled BMAC-versus-saline adjunct study during mandibular distraction, using six-month CBCT bone density. This is regenerative-surgery research, not established stem-cell therapy. (NCT03861650 chunk 2)
NCT02639312: recruiting NIH observational natural-history/genomics study, target enrollment 2,400; not a treatment trial. (NCT02639312 chunk 1)

No approved CFM-specific pharmacotherapy, pharmacogenomic algorithm, gene therapy, RNA therapy, immunotherapy, or molecularly targeted treatment exists.

13. Prevention

Primary prevention is limited because most cases are sporadic and causes are incompletely known. Recommended measures are standard preconception/pregnancy care: folic acid at guideline doses, glycemic and weight optimization, smoking/alcohol avoidance, review of vasoactive or teratogenic medicines, and avoidance of known teratogens. These measures should not be represented as proven CFM-specific prophylaxis. (zhang2016genomewideassociationstudy pages 7-8)

Secondary/tertiary prevention is more actionable: prenatal ultrasound may detect micrognathia, facial asymmetry, microtia, or systemic anomalies; postnatal early hearing, airway, feeding, cardiac, renal, spinal, visual, and developmental assessment can prevent avoidable complications. Early amplification and speech intervention reduce secondary communication disability.

For a known familial pathogenic variant, genetic counseling should explain incomplete penetrance and variable expressivity. Prenatal diagnosis and preimplantation genetic testing may be technically possible for a clearly pathogenic familial variant, but phenotype severity may remain unpredictable. No vaccine or medication prevents CFM.

14. Other species and natural disease

CFM is not transmissible or zoonotic. Naturally occurring FOXI3 variation in hairless dog breeds produces ectodermal hair/dental phenotypes rather than a complete human CFM analogue, illustrating conserved FOXI3 developmental biology but limited phenotypic equivalence. (mao2023foxi3pathogenicvariants pages 8-9)

Species annotations of relevance include Homo sapiens (NCBI Taxon 9606), Mus musculus (10090), Danio rerio (7955), and Canis lupus familiaris (9615). Ortholog studies support conservation of FOXI3 and neural-crest/pharyngeal-arch pathways. No veterinary syndrome should be labeled identical to human CFM without direct comparative evidence.

15. Model organisms

The strongest model is the CRISPR knock-in mouse. Foxi3 F218L, R224H, and triple-mutant R220W/R222Q/R224H lines were developed. Homozygous mutants showed mandibular underdevelopment, absent or severe microtia, skull asymmetry, absent ear bones, syngnathia, and cleft palate in approximately 50%; the triple homozygous state was embryonic/neonatal lethal, while heterozygotes were viable with milder/variable skeletal findings. (mao2023foxi3pathogenicvariants pages 6-7, mao2023foxi3pathogenicvariants pages 7-8, mao2023foxi3pathogenicvariants pages 12-13)

These models recapitulate ear, jaw, palate, and craniofacial skeletal abnormalities and support FOXI3 dosage sensitivity. Limitations are greater severity and lethality than typical human heterozygous CFM, species-specific craniofacial anatomy, and incomplete modeling of psychosocial, hearing-language, and long-term surgical outcomes.

GWAS candidate-gene mutant mice and developmental zebrafish systems are useful for neural-crest migration, pharyngeal-arch patterning, vascular signaling, cartilage, and osteogenesis studies. Nine GWAS candidate-gene mouse models reportedly displayed craniofacial abnormalities, but they model pathway perturbation rather than proving each locus causes human CFM. (zhang2016genomewideassociationstudy pages 4-5)

Recent developments, expert interpretation, and evidence gaps

The most consequential 2023 development was FOXI3 gene validation across human genetics, cell biology, and knock-in mice. Its diagnostic contribution is real but modest—3.1% in the reported cohort—so a negative FOXI3 result does not exclude CFM. The study’s modifier-haplotype result also explains why apparently unaffected parents can transmit a clinically important allele. (mao2023foxi3pathogenicvariants pages 1-2, mao2023foxi3pathogenicvariants pages 8-9)

Recent work has also emphasized standardized research criteria, 3D phenotyping, registries, longitudinal outcomes, psychosocial experience, and digitally guided surgery. The field is moving from descriptive morphology toward integrated genomic–phenomic models, but practice remains variable and comparative treatment trials are small.

Major knowledge gaps are: validated diagnostic criteria; ancestry-diverse incidence estimates; penetrance and genotype–phenotype data for genes other than FOXI3; rigorous G×E estimates; disease-specific biomarkers or omics signatures; standardized patient-reported outcomes; and adequately powered comparisons of distraction, grafting, orthognathic, ear, and soft-tissue strategies. The 991-patient anomaly cohort is authoritative for systemic burden but retrospective and referral-center based, while current interventional studies generally enroll only 12–30 participants. (renkema2019extracraniofacialanomaliesin pages 1-2, NCT01674439 chunk 1, NCT03869021 chunk 2, NCT03806361 chunk 1)

Key references

Mao K, et al. FOXI3 pathogenic variants cause one form of craniofacial microsomia. Nature Communications. Published April 2023. DOI: https://doi.org/10.1038/s41467-023-37703-6. PMID: https://pubmed.ncbi.nlm.nih.gov/37041148/ (mao2023foxi3pathogenicvariants pages 1-2)
Renkema RW, et al. Extracraniofacial anomalies in craniofacial microsomia: retrospective analysis of 991 patients. International Journal of Oral and Maxillofacial Surgery. Published September 2019. DOI: https://doi.org/10.1016/j.ijom.2019.01.031. (renkema2019extracraniofacialanomaliesin pages 1-2)
Zhang Y-B, et al. Genome-wide association study identifies multiple susceptibility loci for craniofacial microsomia. Nature Communications. Published February 2016. DOI: https://doi.org/10.1038/ncomms10605. (zhang2016genomewideassociationstudy pages 4-5, zhang2016genomewideassociationstudy pages 3-3)
Open Targets. Craniofacial microsomia–target associations: SF3B2, FOXI3, and CHAF1A; includes PMID 34344887 for SF3B2 and PMIDs 36260083/37041148 for FOXI3. Accessed through the current tool query. (OpenTargets Search: craniofacial microsomia)
ClinicalTrials.gov. Natural History of Craniofacial Anomalies and Developmental Growth Variants, NCT02639312. NIH/NIDCR; recruiting observational study, planned enrollment 2,400. https://clinicaltrials.gov/study/NCT02639312 (NCT02639312 chunk 1)
ClinicalTrials.gov. Clinical Trial of Fat Grafts Supplemented With Adipose-derived Regenerative Cells, NCT01674439. https://clinicaltrials.gov/study/NCT01674439 (NCT01674439 chunk 1)

Curation conclusion: CFM should be represented as a congenital, complex, etiologically heterogeneous craniofacial-developmental spectrum. Gene-defined FOXI3- and SF3B2-associated forms can be separately annotated, but most cases remain multifactorial/unsolved. Phenotype and systemic screening data are stronger than evidence for any one reconstructive treatment algorithm.

References

(renkema2019extracraniofacialanomaliesin pages 1-2): R.W. Renkema, C.J.J.M. Caron, E. Pauws, E.B. Wolvius, J.A.M. Schipper, W. Rooijers, D.J. Dunaway, C.R. Forrest, B.L. Padwa, and M.J. Koudstaal. Extracraniofacial anomalies in craniofacial microsomia: retrospective analysis of 991 patients. International journal of oral and maxillofacial surgery, 48:1169-1176, Sep 2019. URL: https://doi.org/10.1016/j.ijom.2019.01.031, doi:10.1016/j.ijom.2019.01.031. This article has 50 citations and is from a peer-reviewed journal.
(OpenTargets Search: craniofacial microsomia): Open Targets Query (craniofacial microsomia, 7 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(mao2023foxi3pathogenicvariants pages 1-2): Ke Mao, Christelle Borel, Muhammad Ansar, Angad Jolly, Periklis Makrythanasis, Christine Froehlich, Justyna Iwaszkiewicz, Bingqing Wang, Xiaopeng Xu, Qiang Li, Xavier Blanc, Hao Zhu, Qi Chen, Fujun Jin, Harinarayana Ankamreddy, Sunita Singh, Hongyuan Zhang, Xiaogang Wang, Peiwei Chen, Emmanuelle Ranza, Sohail Aziz Paracha, Syed Fahim Shah, Valentina Guida, Francesca Piceci-Sparascio, Daniela Melis, Bruno Dallapiccola, Maria Cristina Digilio, Antonio Novelli, Monia Magliozzi, Maria Teresa Fadda, Haley Streff, Keren Machol, Richard A. Lewis, Vincent Zoete, Gabriella Maria Squeo, Paolo Prontera, Giorgia Mancano, Giulia Gori, Milena Mariani, Angelo Selicorni, Stavroula Psoni, Helen Fryssira, Sofia Douzgou, Sandrine Marlin, Saskia Biskup, Alessandro De Luca, Giuseppe Merla, Shouqin Zhao, Timothy C. Cox, Andrew K. Groves, James R. Lupski, Qingguo Zhang, Yong-Biao Zhang, and Stylianos E. Antonarakis. Foxi3 pathogenic variants cause one form of craniofacial microsomia. Nature Communications, Apr 2023. URL: https://doi.org/10.1038/s41467-023-37703-6, doi:10.1038/s41467-023-37703-6. This article has 41 citations and is from a highest quality peer-reviewed journal.
(mao2023foxi3pathogenicvariants pages 5-6): Ke Mao, Christelle Borel, Muhammad Ansar, Angad Jolly, Periklis Makrythanasis, Christine Froehlich, Justyna Iwaszkiewicz, Bingqing Wang, Xiaopeng Xu, Qiang Li, Xavier Blanc, Hao Zhu, Qi Chen, Fujun Jin, Harinarayana Ankamreddy, Sunita Singh, Hongyuan Zhang, Xiaogang Wang, Peiwei Chen, Emmanuelle Ranza, Sohail Aziz Paracha, Syed Fahim Shah, Valentina Guida, Francesca Piceci-Sparascio, Daniela Melis, Bruno Dallapiccola, Maria Cristina Digilio, Antonio Novelli, Monia Magliozzi, Maria Teresa Fadda, Haley Streff, Keren Machol, Richard A. Lewis, Vincent Zoete, Gabriella Maria Squeo, Paolo Prontera, Giorgia Mancano, Giulia Gori, Milena Mariani, Angelo Selicorni, Stavroula Psoni, Helen Fryssira, Sofia Douzgou, Sandrine Marlin, Saskia Biskup, Alessandro De Luca, Giuseppe Merla, Shouqin Zhao, Timothy C. Cox, Andrew K. Groves, James R. Lupski, Qingguo Zhang, Yong-Biao Zhang, and Stylianos E. Antonarakis. Foxi3 pathogenic variants cause one form of craniofacial microsomia. Nature Communications, Apr 2023. URL: https://doi.org/10.1038/s41467-023-37703-6, doi:10.1038/s41467-023-37703-6. This article has 41 citations and is from a highest quality peer-reviewed journal.
(NCT02639312 chunk 1): Natural History of Craniofacial Anomalies and Developmental Growth Variants. National Institute of Dental and Craniofacial Research (NIDCR). 2016. ClinicalTrials.gov Identifier: NCT02639312
(mao2023foxi3pathogenicvariants pages 9-10): Ke Mao, Christelle Borel, Muhammad Ansar, Angad Jolly, Periklis Makrythanasis, Christine Froehlich, Justyna Iwaszkiewicz, Bingqing Wang, Xiaopeng Xu, Qiang Li, Xavier Blanc, Hao Zhu, Qi Chen, Fujun Jin, Harinarayana Ankamreddy, Sunita Singh, Hongyuan Zhang, Xiaogang Wang, Peiwei Chen, Emmanuelle Ranza, Sohail Aziz Paracha, Syed Fahim Shah, Valentina Guida, Francesca Piceci-Sparascio, Daniela Melis, Bruno Dallapiccola, Maria Cristina Digilio, Antonio Novelli, Monia Magliozzi, Maria Teresa Fadda, Haley Streff, Keren Machol, Richard A. Lewis, Vincent Zoete, Gabriella Maria Squeo, Paolo Prontera, Giorgia Mancano, Giulia Gori, Milena Mariani, Angelo Selicorni, Stavroula Psoni, Helen Fryssira, Sofia Douzgou, Sandrine Marlin, Saskia Biskup, Alessandro De Luca, Giuseppe Merla, Shouqin Zhao, Timothy C. Cox, Andrew K. Groves, James R. Lupski, Qingguo Zhang, Yong-Biao Zhang, and Stylianos E. Antonarakis. Foxi3 pathogenic variants cause one form of craniofacial microsomia. Nature Communications, Apr 2023. URL: https://doi.org/10.1038/s41467-023-37703-6, doi:10.1038/s41467-023-37703-6. This article has 41 citations and is from a highest quality peer-reviewed journal.
(renkema2019extracraniofacialanomaliesin pages 7-8): R.W. Renkema, C.J.J.M. Caron, E. Pauws, E.B. Wolvius, J.A.M. Schipper, W. Rooijers, D.J. Dunaway, C.R. Forrest, B.L. Padwa, and M.J. Koudstaal. Extracraniofacial anomalies in craniofacial microsomia: retrospective analysis of 991 patients. International journal of oral and maxillofacial surgery, 48:1169-1176, Sep 2019. URL: https://doi.org/10.1016/j.ijom.2019.01.031, doi:10.1016/j.ijom.2019.01.031. This article has 50 citations and is from a peer-reviewed journal.
(petrin2026familialoculoauriculovertebralspectrum pages 11-13): Aline L Petrin, Ligiane Alves Machado-Paula, Austin Hinkle, Luke Hovey, Waheed Awotoye, Michael Chimenti, Benjamin Darbro, Lucilene A Ribeiro-Bicudo, Shareef M Dabdoub, Tabitha Peter, Patrick Breheny, Jeffrey C Murray, Eric Van Otterloo, Shankar Rengasamy Venugopalan, and Lina M Moreno-Uribe. Familial oculoauriculovertebral spectrum: a genomic investigation of autosomal dominant inheritance. The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association, pages 10556656241306202, Jan 2026. URL: https://doi.org/10.1177/10556656241306202, doi:10.1177/10556656241306202. This article has 0 citations.
(petrin2026familialoculoauriculovertebralspectrum pages 1-3): Aline L Petrin, Ligiane Alves Machado-Paula, Austin Hinkle, Luke Hovey, Waheed Awotoye, Michael Chimenti, Benjamin Darbro, Lucilene A Ribeiro-Bicudo, Shareef M Dabdoub, Tabitha Peter, Patrick Breheny, Jeffrey C Murray, Eric Van Otterloo, Shankar Rengasamy Venugopalan, and Lina M Moreno-Uribe. Familial oculoauriculovertebral spectrum: a genomic investigation of autosomal dominant inheritance. The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association, pages 10556656241306202, Jan 2026. URL: https://doi.org/10.1177/10556656241306202, doi:10.1177/10556656241306202. This article has 0 citations.
(mao2023foxi3pathogenicvariants pages 6-7): Ke Mao, Christelle Borel, Muhammad Ansar, Angad Jolly, Periklis Makrythanasis, Christine Froehlich, Justyna Iwaszkiewicz, Bingqing Wang, Xiaopeng Xu, Qiang Li, Xavier Blanc, Hao Zhu, Qi Chen, Fujun Jin, Harinarayana Ankamreddy, Sunita Singh, Hongyuan Zhang, Xiaogang Wang, Peiwei Chen, Emmanuelle Ranza, Sohail Aziz Paracha, Syed Fahim Shah, Valentina Guida, Francesca Piceci-Sparascio, Daniela Melis, Bruno Dallapiccola, Maria Cristina Digilio, Antonio Novelli, Monia Magliozzi, Maria Teresa Fadda, Haley Streff, Keren Machol, Richard A. Lewis, Vincent Zoete, Gabriella Maria Squeo, Paolo Prontera, Giorgia Mancano, Giulia Gori, Milena Mariani, Angelo Selicorni, Stavroula Psoni, Helen Fryssira, Sofia Douzgou, Sandrine Marlin, Saskia Biskup, Alessandro De Luca, Giuseppe Merla, Shouqin Zhao, Timothy C. Cox, Andrew K. Groves, James R. Lupski, Qingguo Zhang, Yong-Biao Zhang, and Stylianos E. Antonarakis. Foxi3 pathogenic variants cause one form of craniofacial microsomia. Nature Communications, Apr 2023. URL: https://doi.org/10.1038/s41467-023-37703-6, doi:10.1038/s41467-023-37703-6. This article has 41 citations and is from a highest quality peer-reviewed journal.
(mao2023foxi3pathogenicvariants pages 4-5): Ke Mao, Christelle Borel, Muhammad Ansar, Angad Jolly, Periklis Makrythanasis, Christine Froehlich, Justyna Iwaszkiewicz, Bingqing Wang, Xiaopeng Xu, Qiang Li, Xavier Blanc, Hao Zhu, Qi Chen, Fujun Jin, Harinarayana Ankamreddy, Sunita Singh, Hongyuan Zhang, Xiaogang Wang, Peiwei Chen, Emmanuelle Ranza, Sohail Aziz Paracha, Syed Fahim Shah, Valentina Guida, Francesca Piceci-Sparascio, Daniela Melis, Bruno Dallapiccola, Maria Cristina Digilio, Antonio Novelli, Monia Magliozzi, Maria Teresa Fadda, Haley Streff, Keren Machol, Richard A. Lewis, Vincent Zoete, Gabriella Maria Squeo, Paolo Prontera, Giorgia Mancano, Giulia Gori, Milena Mariani, Angelo Selicorni, Stavroula Psoni, Helen Fryssira, Sofia Douzgou, Sandrine Marlin, Saskia Biskup, Alessandro De Luca, Giuseppe Merla, Shouqin Zhao, Timothy C. Cox, Andrew K. Groves, James R. Lupski, Qingguo Zhang, Yong-Biao Zhang, and Stylianos E. Antonarakis. Foxi3 pathogenic variants cause one form of craniofacial microsomia. Nature Communications, Apr 2023. URL: https://doi.org/10.1038/s41467-023-37703-6, doi:10.1038/s41467-023-37703-6. This article has 41 citations and is from a highest quality peer-reviewed journal.
(zhang2016genomewideassociationstudy pages 4-5): Yong-Biao Zhang, Jintian Hu, Jiao Zhang, Xu Zhou, Xin Li, Chaohao Gu, Tun Liu, Yangchun Xie, Jiqiang Liu, Mingliang Gu, Panpan Wang, Tingting Wu, Jin Qian, Yue Wang, Xiaoqun Dong, Jun Yu, and Qingguo Zhang. Genome-wide association study identifies multiple susceptibility loci for craniofacial microsomia. Nature Communications, Feb 2016. URL: https://doi.org/10.1038/ncomms10605, doi:10.1038/ncomms10605. This article has 46 citations and is from a highest quality peer-reviewed journal.
(zhang2016genomewideassociationstudy pages 7-8): Yong-Biao Zhang, Jintian Hu, Jiao Zhang, Xu Zhou, Xin Li, Chaohao Gu, Tun Liu, Yangchun Xie, Jiqiang Liu, Mingliang Gu, Panpan Wang, Tingting Wu, Jin Qian, Yue Wang, Xiaoqun Dong, Jun Yu, and Qingguo Zhang. Genome-wide association study identifies multiple susceptibility loci for craniofacial microsomia. Nature Communications, Feb 2016. URL: https://doi.org/10.1038/ncomms10605, doi:10.1038/ncomms10605. This article has 46 citations and is from a highest quality peer-reviewed journal.
(zhang2016genomewideassociationstudy pages 3-3): Yong-Biao Zhang, Jintian Hu, Jiao Zhang, Xu Zhou, Xin Li, Chaohao Gu, Tun Liu, Yangchun Xie, Jiqiang Liu, Mingliang Gu, Panpan Wang, Tingting Wu, Jin Qian, Yue Wang, Xiaoqun Dong, Jun Yu, and Qingguo Zhang. Genome-wide association study identifies multiple susceptibility loci for craniofacial microsomia. Nature Communications, Feb 2016. URL: https://doi.org/10.1038/ncomms10605, doi:10.1038/ncomms10605. This article has 46 citations and is from a highest quality peer-reviewed journal.
(mao2023foxi3pathogenicvariants pages 7-8): Ke Mao, Christelle Borel, Muhammad Ansar, Angad Jolly, Periklis Makrythanasis, Christine Froehlich, Justyna Iwaszkiewicz, Bingqing Wang, Xiaopeng Xu, Qiang Li, Xavier Blanc, Hao Zhu, Qi Chen, Fujun Jin, Harinarayana Ankamreddy, Sunita Singh, Hongyuan Zhang, Xiaogang Wang, Peiwei Chen, Emmanuelle Ranza, Sohail Aziz Paracha, Syed Fahim Shah, Valentina Guida, Francesca Piceci-Sparascio, Daniela Melis, Bruno Dallapiccola, Maria Cristina Digilio, Antonio Novelli, Monia Magliozzi, Maria Teresa Fadda, Haley Streff, Keren Machol, Richard A. Lewis, Vincent Zoete, Gabriella Maria Squeo, Paolo Prontera, Giorgia Mancano, Giulia Gori, Milena Mariani, Angelo Selicorni, Stavroula Psoni, Helen Fryssira, Sofia Douzgou, Sandrine Marlin, Saskia Biskup, Alessandro De Luca, Giuseppe Merla, Shouqin Zhao, Timothy C. Cox, Andrew K. Groves, James R. Lupski, Qingguo Zhang, Yong-Biao Zhang, and Stylianos E. Antonarakis. Foxi3 pathogenic variants cause one form of craniofacial microsomia. Nature Communications, Apr 2023. URL: https://doi.org/10.1038/s41467-023-37703-6, doi:10.1038/s41467-023-37703-6. This article has 41 citations and is from a highest quality peer-reviewed journal.
(mao2023foxi3pathogenicvariants pages 8-9): Ke Mao, Christelle Borel, Muhammad Ansar, Angad Jolly, Periklis Makrythanasis, Christine Froehlich, Justyna Iwaszkiewicz, Bingqing Wang, Xiaopeng Xu, Qiang Li, Xavier Blanc, Hao Zhu, Qi Chen, Fujun Jin, Harinarayana Ankamreddy, Sunita Singh, Hongyuan Zhang, Xiaogang Wang, Peiwei Chen, Emmanuelle Ranza, Sohail Aziz Paracha, Syed Fahim Shah, Valentina Guida, Francesca Piceci-Sparascio, Daniela Melis, Bruno Dallapiccola, Maria Cristina Digilio, Antonio Novelli, Monia Magliozzi, Maria Teresa Fadda, Haley Streff, Keren Machol, Richard A. Lewis, Vincent Zoete, Gabriella Maria Squeo, Paolo Prontera, Giorgia Mancano, Giulia Gori, Milena Mariani, Angelo Selicorni, Stavroula Psoni, Helen Fryssira, Sofia Douzgou, Sandrine Marlin, Saskia Biskup, Alessandro De Luca, Giuseppe Merla, Shouqin Zhao, Timothy C. Cox, Andrew K. Groves, James R. Lupski, Qingguo Zhang, Yong-Biao Zhang, and Stylianos E. Antonarakis. Foxi3 pathogenic variants cause one form of craniofacial microsomia. Nature Communications, Apr 2023. URL: https://doi.org/10.1038/s41467-023-37703-6, doi:10.1038/s41467-023-37703-6. This article has 41 citations and is from a highest quality peer-reviewed journal.
(petrin2026familialoculoauriculovertebralspectrum pages 10-11): Aline L Petrin, Ligiane Alves Machado-Paula, Austin Hinkle, Luke Hovey, Waheed Awotoye, Michael Chimenti, Benjamin Darbro, Lucilene A Ribeiro-Bicudo, Shareef M Dabdoub, Tabitha Peter, Patrick Breheny, Jeffrey C Murray, Eric Van Otterloo, Shankar Rengasamy Venugopalan, and Lina M Moreno-Uribe. Familial oculoauriculovertebral spectrum: a genomic investigation of autosomal dominant inheritance. The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association, pages 10556656241306202, Jan 2026. URL: https://doi.org/10.1177/10556656241306202, doi:10.1177/10556656241306202. This article has 0 citations.
(petrin2026familialoculoauriculovertebralspectrum pages 15-19): Aline L Petrin, Ligiane Alves Machado-Paula, Austin Hinkle, Luke Hovey, Waheed Awotoye, Michael Chimenti, Benjamin Darbro, Lucilene A Ribeiro-Bicudo, Shareef M Dabdoub, Tabitha Peter, Patrick Breheny, Jeffrey C Murray, Eric Van Otterloo, Shankar Rengasamy Venugopalan, and Lina M Moreno-Uribe. Familial oculoauriculovertebral spectrum: a genomic investigation of autosomal dominant inheritance. The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association, pages 10556656241306202, Jan 2026. URL: https://doi.org/10.1177/10556656241306202, doi:10.1177/10556656241306202. This article has 0 citations.
(mao2023foxi3pathogenicvariants pages 12-13): Ke Mao, Christelle Borel, Muhammad Ansar, Angad Jolly, Periklis Makrythanasis, Christine Froehlich, Justyna Iwaszkiewicz, Bingqing Wang, Xiaopeng Xu, Qiang Li, Xavier Blanc, Hao Zhu, Qi Chen, Fujun Jin, Harinarayana Ankamreddy, Sunita Singh, Hongyuan Zhang, Xiaogang Wang, Peiwei Chen, Emmanuelle Ranza, Sohail Aziz Paracha, Syed Fahim Shah, Valentina Guida, Francesca Piceci-Sparascio, Daniela Melis, Bruno Dallapiccola, Maria Cristina Digilio, Antonio Novelli, Monia Magliozzi, Maria Teresa Fadda, Haley Streff, Keren Machol, Richard A. Lewis, Vincent Zoete, Gabriella Maria Squeo, Paolo Prontera, Giorgia Mancano, Giulia Gori, Milena Mariani, Angelo Selicorni, Stavroula Psoni, Helen Fryssira, Sofia Douzgou, Sandrine Marlin, Saskia Biskup, Alessandro De Luca, Giuseppe Merla, Shouqin Zhao, Timothy C. Cox, Andrew K. Groves, James R. Lupski, Qingguo Zhang, Yong-Biao Zhang, and Stylianos E. Antonarakis. Foxi3 pathogenic variants cause one form of craniofacial microsomia. Nature Communications, Apr 2023. URL: https://doi.org/10.1038/s41467-023-37703-6, doi:10.1038/s41467-023-37703-6. This article has 41 citations and is from a highest quality peer-reviewed journal.
(NCT03270618 chunk 1): Xudong Wang. Accuracy of a CAD/CAM Surgical Template for Mandible Distraction. Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University. 2014. ClinicalTrials.gov Identifier: NCT03270618
(NCT01674439 chunk 1): Daniela Y. S. Tanikawa. Clinical Trial of Fat Grafts Supplemented With Adipose-derived Regenerative Cells. University of Sao Paulo. 2010. ClinicalTrials.gov Identifier: NCT01674439
(NCT03869021 chunk 2): Yasser Mohamed Nabil Ahmed Khirat El Hadidi. Computer Guided for Mandibular Distraction Osteogenesis. Yasser Mohamed Nabil Ahmed Khirat El Hadidi. 2015. ClinicalTrials.gov Identifier: NCT03869021
(NCT03806361 chunk 1): Daniela S Tanikawa. Fat Grafts With Adipose-derived Regenerative Cells for Soft Tissue Reconstruction in Children. Hospital Sirio-Libanes. 2019. ClinicalTrials.gov Identifier: NCT03806361
(NCT03861650 chunk 2): Yasser Mohamed Nabil Ahmed Khirat El Hadidi. Evaluation of Effect of Bone Marrow Aspirate Concentrate on Distracted Mandibular Bone Properties. Yasser Mohamed Nabil Ahmed Khirat El Hadidi. 2015. ClinicalTrials.gov Identifier: NCT03861650
(NCT00340964 chunk 1): Positive Exposure: A Photography and Video Intervention for Individuals With Craniofacial Differences. National Human Genome Research Institute (NHGRI). 2005. ClinicalTrials.gov Identifier: NCT00340964

Artifacts

Edison artifact artifact-00

Ask OpenScientist

OpenScientist Report

Classifications

Definitions

Inheritance

Subtypes

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Environmental Factors

Prevalence

Differential Diagnoses

Clinical Trials

Source YAML

References & Deep Research

References

Deep Research

Craniofacial Microsomia: Disease-Characteristics Research Report

Executive summary

1. Disease information

Definition and terminology

Identifiers

2. Etiology and risk factors

Causal model

Genetic factors

Environmental and maternal factors

Protective factors and gene–environment interaction

3. Phenotypes

Extracraniofacial phenotype frequencies

4. Genetic and molecular information

FOXI3

SF3B2 and other genes

Variant interpretation

5. Environmental information

6. Mechanism and pathophysiology

Proposed causal chain

7. Anatomical structures affected

8. Temporal development

9. Inheritance and population

10. Diagnostics

Clinical diagnosis

Baseline evaluation

Genetic testing

Differential diagnosis

11. Outcome and prognosis

12. Treatment and current implementation

Multidisciplinary strategy

Trials and applications

13. Prevention

14. Other species and natural disease

15. Model organisms

Recent developments, expert interpretation, and evidence gaps

Key references

Artifacts